You are on page 1of 78

23 .

Mercury Exposure Levels from Amalgam
Dental fillings; Documentation of
Mechanisms by which Mercury causes over
40 Chronic Health Conditions; Results of
Replacement of Amalgam fillings; and
Occupational Effects on Dental Staff
By Bernard Windham

Mercury Exposure Levels from Amalgam Dental Fillings; Documentation of Mechanisms by Which
Mercury Causes over 40 Chronic Health Conditions; Results of Replacement of Amalgam Fillings;
and Occupational Effects on Dental Staff
Bernard Windham, Editor- Chemical Engineer 12164 Whitehouse Road
850-878-9024
Tallahassee, FL,323 11
1. Introduction
Il. Toxicity and Health Effects of Mercury
III. Systemic Mercury Intake Levels from Amalgam Filling Exposure
IV. Immune System Effects and Autoimmune Disease
V. Medical Studies Finding Health Problems Related to Amalgam Fillings
VI. Documented Results of Removal of Amalgam Fillings
VII. Tests for Mercury Level and Toxicity and Treatments
VIII. Health Effects from Dental Staff Exposure to Mercury
IX. Scientific Panel and Government Bodies That Have Found Amalgam Fillings Unsafe
Toxic metals such as mercury, lead, cadmium, etc. have been documented to be neurotoxic,
I.
immunotoxic, reproductive/developmental toxins that according to U.S. Government agencies cause
adverse health effects and learning disabilities to millions in the U.S. each year, especially children
and the elderly( 105,160). Exposure of humans and animals to toxic metals such as mercury, cadmium,
lead, copper, aluminum, arsenic, chromium, manganese, etc. is widespread and in many areas
increasing. . The U.S. Center for Disease Control(276) ranks toxic metals as the number one
environmental health threat to children. According to an EPA/ATSDR assessment,the toxic metals
mercury, lead, arsenic, and cadmium are all ranked in the top 7 toxics having the most adverse health
effects on the public based on toxicity and current exposure levels in the U.S., with nickel and
chromium also highly listed. A National Academy of Sciences report of July 2000 and other
studies(39,125) found that even small levels of mercury in fish or levels of mercury in the blood of
women below 10 micrograms per liter(ug/l) appear to result in developmental effects, and represent
unacceptable risks of birth defects and developmental effects in infants.
10 ug/l is the upper
level of mercury exposure recommended by the German Commission on Human Biomonitoring
in the blood(39).
The main factors determining whether chronic conditions are induced by metals appear to be
exposure and genetic susceptability, which determines individuals immune sensitivity and ability to
detoxify metals(405). Very low levels of exposure have been found to seriously affect relatively large
groups of individuals who are immune sensitive to toxic metals, or have an inability to detoxify metals
due to such as deficient sulfoxidation or metallothionein function or other inhibited enzymatic
processes related to detoxification or excretion of metals. For those with chronic conditions, fatigue
regardless of the underlying disease is primarily associated with hypersensitivity to inorganic and
organic mercury, nickel, and gold(369,382).
While there are large numbers of neurological and immune conditions among adults, the
incidence of neurotoxic or immune reactive conditions in infants such as autism, schizophrenia,
ADD, dyslexia, learning disabilities, etc. have been increasing especially rapidly in recent years
(2,409,441). A recent report by the National Research Council found that 50% of all pregnancies
in the U.S. are now resulting in prenatal or postnatal mortality, significant birth defects,
developmental neurological or immune conditions, or otherwise chronically unhealthy babies(441).
Exposure to toxic chemicals or environmental factors appear to be a factor in as much as 28 percent
of the 4 million children born each year-(44l), with 1 in 6 having one of the neurological conditions

previously listed. EPA estimates that over 3 million of these are related to lead or mercury
toxicity(2,125,276,409). A study at the U.S. CDC found “statistically significant associations”
between certain neurologic developmental disorders such as attention deficit disorder(ADD) and
autism with exposure to mercury from thimerosal-containing vaccines before the age of 6
months(476).
While there is considerable commonality to the health effects commonly caused by these toxic
metals, and effects are cumulative and synergistic in many cases, this paper will concentrate on the
health effects of elemental mercury from amalgam fillings. Studies have found considerable genetic
variability in susceptibility to toxic metals as well. The public appears to be generally unaware that
considerable scientific evidence supports that mercury is the metal causing the most widespread
adversehealth effects to the public, and amalgam fillings have been well documented to be the number
one source of exposure of mercury to most people, with exposure levels often exceeding Government
health guidelines and levels documented to cause adverse health effects.
Toxicity and Health Effects of Mercury
II.
Dental amalgam contains about 50 % mercury, as well as other toxic metals such as
1.
tin,copper,nickel, palladium, etc. The average filling has 1 gram of mercury and leaks mercury vapor
continuously due to mercury’s low vapor pressure along with loss due to galvanic action of mercury
with dissimilar metals in the mouth (182,192,292,348,349,525), resulting in significant exposure for
most with amalgam fillings(see Section III). Mercury vapor is transmitted rapidly throughout the
body, easily crosses cell membranes, and like organic methyl mercury has significant toxic effects at
much lower levels of exposure than other inorganic mercury forms (38,281,287,304,329). The OSHA
level for mercury vapor in air is 50% lower than for organic mercury in air. According to the U.S.
EPA & ATSDR, mercury is among the top 3 toxic substances adversely affecting large numbers of
people(2 17), and amalgam is the number one source of exposure for most people(see III).
Mercury is the most toxic of the toxic metals. Mercury (vapor) is carried by the blood to cells
2.
in all organs of the body where it:
(a) is cytotoxic(kills cells) (2,2 1,27,36,56,147,14&l 50,160,2 10,259,295,333/333)
(b) penetrates and damages the blood brain barrier(3 1 I), resulting in accumulation of mercury and
other toxic substances in the brain( 14,20,21b,25,85,99,175,273,301,305,/149,262,274); also
accumulates in the motor function areas of the brain and CNS(48,175,29 1,327,329).
0 is neurotoxic(kills brain and nerve cells): damages brain cells and nerve cells (19,27,34,36, 43,
69,70, 147,148,175,207,211,273,291,295,327,329,301,303,305,395/39,262,274,303); generates high
levels of reactive oxygen species(ROS) and oxidative stress, depletes glutathione and thiols causing
increased neurotoxicity from interactions of ROS, glutamate, and dopamine (13,56,98,102,126,
145,169,170, 184,2 13,2 19,250,257,259,286,290,291,302,324,326,329,424,442,496); kills or inhibits
production of brain tubulin cells (66,67,16 1,166,207,300); inhibits production of neurotransmitters
bY inhibiting: calcium-dependent neurotransmitter release(372,432), dihydroteridine reductase
(27,122,257,333), nitric oxide synthase(259), blocking neurotransmitter amino acids (4 12), and
effecting phenylalanine, serotonin, tyrosine and tryptophan transport to neurons
(34,122,126,257,285,288,333,372,374,4 12/255,333)
(d) is immunotoxic(damages and inhibits immune T-cells, B-cells, neutrophil function, etc.)
(17,27,31,38,44,45,46,60,127,128,129,130,152,155,165,181,226,252,270,285,316,343,355,425,46
7/272) and induces ANA
antibodies and autoimmune disease (38,43,45,59,60,118,18 1,
234,269,270,313,314,334,342,343,425,405)
(e) is nepthrotoxic(toxic to kidneys) (14,20,203,209~,223,254,260,268,334,438)
(f) is endocrine system-disrupting chemical(accumulates in pituitary gland and damages or inhibits

276e.39.509/241).20/4.40).228.).194.275.27.228b.60. 338.35. adrenal gland function(84.35. 149.162.105.264.267.161. viral.37.chronic fatigue syndrome(CFS). sarcolemma.264.459.85.38.347.273.105.329. and disrupts enzyme production processes at very low levels of exposure (9.10.375.. damages DNA(296.327.381).38.265.366.19.212.70. lupus.112.31.296. zinc and Vit B 12 (43.232. causes birth defects (23.8 8 8 8 1 8 8 8 8 8 8 8 4 I 8 8 8 8 8 pituitary glands hormonal functions at very low levels (9.33.350. 281.35.45.405.305~~8.131.342.99. causesimmune system damage resulting in allergies. 348.90.3.427).226. a suspected major factor in stomach ulcers and stomach cancer(256) and candida albicans.446/272) and neutrophil functional impairment(285.459.26.35). incompletely digested complexes in the blood(222.433.287.445.59.84.304. and increased risk of acute myocardial infarction (35.369/274).339.159.schleraderma(468).86. damage to sarcoplasmic reticula..367.338.338c.510.38. impairs astrocyte function. tachycardia.38.75.308.119.35) and accumulation of heliobacter pylori. inhibits cytochrome P450Areme synthesis(84. asthma.381. causes interruption of the cytochromeC oxidase systern/ATP energy function (43.etc.20.263. thyroid gland function (50. causes learning disabilities and impairment.154.186. reproductive and developmental toxin (2.10.181.410-412) (g) exposure to mercury vapor (or methyl mercury) causes rapid transmittal through the placenta to the fetus (20.~. and reduction in IQ (1.160. and porphyrins in urine (34.91.4.232.348.194.55.73.38.38.333.43Z).129.111.205.and increased antibiotic resistance( 116.222.156.338~. as well as poor nutrient absorption.511/4.59. reduces bloods ability to transport oxygen to fetus and transport of essential nutrients including amino acids. causes infertility (4.39) causes cardiovascular damage and disease: including damage to vascular endothelial cells.132. resulting in 09 damage to stomach lining which along with mercury’s ability to bind to SH hydroxyl radical in cell membranes alters permeability(338.101.258.230.17.202. prenatal/early postnatal exposure affects level of nerve growth factor in the brain.1 IO. mercury causes significant destruction of stomach and intestine epithelial cells.509/39).327.97.281.13.50/201. thymus gland function(5 13).35/149).389.25. 35) .and multiple sensitivities(MCS) (8.285c.I~.241. high blood pressure.367.361.351.37.24.69.37.22-24. and contractile proteins.9.369.35.339.55.369.39.39.as well as altering molecular (h) (0 6) (w (1) .392.161. (0) forming strong bonds with and modification of the-SH groups of proteins causes mitochondrial release of calcium (1.234.41.5085 11.105.35.142.304.305. causes reduced iodine uptake & hypothyroidism (50.35).3 11.175.365.348.23.260) (m) inhibition of immune system facilitates increased damage by bacterial.35/4. imbalances in development of brain (38.21c) and adversely alters bacterial populations in the intestines causing leaky gut syndrome with toxic.226. glucose.61 .131.212.382.357).355.22.10.56.121.27. 388.128.35.296.35) and inhibits DNA & RNA synthesis (114.55.2 10.45.142.3 12. (4.).308).162). depresses enzyme isocitric dehydrogenase (ICD) in fetus.42.110.53). and fungal infections (17.313.52.38.212.232.125. 382.61.41.198.272.146.87. lowers sperm counts and reduces motility.306.175.117.361.2 12.168.37.50.2014.467/59.35) and blocks enzymes needed to convert porphyrins to adenosine tri phosphate(ATP) causing progressive porphyrinuria.339.25 1. causes menstrual disturbances (9.160.338.46.21.24.43. damages sperm.131.357. digestive problems. resulting in low energy.129.etc. increased white cell count.263.22.369.404. 95. magnesium.104. decreased oxyhemoglobin level.146).41.96.9.310. 255.175. 160.2 12.162).42) and significant developmental effects-much more damage to the fetus than for maternal exposure to inorganic mercury and at lower exposure levels than for organic mercury(287.

Another study of pregnant women who suffer from hypothyroidism (underactive thyroid) found a four-times greater risk for miscarriage during the second trimester than those who don’t.252.459. Mercury also damages the blood brain barrier and facilitates penetration of the brain by other toxic metals and substances(311). Such hormonal secretions are affected at levels of mercury exposure much lower than the acute toxicity effects normally tested.366. and women with untreated thyroid deficiency were four-times more likely to have a child with a developmental disabilities and lower I. Hypothyroidism is a well documented cause of mental retardation.20.338).Mercury has been well documented to be an endocrine system disrupting chemical in animals and people.274. 3. Mercury damage thus commonly results in poor bodily temperature control. as previously confirmed by hormonal/reproductive problems in animal populations( 104.50.162.19. 8 to 10 % of untreated women were found to have thyroid imbalances so the actual level of hypothyroidism is higher commonly recognized(508). damage of thyroid RNA(458). Low first trimester levels of free T4 and positive levels of anti-TP antibodies in the mother during pregnancy have been found to result significantly reduces lQS(509). (50). maternal hypothyroidism appears to play a role in at least 15% of children whose IQS are more than I standard deviation below the mean. Based on study findings. and reduced glutathione availability (necessary for detoxification)( 13. Studies have also established a “clear association” between the presence of thyroid antibodies and spontaneous abortions(511).254).34.35.85.38. autoimmune thyroiditis and impairment of conversion of thyroid T4 hormone to the active T3 form(369. Levels of recurrent abortions in a population with positive levels of thyroid antibodies in one study were 40%. 327.111.360. damaged sulfur oxidation processes(33. thyroid gland. in addition to many problems caused by hormonal imbalances such as depression.91). hypothalamus. inhibited glucose transfer and uptake(338. Studies have documented that mercury causeshypothyroidism(50. The pituitary gland controls many of the body’s endocrine system functions and secretes hormones that control most bodily processes.273. 369) Thus mercury has a greater effect on the functions of these areas. including the immune system and reproductive systems.382. and occipital cortex in direct proportion to the number and extent of dental amalgam surfaces (1. One study found mercury levels in the pituitary gland ranged from 6.50).348.14.194. Even larger percentages of women had elevated levels of antithyroglobulin(anti-TG) or antithyroid peroxidase antibody(anti-TP).41O-412) resulting in improper cysteine regulation( 194).25. Studies indicate that slight imbalances of thyroid hormones in expectant mothers can cause permanent neuropsychiatric damage in the developing fetus(509.35).126. 5 times the normal rate(511).405. Women with the highest levels of thyroid-stimulating-hormone(TSH) and lowest free levels of thyroxine I7 weeks into their pregnancies were significantly more likely to have children who tested at least one standard deviation below normal on an IQ test taken at age 8.3 to 77 ppb(85).38 1).54). while . millions of children. Mercury blocks thyroid hormone production by occupying iodine binding sites and inhibiting hormone action even when the measured thyroid level appears to be in proper range(35).338.Q.99.(p) function of amino acids and damaging enzymatic process(33.211. Mercury (especially mercury vapor) rapidly crosses the blood brain barrier and is stored preferentially in the pituitary gland. thyroid gland. and many hormonal functions at very low levels of exposure .96. enzyme production processes.16. According to survey tests. Hypothyroidism is also known to be a major factor in cardiovascular disease(510).50. disrupting function of the pituitary gland.194.287. HgC12 inhibits aquaporin-mediated water transport in red blood cells(479). Hypothyroidism is a well documented risk factor in spontaneous abortions and infertility(9). The thyroid and hypothalamus regulate body temperature and many metabolic processes including enzymatic processes that when inhibited result in higher dental decay(35) .61.

Supplementary oxytocin extract has been found to alleviate many of these mood problems(35). Mercury at very low concentrations has been seen to impair some lymphocytic functions causing subclinical manifestations in exposed workers.432). Amalgam fillings.296.392/l 49).145.272.114. Inhibition of thymus function can thus affect proper development of the immune and lymphatic systems. alteration of protein structure (33.43. and immune system damage (34. I I I . Pyruvate and glycolysis problems are often seen in mercury toxic children being treated for autism(409).38. and increases fertility(35. inhibition of glutathione peroxidase enzyme( 13.194. endometriosis.I 14. MS. Part of the toxic effects of mercury. stimulate DNA synthesis of both immature and mature thymocytes at low levels of exposure.453. Oxidative stress and reactive oxygen species(ROS) have been implicated as major factors in neurological disorders including stroke. There was a particular association between the T-cell defects and inhibition of thymic pyruvate kinase.194.254.496). nickel and gold crowns are major factors in reducing pituitary function(35.4 1.etc.355). Mercury inhibits sulfur ligands in MT and in the case of intestinal cell membranes inactivates MT that normally bind cuprous ions(477).169.). MND.464).175. lead. depression.98.252/l 14).197.54.198.272. so chronic exposure can have long term effects(5 13b). thus .489. endothelial cell damage(202). inhibition of DNA and RNA synthesis(4.254. etc. Lymphocyte differentiation.).496).111. Metalloprotein(MT) are involved in metals transport and detoxiflcation(442. etc.142. ALS.226.9).CFS.96. This appears to be a factor in deregulation of basic cellular events and in autoimmunity caused by mercury. and appear to be a major factor in suicide of teenagers and other vulnerable groups.494-496). micromolar levels of mercuric ions specifically blocked synthesis of ribosomal RNA. induction of free radical formation( 13.305. The thymus gland plays a significant part in the establishment of the immune system and lymphatic system from the 12* week of gestation until puberty. Mercury induced lipid peroxidation has been found to be a major factor in mercury’s neurotoxicity.462.207b.252.50.1 I I I 1 I 1 I I I I I I I I I I I 1 another(348) found the mean level to be 30ppb.496). alteration of the transport of calcium(333. along with leading to decreased levels of glutathione peroxidation and superoxide dismustase(SOD)( 13. the rate-limiting enzyme for glycolysis(5 13~).). disabling the necessary enzymatic processes.84.338.263.369.42.424. The normalization of pituitary function also often normalizes menstrual cycle problems.cadmium. This may explain why dentists have much higher levels of emotional problems. causing fibrillarin relocation from the nucleolus to the ncleoplasm in epitheial cells as a consequence of the blockade of ribosomal RNA synthesis.126).347. Alzheimer’s.FM. PD. (13. Mercury’s biochemical damage at the cellular level include DNA damage.339.254. The immunological defects were consistent with altered T-cell function as evidenced by decreases in both T-cell mitogen and mixed leukocyte responses. inhibition glucose transport(338.levels found to be neurotoxic and cytotoxic in animal studies. 4. are through their replacing essential minerals such as zinc at their sites in enzymes. Animal studies have shown mercury significantly inhibits thymulin production at very low micromolar levels of The metal allergens mercuric chloride and nickel sulfate were found to exposure(5 13a). maturation and peripheral functions are affected by the thymic protein hormone thymulin.56. along with replacement of metals in the mouth(Section VI.264. abnormal migration of neurons in the cerebral cortex( 149). and of function and other of enzyme essential nutrients(96. suicide.325.38.4 1O-4 12).etc(Section VIIl. Low levels of pituitary function are associated with depression and suicidal thoughts. Some of the effect on depression is related to mercury’s effect of reducing the level of posterior pituitary hormone(oxytocin). depletion of cellular glutathione(necessary for detoxification processes) (111. The pituitary glands of a group of dentists had 800 times more mercury than controls(99).254). There were specific immunotoxic and biochemical alterations in lymphoid organs of mice treated at the lower doses of mercury.3 16.329.442-444. Also.

enzymatic processes involving vitamins B6 and B 12(41 S).498).3 13).275).442. effects on the cytochrome-C energy processes (43.226.305.412) as well as of xanthine oxidase(439). Additional cellular level enzymatic effects of mercury’s binding with proteins include blockage of sulfur oxidation processes(33. eczema and psoriasis (323. and that supplenting both thyrotropinreleasing hormone and growth control hormone is more effective at increasing all of these hormone levels in the patient(499). It has also been found that in chronically ill patients the levels of pituitary and thyroid hormones that control many bodily processes are low.147.194.232. 22% tested positive for inorganic mercury and 8% for methyl mercury . 33.149). but males have been found more responsive to this factor than women(497).160).132.33). Elimination of milk products from the diet has been found to improve the condition. Another neurological effect of mercury that occurs at very low levels is inhibition of nerve growth factors.464).330.446.495).3 13.255. Such populations have also been found to have high levels of mercury and to recover after mercury detox(413.234. This is a level that is common in the population with several amalgam fillings or other exposures(500). Exposure to mercury results in changes in metalloprotein compounds that have genetic effects. along with mercury’s adverse effects on cellular mineral levels . As mercury levels are reduced the protein binding is reduced and improvement in the enzymatic process occurs.419.468. and adrenal stress response systems.296. Mercury vapor is lipid soluable Only a few micrograms of mercury and has an affinity for red blood cells and CNS ceIIs(2 1a). IGF-I controls the survival of spinal motor neruons affected in ALS during development as well as later in Iife(497.95. 445.412).330.331.464. (11) A direct mechanism involving mercury’s inhibition of cellular enzymatic processes by binding with the hydroxyl radical(SH) in amino acids appears to be a major part of the connection to allergic/immune reactive conditions such as autism(408-414.442.476.156.152. and allergies (26.385.369.455.439. Prenatal or neonatal exposures have been found to have life long effects on nerve function and susceptability to toxic effects.allowing buildup of copper to toxic levels in many and malfunction of the ZnKu SOD function.342.46. having both structural and catalytic effects on gene expression( 114.60. lupus 3.338~. enzymatic processes.375.114.477. metal-specific homeostasis. Insulin-like-growth factor I (IGF-I) are positively correlated with growth hormone levels and have been found to be the best easily measured marker for levels of growth hormone.60.313.468). ScIeroderma(468).468).241.33 1. for which deficiencies result in nerve degeneration.498). Significant physiological changes occur when metal ion concentrations exceed threshold levels.35). metabolism.84. IGF-I and insulin levels have been found to be reduced in ALS pateients with evidence this is a factor in ALS(497. For example mercury has been found to strongly inhibit the activity of dipeptyl peptidase (DPP IV) which is required in the digestion of the milk protein casein(411. schizophrenia(409.271. Several clinical trials have found IGF-I treatment is effective at reducing the damage and slowing the progression of ALS and Alzheimer’s with no medically important adverse effects(498).410). Of a population of over 3000 tested by the immune lymphocyte reactivity test(MELISA.60. Studies involving a large sample of autistic and schizophrenic patients found that over 90 % of those tested had high levels of the milk protein betacasomorphin-7 in their blood and urine and defective enzymatic processes for digesting milk protein(410).60.464. Prenatal mercury vapor expsoure that results in levels of only 4 parts per billion in newborn rat brains was found to cause decreases in nerve growth factor and other effects(305). Such MT formation also appears to have a relation to autoimmune reactions in significant numbers of people (114. Some of the processes affected by such MT control of genes include cellular respiration. severely disturb cellular function and inhibits nerve growth (175.

27. minks.160). Over half the rivers and lakes in Florida have such health warnings banning or limiting eating of fish.9 19. Other studies have found similar results(5 12). seals. mercury has other documented hormonal effects including effects on the reproductive system resulting in lowered sperm counts.433.288.3 13.381. as part of the total of over 50. In addition to having estrogenic effects. aberrant chromosome numbers rather than the normal 46.of calcium.290.4 32.37.465.503b.96. since mouth bacteria and other organisms in the body methylate inorganic mercury to organic mercury(5 1.272). damaged DNA. 386.273). the majority of the rest cannot reproduce. Some wading birds and Florida panthers that eat birds and animals that eat fish containing very low levels of mercury(about 1 part per million) have died from chronic mercury poisoning (104.333.175. This may explain why dentists have much higher levels of emotional problems. Bacteria also oxidize mercury vapor to the water soluble.254.119.104.146. allergies.3 13.3 14. only l/2 gram is required to contaminate a IO acre lake to the extent that a health warning would be issued by the government to not eat the fish( 15 I.85.45 1.225. suicide. The average male Florida panther has higher estrogen levels than females.2).25.. Wisconsin has fish consumption warnings for over 250 lakes and rivers and Minnesota even more. polar bears. And along with these blockages of cellular enzymatic processes.506. and acety1cho1inesterase(35.23.367. asthma. chromosome breaks. .14 1. Similar is true of some other animals at the top of the food chain like alligators.432.365. and sensitivity to other lesser allergens.484). and most other states and 4 Canadian provinces have similar health wamings(2). ionic form Hg(I1) (431).10. and lowered testosterone levels in males and menstrual disturbances and infertility in women(4.38).427. zinc. magnesium. river miles. Low levels of pituitary function are associated with depression and suicidal thoughts. serotonin. ovaries. But the effect on the immune system of exposure to various toxic substances such as toxic metals and environmental pollutants has also been found to have additive or synergistic effects and to be a factor in increasing eczema. defective sperm cells. mercury has been found to cause additional neurological and immune system effects in many through immune/autoimmune reactions (60.etc(Section .8 1. and lithium (43. 6. and organochlorine compounds (4 13.372.38. which are affected by mercury and other hormone disrupting chemicals.3 1.S.140.38). All Great Lakes as well as many coastal bays and estuaries and large numbers of salt water fish carry similar health warnings.35.105. I 60. the brain is also organic (220. A clinical study found that methyl mercury in saliva is significantly higher in those with amalgam fillings than those without.107.159. The pituitary glands of a group of dentists had 800 times more mercury than controls(99). etc. testes.296. Since mercury is an estrogenic chemical and reproductive toxin.198. Most doctors treating such conditions also usually recommend supplementing the deficient essential minerals previously noted that mercury affects. often obtaining a hair element test to determine imbalances and needs(386..21).Because of the extreme toxicity of mercury. S.4 15).9.412).275.000 such lakes with warnings(2) and 7% of all U. Most of the children tested for toxic exposures have found high or reactive levels of Much mercury in saliva and other toxic metals.125. depression. Mercury accumulates in the pituitary glands. beluga and orca whales.20.512). Some of the effect on depression is related to mercury’s effect of reducing the level of posterior pituitary hormone(oxytocin). and prostrate gland(35.99. due to the estrogenic properties of mercury( 105.1 60). and increased neurological problems related to lowered levels of neurotransmitters dopamine. noreprenephrine.305. and appear to be a major factor in suicide of teenagers and other vulnerable groups. and correlated with the number of amalgam fillings(506).395.

having low pressure and being subject to galvanic action with other metals in an oral environment(lS2. cadmium.525). A study in Sweden found significant occupational and environmental exposures at crematoria.35. 11a. A Japanese study estimated mercury emissions from a small crematorium there as 26 grams per day(421).). The amount of mercury released by a gold alloy bridge over amalgam over a 10 year period was measured to be approx.2la. cremation released over 65 kilograms of mercury per year as emissions. This is in addition to air emissions.9). and behavioral effects have been found from mercury vapor at much lower levels than for exposure to methyl mercury(287. often exceeding site air mercury standards(420). learning ability. and also in mental patients and criminals behavior(3.192.304. Large numbers of animal studieshave documented that genetically susceptible strains are more affected by xenobiotic exposures than less susceptible strains (234.526.383. mercury standards).105.369.7e.329).). The normalization of pituitary function also often normalizes menstrual cycle problems. while another Swiss study found mercury levels during cremation of a person with amalgam fillings as high as 200 micrograms per cubic meter(considerably higher than U. so that within 10 years up to half has been found to have been transferred to the body of the host( l&34. Additionally cremation of those with amalgam fillings adds to air emissions and deposition onto land and lakes. Similarly for inhibition of some essential cellular processes(333. endometriosis. Suplementary oxytocin extract has been found to alleviate many of these mood problems(35).22-24.85. Some genetic types are susceptible to mercury induced autoimmunity and some are resistant and thus much less affected(234.304).etc.376e.23 1. Studies have found that levels of exposure to the toxic metals mercury. 8. 10.425. The amount of mercury in the mouth of a person with fillings was on average 2.).1 82.348.etc. & section III).311) and placenta of pregnant women (20.Amalgam fillings. along with replacement of metals in the mouth(Section VI.230b. enough to contaminate 5 ten acre lakes to the extent there would be dangerous levels in fish(151). 101 milligrams(mg)(60% of total) or 30 micrograms per day(18). and the average adult had at least 5 grams of mercury in fillings(unless most has vaporized).338.336. One study found dental offices discharge into waste water between 65 and 842 milligrams per dentist per day(231).27.349.etc.2ld).S.28 1.287.336. Mercury in solid form is not stable.38. A study in Switzerland found that in that small country.183. 3 11. Studies found that mercury causes or accelerates various systemic conditions in a strain dependent . and increases fertility(35. and since the requirement to install selenium filters mercury emission levels in crematoria have been reduced 85%(422). Running shoes with ‘/2 gram of mercury in the heels were banned by several states. An average amalgam filling contains over % gram of mercury.). according to the World Health Organization and other studies (38. Mercury vapor rapidly crosses the blood-brain barrier( 14. function(35. Elemental mercury vapor is more rapidly transmitted throughout the body than most other forms of mercury and has more much toxic effects on the CNS and other parts of the body than inorganic mercury due to its much greater capacity to cross cell membranes.292.308.361) Developmental.5 grams. 162. and lead have major effects on classroom behavior.50. because the amount of mercury was considered dangerous to public health and created a serious disposal problem. Studies have found that both genetic susceptibility and environmental exposures are a factor in xenobiotic related effects and disease propagation(2 1d. nickel and gold crowns are major factors in reducing pituitary VIII. 7. Mercury from dental offices and human waste from people with amalgam fillings has much higher levels and is a major source of mercury in Florida waters. 9. learning.186. section III).160).360.425.287.82. amounting to several hundred grams per year per office.).

multiple chemical sensitivity and chronic fatigue syndromes are identical to those of chronic mercurialism and remit after removal of amalgam combined with appropriate supplementation and gave evidence to implicate amalgam as the only underlying etiologic factor that is common to all(404). personality.285. whereas those with type APOE.18l. Other studies(285b.128. Other studies have also found a connection between mercury with peripheral neuropathy and pareshesia(I 90. lability. Another genetic difference found in animals and humans is cellular retention differences for metals related to the ability to excrete mercury(426).395c).449. Occupational exposure studies have found mercury impairs the body’s ability to kill Candida albicans by impairment of the Iytic activity of neutrophils and myeloperoxidase in workers whose mercury excretion levels are withing current safety Iimits(285.7 ug/ g creatinine had long lasting increases in humoral immunological stimulation of IgG. For example it has been found that individuals with genetic blood factor type APOE. resulting in susceptibility to chronic autoimmune conditions such as Alzheimer’s. polyneuropathy. Vit B6. increased tremor. Also when a condition has been initiated and exposure levels decline.405).60. decreased coordination.395) found that workers exposed at high levels at least 20 years previous(urine peak levels above 600 ug/L demonstrated significantly decreased strength.manner. fatigue.with effects on memory at very low exposure . Significant correlations between increasing urine mercury concentrations and prolonged motor and sensory distal Iatencies were established(285g).are intermediate to the other 2 types(437.467).readily excrete mercury and are less susceptible. A population of plant workers with average mercury excretion of 20 ug/ g creatinine was found to have long lasting impairment of neutrophil function(285. One genetic factor in Hg induced autoimmunity is major histocompatibility complex(MHC) linked.285. paresthesia. Another group of workers with average excretion rates of 24. with the potential of inducing type II diabetes .). the cells responsible for insulin production can be cytokines( 152. Such levels of mercury exposure were also found to inhibit cellular respiratory burst. with significant reductions in insulin need after replacement of amalgam filings and normalizing of blood sugar(35). and IgM levels. inositol.457.do not excrete mercury readily and bioaccumulate mercury.404b). as early as age 40. and that lower levels of exposure adversely affect some strains but not others. and other neruological condtions(502) Another study found that many of the symptoms and signs of chronic candid&is.404). Elemental mercury can affect both motor and sensory peripheral nerve conduction and the degree of involvement is related to time-integrated urine mercury concentrations. etc. and folic acid supplementation to alleviate peripheral neuropathies.342.etc.234c. resulting in more inflammatory damage.35). Other studies(285c) found that mercury at levels below the current occupational safety limit causes adverse effects on mood.7 1bd. Higher levels have been found to cause more serious neurological problems (119. tin&us. Thirty percent of dentists with more than average exposure were found to have neuropathies and visuogrphic dysfimction(395). etc. autoimmune antibodies also decline in animals or humans(233. decreased sensation. etc. Long term occupational exposure to low levels of mercury can induce slight cognitive deficits. including inducing of autoimmunity. Parkinson’s. decreased stress tolerance. Both immune cell type Thl and Th2 cytokine responses are involved in autoimmunity(425c). pain. 11. Another study(59) found such impairment of neutrophils decreasesthe body’s ability to combat viruses such as those that cause heart damage. IgA.g.502. Mercury inhibits production of insulin and is a factor in diabetes and hypoglycemia. and memory. Several doctors have found thiamin(B3). Mercury has been found to affect both Thl and Th2 cytokines causing an increase in inflammatory TIQ In the pancreas.404.even in otherwise healthy individuals with no other risk factors for diabetes(501).I60. damaged or destroyed by the chronic high levels of cytokines. The incidence of autoimmune conditions have increased to the extent this is now one of the leading causes of death among women(450). Those with type APOE.

199.303.199).352. based on the average levels found per number of fillings and using daily saliva volumes of 890 ml for unstimulated saliva flow and 80 ml for stimulated flow (estimated from measurements made in the study and comparisons to other studies). The tolerable daily exnosure level for mercury developed in a report for Health Canada is . with the average after chewing being 3 times this level. The upper level of mercury exposure recommended by the German Commission on Human Biomonitoring is 10 micrograms per liter in the blood(39).192. The FDA limit for mercury in seafood is 1 ppm.35.77.38.298.S.000 persons with amalgam fillings was measured(199). 85. some of both types are present in the body.3 @kg body weight/day(217).335.241.37..371. (see further details continued) A large study was carried out at the Univ.26. but adverse effects such as increases in blood pressure and cognitive effects have been documented as low as I ug/L. The U. 14 ug for the ATSDR acute oral toxicicity standard. It also gives the 84th percentile mercury exposure from saliva for the 20. and even more so for those with more than 4 fillings. III.36.3 1.S. The WHO limit for women of childbearing age at which there is a significant risk of developmental disabilities in fetal exposure is 10 ppm in hair or 40 ug/L in mother’s blood( 183) 2.209. ATSDR health standard(MRL) for mercury vapor is 0. Note that 16% of all of those tested with 4 amalgam fillings had daily exposure from their amalgam fillings of over 17 ug per day. 1 % had unstimulated levels over 200 ug/L.18.2 ug/ M3 of air. 42 @day. air per day. this amounts to an exposure of 4 or 6 ug/day for the 2 elemental mercury standards.525. with a warning at ‘/2 ppm (125).182. Systemic Mercury Intake Level from Amalgam Fillings 1.361.371).182.50.211.83.000 tested by number of fillings. The daily total exposure of mercury from fillings is from 3 to 1000 micrograms per day.179. with the average exposure being above 10 micrograms per day and the average uptake over 5 @day (183.436.332. The level of mercury in unstimulated saliva was found to average 11. Table: Average daily mercury exposure in saliva by number of amalgam tillings( 199) .levels.338~/241). and 10 % had unstimulated mercury saliva levels of over 100 Q/L. Several were found to have mercury levels over 1100 q/L.142. The level of mercury in saliva has been found to be proportional to the number of amalgam fillings.199.83. The older World Health Organization( 183) mercury health guideline(PTW1) is 300 ug per week total exposure or approx. The EPA drinking water standard for mercury is 2ppb( 125). and the MRL For the average adult breathing 20 M3 of for methyl mercury is 0. More studies found that long term exposure causes increased micronuclei in lymphocytes and significantly increased IgE levels at exposures below current safety levels(128).19. Mercury in the presence of other metals in the oral environment undergoes galvanic action. or approx.183. Mercury in solid form is not stable due to low vapor pressure and evaporates continuously from in the mouth.6 ug Hg/L. Since mercury is methylized in the body. Of Tubingen Health Clinic in which the level of mercury in saliva of 20.3 micrograms per cubic meter of sir(2).79.etc. The U. causing movement out of amalgam and into the oral mucosa and saliva( 174.100. as well as maternal linked to retardation( 1 IO) and birth mental being exposure defects(23. with impacts higher in low birth weight babies(39).335. The EPA health guideline for methyl mercury is 0.299.014 micrograms/kilogram body weight(ug/kg) or approximately 1 ug/day for average adult(2 17).).1 ug/kg body weight per day or 7 ug for the average adult(2). The following table gives the average daily mercury exposure from saliva alone for those tested. and generally was higher for those with more fillings. being transferred over a period of time to the host(l5amalgam fillings 19. EPA Health Standard for elemental mercury exposure(vapor) is 0.

It found that the majority of excretion is through feces.5 I1 12. Chewing gum or drinking hot liquids can result in 10 to 100 times normal levels of mercury exposure from amalgams during that period( 15.7 ug/L (292c). etc. with average mercury level in unstimulated saliva of 29 ug/L( 1S). The Tubingen study did not assessthe significant exposure route of intraoral air and lungs.8 48. The average for those with 4 or less fillings was 8 ug/L( 18). The main exposure paths for mercury from amalgam fillings are absorption by the lungs from intraoral air. Another large German study(352) found significantly higher levels than the study summarized here.. 3.94. The authors of the Tubingen study calculated that based on the test results with estimates of mercury from food and oral air included. EPA and ATSDR health guideline for mercury(2.348. there is considerable variability for a given number of fillings. while a Norwegian study found the average level in oral air to be 0. bruxism.209. Daily excretion .5 35 41.6 61.209.6 50.4 64.79.5 43.4 16.etc.95).5 Saliva tests for mercury are commonly performed in Europe. 32.179. for subjects with number of filling surfaces ranging from 18 to 82.5 8 9.335.31.211.4 14 15. gums. whether person chews gum or drinks hot liquids.3 19. without consideration of exposure from food. with some with exposure levels over 1000 ug/day.317.9b. with age of filling being much less significant(3 l9b). vapor absorbed by saliva or swallowed. While it will be seen that there is a significant correlation between exposure levels and number of amalgam surfaces and exposure generally increases as number of fillings increases.8 24.182.3 46.216.3 84th percentile(ug) 17 23.).Number of fillings: 4 5 6 7 8 9 10 11 12 13 14 15 16 Av. Most of those whose intraoral air mercury levels were measured exceeded Gov’t health guidelines for workplace exposure(2). Some of the factors that will be seen to influence this variability include composition of the amalgam.436) The sublingual venal olfactory. olfactory.77. and neural path transfer of mercury absorbed by oral mucosa.17. and 175 ug/day(352).18. and many other studies have been carried out with generally comparable results(292. Different filling composition/manufacturer can also make a difference in exposure levels( as will be firther discussed).83.7 56. and some individuals have been found to have intraoral air mercury levels above 400 ug/ M3 (3 19). sublingual venal. (6.34.335. type of tooth paste used.133. A study at Stockholm Univ. Three studies that looked at a population with more than 12 fillings found generally higher levels than this study.3 22.174. oral environmental factors such as acidity. and neural pathways are direct pathways to the brain and CNS bypassing the liver’s detox iystem and appear to represent major pathways of exposure(34) based on the high levels of mercury vapor and methyl mercury found in saliva and oral cavity of those with amalgam. One study that looked at this estimated a daily average burden of 20 ug from ionized mercury from amalgam fillings absorbed through the lungs( I9 I). and membrane.8 21. Daily exposure from intraoral air ranged from 20 to 125 ug of mercury vapor.352).79.5 26 30.319.9 18. As can be seen most people with several fillings have daily exposure exceeding the Health Canada TDE and the U. amalgam particles swallowed. Daily Hg(ug) 6.364. etc.S. Other studies found similar resuIts(83. over 40 % of those tested in the study received daily mercury exposurehigher than the WHO standard(PTWI).8 ug/M3(176).199.3 15. for persons with from 18 to 82 filling surfaces. and many tested in past studies have exceeded the older and higher WHO guideline for mercury( 183). etc.35). Another study at a Swedish University(335) measured intraoral air mercury levels from fiIlings of from 20 to 125 ug per day.(335) made an effort to determine the respective parts in exposure made by these paths. The studies also determined that the number of fillings is the most important factor related to mercury level. and that the majority of mercury exposure was from elemental vapor.222.

compared to the reference average level for those without amalgam fillings of .55 ug5.etc.348).19. Elemental mercury swallowed in saliva can be absorbed in the digestive tract by the blood or bound in sulfhydryl compounds and excreted through the feces. As is known from autopsy studies for those with chronic exposure such as amalgam fillings mercury (1.likely originating as vapor. and oral mucosa( 174. The range of mercury excreted in urine per day by those with amalgams is usually less than 15 ug(6.02 mg/kg(528). but approx 60% of swallowed mercury vapor is absorbed(292. The average in those with amalgam was 4.273.348. and also cellular membranes into major organs such as the heart since the oxidation rate of HgO though relatively fast is slower than the time required by pumped blood to reach these organs(290. 20 % of swallowed mercury sulfhydryl compounds are absorbed in the digestive tract.20.3 11.liver.335. at much higher levels than inorganic mercury and also higher levels than organic mercury.85).335.252). but some patients are much higher(93). once in cells they form inorganic mercury that does not readily cross cell membranes or the blood brain barrier readily and is responsible for the majority of toxicity effects. Thus the level in the brain and heart is higher after exposure to Hg vapor than for other forms(360. Approx. Elemental mercury vapor is transmitted throughout the body via the blood and readily enters cells and crosses the blood-brain barrier.S. EPA maximum limit for mercury in drinking water(2 18). This level of mercury gives a daily excretion of over 30 micrograms per day.436) with the half life in the brain being over 20 years. In a population of women tested In the Middle East(254). At least 80% of particle mercury is excreted.327.S.16. kidneys(85.3 1.274.)e. Other labs found similar results(386).370).174.31.61.85)heart(59.348.17. .192. Their study and others reviewed found that at least 80% of mercury vapor reaching the lungs is absorbed and enters the blood from which it is taken to all other parts of the body(335. with fillings appearing to be responsible for over 75% of total mercury. mean= 7 ug/L.etc. with 93% being inorganic mercury. The feces mercury was essentially all inorganic with particles making up at most 25%.49. while another study(363) found on average 77% of the mercury in the occipital cortex was inorganic. The reference average level of mercury in feces(dry weight) for those tested at Doctors Data Lab with amalgam fillings is .386. military population(49) with an average of 19. The primary detoxification/excretion pathway for mercury absorbed by the body is as mercury-glutathione compounds through the liver/bile loop to feces( 111.205.370).361). the number of fillings was highly correlated with the mercury level in urine.36.329. and the majority being mercury sulfuhydryl compounds.83.287.34. 80% of swallowed methyl mercury is absorbed(335. 85.138. with most of the rest being converted to inorganic forms apparently.18.19.115. (I 4.79. The average level of those with over 49 surfaces was over 8 times that of controls. A review determined that approx.25. Significant levels are able to cross the blood brain barrier.) Most with several amalgams had daily fecal excretion levels over 50 @day. and the placenta of pregnant women(38. but some mercury is also excreted though the kidneys in urine and in sweat.273).5 times that of controls and more than the U. being more variable than other paths.26 mg/kg.14.80.15. 196. I ug/L. (13 times that of the population w/o amalgam). The same study found that the average blood level was 2. From the study results it was found that each 10 amalgam surfaces increased urine mercury by approx.349.9 amalgam surfaces and range of 0 to 60 surfaces found the average urine level was 3.363).199. While mercury vapor and methyl Hg readily cross cell membranes and the blood-brain barrier. Nutrient transport and renal function were also found to be adversely affected by higher levels of mercury in the urine.).348)).through feces amountedto from 30 to 190 ug of mercury.83. Other studies had similar findings(6. placenta. A large NIDH study of the U.77. also bioaccumulates in the brain/CNS (301. with 79 % being organic mercury.1 ug5. A study of mercury species found blood mercury was 89% organic and urine mercury was 87% inorganic(349b).18.94). The total mercury level had a significant correlation to the number of amalgam fillings.

47.61.382.5 grams(500.183.17.35. Mercury vapor from amalgam is the single largest source of svstemic mercury intake for persons with amalgam fillings.I I I Thus inorganic mercury in the brain has a very long half life(85.35. disease. which have been found to accumulate in the oral mucosa as granules along collagen bundles.94. After filling replacement levels of mercury in the blood.29.79. in addition to migration to other parts of the body(200.2 11. and acini of minor salivary glands. Studies have shown that mercury in the gums such as from root caps for root canaled teeth result in chronic inflammation. and fibroblasts.36. These levels are among the highest levels ever measured in tissues of living organisms. and are the result of flow of mercury into the mucous membrane because of galvanic currents with the mucous membrane serving as cathode and amalgam as cathode( 192). and dental materials researchers advise against having amalgam in the mouth with other metals such as gold(446.g.91).57. multinucleated giant cells. electrical higher and levels much mercury levels in tissues. Having dissimilar metals in the teeth(e.204).503b.35). elastic fibers. Peopole who tested hypothyroid usually have significantly higher levels of homocysteine and cholesterol.etc. Dept. Concentrationsof mercury in oral mucosa for a population of patients with 6 or more amalgam fillings taken during oral surgery were 20 times the level of controls(l74).77-83.25. and (182. with levels in roots tips as high as 4 1 ppm( 192).25. The average amalgam filling has approximately 0. Studies have shown mercury travels from amalgam into dentin. which are documented to be commonly caused by Thyroid mercury(369. Of Health/EPA drinking water limit for mercury which is 2 parts per billion(2 18). or animals that died from mercury poisoning. Mercury levels in saliva and feces usually decline between 80 to 95% (79. (14. imbalances.303).130.48). blood vessels. ranging from 50 to 90 % of total exposure.274. and feces typically temporarily are increased for a few days.OOOug) of mercury.47.167. There is in most cases chronic inflammatory response or macrophagic reaction the metals(47).S.459.50. urine. It is well documented that amalgam fillings are a major factor . have been found to play a major role in chronic heart conditions such as clogged arteries and chronic heart failure(5 IO).332.386) 5.30.27. but levels usually decline in blood and urine within 6 months to from 60 to 85% of the original levels(57. endothelial cells.35.129. 196. These levels are much higher than the FDA/EPA action level for prohibiting use of food with over 1 ppm mercury. 4. Likewise the level is tremendously over the U.35).273. Mercury and silver from fillings can be seen in the tissues as amalgam “tatoos”.390. As much as 50% of mercury in fillings has been found to have vaporized after 5 years and 80% by 20 years(182.). which are documented factors in heart also had high Ievels of 50% of those testing hypothyroid. dental school texts.348. averaging about 80% of total systemic intake. and the gums.216.335.19. Average mercury levels are often 1000 ppm near a gold cap on an amalgam filling due to higher currents when gold is in contact with amalgam (30.273. vapor currents. exceeding the highest levels found in chronically exposed chloralkali workers.-gold and mercury) causes galvanic action. membranes.196. These are also known factors in developing arteriosclerotic vascular disease.303.100) Average mercury levels in gum tissue near amalgam fillings are about 200 ppm.48.89. hyperhomocystemic or and 90% either were homocysteine(hyperhomocysteinenic) hypercholesterolemic(5 10). Amalgam manufacturers. usually in the form of a foreign body granuloma with multinucleated giant cells of the foreign body and Langhans types( 192). striated muscle fibers.525. German oral surgeons have found levels in the jaw bone under large amalgam fillings or gold crowns over amalgam as high as 5760 ppm with an average of 800 ppm(436).292. but many dentists ignore the warnings.16. Government health agencies such as Health Canada.349. nerve sheaths.82.19. root tips.196. Dark granules are also present intracellularly within macrophages. those who died in Minamata.138.). 191.192.292.161.

Recent studies have concluded that becausethe high mercury release levels of modem amalgams.211.19. 7.35.366) 09 (I) liver( 14. The level of mercury and copper released from high copper amalgam is as much as 50 times that of low copper amalgams( 19 1). . Numerous other studies also support this finding(Section IV). and copper which also have toxic effects.112.21 l)(usually not as strong as other measures) @I urine mercury level (38.82.49.77.57. oral gum tissue inflamation. comparable to the similar enzymatic disruptions caused by mercury and previously discussed(35.115. mercury poisoning from amalgam fillings is widespread throughout the population”(95.292.80.332.199. while alloys containing copper or iron were very corrosive in acid environments(297).348. 10 ug/day.138. 138. The periodontal ligament of extracted teeth is often not fully removed and results in incomplete jawbone regrowth resulting in a pocket where mouth bacteria in anaerobic conditions along with similar conditions in the dead tooth produce extreme toxins similar to botulism which like mercury are extremely toxic and disruptive to necessarybody enzymatic processes at the cellular level.335) saliva and oral mucosa( 18. the median daily exposure for those with fillings through saliva was approx. rhombencephalon. more neurotoxic than with organic tin compounds formed in the body being even mercury(5 1.83.179.329.176. Studies have consistently found modem high copper non gamma-two amalgams have a high negative current and much greater release of mercury vapor than conventional silver amalgams and are more cytotoxic (35.77. Clinics have found the increased toxicity and higher exposures to be factors in increased incidence of chronic degenerative diseases(35.20.3 17) (4 feces mercury (25.18.199. dorsal (i> root ganglia.273/274) (g) brain occipital cortex (14. and 1% had over 160 ug/day( 199).21 ab.79.23 1.297). While the non gamma-two amalgams were developed to be less corrosive and less prone to marginal fractures than conventional silver amalgams.100.298.254. In a large German study. A person with amalgam fillings has daily systemic intake from mercury vapor of between 3 and 70 micrograms of mercury.348. tin.9.117.133.23.291.89. they have been found to be instable in a different mechanism when subjected to wear/polishing/ chewing/ brushing: they form droplets of mercury on the surface of the amalgams( 182.2 11. Amalgam also releasessignificant amounts of silver.85.7d etc.366/274) renal(kidney) cortex( 14.85. 4% of those with fillings had daily exposurethrough saliva of over 80 ug/day. 3 17.16.25.273.).327.20.254.199.in gingivitis.93.99.30.167. The number of amalgam surfaces has a statistically significant correlation to : (a) blood plasma mercury level (17.292. 6.335). cerebellum.85.25.174.85.303.49.134.19.3 15.3 15.238).76.83.386) 69 (f) pituitary gland (19.16. Alloys containing tin such as amalgam were found to have the highest galvanic corrosion rates.34.182. and bone loss(29.183.77.22) related to maternal fillings.176. The methods and results of the Tubingen study( 199) were similar to those of other German studies(292.79.335.2 11.437).79.138.299).117.442.186.335) 0 oral air( 16.79.83.273. bleeding. This has also been found to be a factor in the much higher release of mercury vapor by the modem non gamma-two amalgams. with the average being at least 7 micrograms per day (18.222.335).) (k) fetal and infant liver/brain levels(61 .222. The component mix in amalgams has also been found to be an important factor in mercury vapor emissions. and anterior horn motor neurons (48.315.etc).19.366) motor function areas of the brain & CNS: brain stem.262).85.22.

(34.292.36. Mercury level in saliva has been found to give much better indication of body levels than blood or urine levels(36).25.273.327).209.16.292. After chewing. and occipital cortex in direct proportion to the number and extent of amalgam surfaces (14. ATSDR and EPA health guideline levels (2.7 ppb(85).348.183).34.209).350).etc. 9. and using fluoride toothpaste significantly increase the intake(15. lymph.Total intake is proportional to the number and extent of amalgam surfaces.34.and a large German study( 199) found median exposure through saliva alone for those with fillings to be about 10 @day. The range in one study was 2. in(35)).85. Other studies have found similar amounts( 18.222.199. and also crosses the blood-brain barrier readily.138.317.3 15).211.93) 8. Once mercury vapor or methyl mercury are converted to inorganic mercury in cells or the brain.20.4 to 28.98. with many having several fillings with over 10 times that level.3 18). A Swedish study estimated the total amount mercury swallowed per day from intra-oral vapor was 10 micrograms per day( 177). and candida albicans in the mouth and intestines(5 1.18. but health effects have been observed in patients in the upper part of this range.17. drinking hot liquids.199.327. and S.etc. (20.S. Mercury also is transported along the axons of nerve fibers (5.sanguis were all found to methylate mercury(81). Teeth are living tissue and have massive communication with the rest of the body via blood.329).35. brushing or polishing.137.1 ug/kg body weight/day( 199). Methyl mercury is 10 times more potent in causing genetic damage than any other known chemical (Ramel.83.( 14.199.3 17.35. Mercury has a long half life in the body and over 20 years in the brain.349.182.) 13.348. Methyl mercury is more toxic to some body processes than inorganic mercury.31.3 18) The average blood level for one large population was 5 ug/l( 176).S. 303.319.mutans.38. The median daily exposure through saliva for those with 10 or more fillings was over 10 times that of those with no fXlings( 199. and the average level of exposure was 29 @day for those with at least 12 occlusal surfaces(18). Some mercury entering nasal passages is absorbed directly into the olfactory lobe and brain without coming from blood(34. I 1. The blood and urine mercury load of a person with amalgam fillings is often 5 times that of a similar person without.83.134-137. the mercury does not readily cross cell membranes or the blood-brain barrier. Vapor emissionsrange up to 200 ug/M3 (35) and are much higher after chewing( 15.315.319).506). Mercury vapor (and bacteria in teeth ) have paths to the rest of the body.183.82. Thus mercury has a very long half life in the brain.274.38. EPA health guideline level(199) of 0. Normal blood levels are less than 20 ppb.182. 12.225.80. Most people with fillings have daily exposure levels exceeding the U. Mercury from amalgam is methylated by bacteria. those with amalgams had levels over 50 times higher than those without.348. Mercury (especially mercury vapor) rapidly crosses the blood brain barrier and is stored preferentially in the pituitary gland( 14. and nerves. N-acetylcysteine . The level of organic mercury in saliva is significantly related to the number of amalgam fillings(506).25.) German studiesof mercury loss from vapor in unstimulated saliva found the saliva of those with amalgams had at least 5 times as much mercury as for controls( 138. and chronic low level intake results in a slow accumulation in body tissues. Oral bacteria streptococommus mitior. At least 30% of those having amalgam fillings tested in a large German study had ingested mercury levels exceeding the WHO PTWI mercury standard of 43 ug/day (199.79.8 1.183. and one study found on average that 77% of the mercury in the occipital cortex was inorganic(363). hypothalamus(348c).99.503b.182.93.85.35. and over 50% of those with 6 or more fillings had daily exposures more than the U. 10. adrenal gland. galvanic electric currents(35).100. thyroid gland(99).211. 292.366) Thus mercury has a greater effect on the functions of these areas.136. High levels of Vit B12 in the system also have been found to result in increased methyl mercury concentrations in the liver and brain(51).217.S. but other factors such as chewing gum.335.34.261.19.292.183.209.287.364).28.89.3 15.

The highest level is in the pituitary gland of the fetus which affects development of the endocrine system.126).61 .119c. asthma(8.34.9 ug/L. 14.212.503.38. The U.165. chronic skin problems. meconium.2 to 6. gastrointestinal problems(2lc). chronic skin problems. and much higher levels in saliva after chewing.528).162. liver. Amalgam results in chronic exposure .287).361) The level of mercury in umbilical cord blood.279).304.304. The level of total mercury in nursing infants was significantly correlated to total mercury level in maternal hair(22. cardiovascular problems. Milk increases the bioavailability of mercury( 112.148.75. plugged ears. and placenta was higher than that in mother’s blood (22.386.) Mercury from amalgam in the blood of pregnant women crosses the placenta and appears in amniotic fluid and fetal blood.59. and in a Norwegian group with average age 12 there was a significant correlation between urine mercury level and number of amalgam fillings( 167).2IO. Several authors suggest use of early mother’s milk as a screen for potential problems since it is correlated both to maternal and infant mercury levels. guidelines(38. 10 times that of amalgam-free mothers.28I .268-270. Immune System Effects and Autoimmune Disease 1.338). 287. hyperventilation. A group of German children with amalgam fillings had urine mercury level 4 times that of a control group without amalgams(76).264. chest pain.61.109. Mercury is transferred mainly by binding to amino acids like albumin(339).186.112. and pituitary gland soon after placement (20. Fertile women should not be exposed to vapor levels above government health 304).38. stuffy nose.2 mcg/M3 (2. IV. and also with the level in mother’s milk (19.61. From clinical experience some of the symptoms of mercury sensitivity/mercury poisoning include chronic fatigue.S. 186.3 1.348. 17.186). and developmental behavioral effects from vapor have been found at levels considerably below that required for similar effects by methyl mercury (20.186. (20. chills.304. There is a significant correlation between number of amalgam fillings of the mother and the level of the fetus and older infants(20. 3 13.22.304).366). immune and autoimmune diseases. The saliva and feces of children with amalgams have approximately 10 times the level of mercury as children without(25. and many thousands who have had amalgam fillings removed(most) have had health problems and symptoms alleviated or greatly improved(see Section VI). insomnia. headaches. irritability.291.36. and many types of neurological problems(21.23. 16.45.22.23. dizziness. ATSDR mercury health MRL of 0.22.304.282). ringing ears.504. new born.l82.70.35. 246.etc. One study found a 60% increase in average cord blood mercury level between 1980 and 1990 in Japan(186).).6 1.290. muscle weakness.9l. The milk sampled ranged from 0.217).61. spacy feeling.182.(NAC) has been found to be effective at increasing glutathione levels and chelating methyl mercury(54.or have amalgams placed or removed during pregnancy (20.36. diabetes(35). frequent urination. and young children is directly proportional to the number of amalgam surfaces in the mother’s mouth. Many thousands of people with symptoms of mercury toxicity have been found in tests to have high levels of mercury.508-5 IO).3 15. with milk from mothers with 7 or more fillings having levels in milk approx.199. metallic taste. Levels for exposure to mercury vapor has been found to be approx 10 times that for maternal exposure to an equivalent dose of inorganic mercury(28 1.391) and mercury is often stored in breast milk and the fetus at much higher levels than that in the mother’s tissues (19.60.287.97).112. The fetal mercury content after maternal inhalation of mercury vapor was found to be higher than in the mother( 4.23. The level of mercury in maternal hair was significantly correlated to level of mercury in nursing infants(279).71.20.294.20.49.69. dry crusts in nose.304).339.210.204.343. rhinitis. The level of mercury in breast milk was found to be significantly correlated with the number of amalgam fillings(61).255.26.20).23 1.23. Dental amalgams are the main source of mercury in breast milk( 112.23.etc. The level of mercury in the tissue of the fetus.112.

and autoimmunity( 181.442). eczema.405).226.165). impairing cellular respiration and cellular energy. damaging and decreasing the dimension of mitochondria. Workers occupationally exposed to mercury at levels within guidelines have been found to have impairment of lytic activity of neutrophils and reduced ability of neutrophils to kill invaders such as candida(285. Candida overgrowth results in production of the highly toxic canditoxin and ethanol which are known to cause fatigue. allergic diseases such as eczema and lupus (234. and hormones.rather than acute exposure and accumulation in body organs over time.404. All types of cells exhibited a dose dependent reduction in cellular glutathione when exposed to mercury. Development of Th2 type immune responses deactivate such defenses(404b). Both mercuric and methyl mercury chlorides caused dose dependent reduction in immune B-cell production. inhibiting generation of GSH by lymphocytes and monocytes(252). so most health effects are of the chronic rather than acute in nature.285).31. Another amalgam effect found is increase in the average blood white cell count significantly (35). in the range of 10 to 25 ug/L.405. coenzymes.3 14.45.226.226.84. but serious health problems have been documented to be related to amalgam and researchershave attributed some deaths as due to amalgam (356. Mercury induced autoimmunity in animals and humans has been found to be associated with mercury’s expression of major histocompatibility complex(MHC) class II genes(314.43). (3 16) B-cell expression of IgE receptors were significantly reduced(3 16.32. Mercury caused adverse effects on both neutrophil and macrophage function and after depletion of thiol reserves.323. Mercury also inhibited B-cell and T-cell RNA and DNA synthesis. Thus some of the main mechanisms of toxic effects of metals include cytotoxicity. with a rapid and sustained elevation in intracellular levels of calcium induced(3 16. causing destruction of cytoplasmic organelles with loss of cell membrane integrity. Both forms are immontoxic and cytotoxic ant very low levels seen in individuals.165. HgC12 also inhibits aquaporin-mediated water transport in red blood cells(479) as well as oxygen transport by hemoglobin(232). anemia. along with OH.38.296.313. NH2. From animal studies it has been determined that mercury damages T-cells by generating reactive oxygen species(ROS).338. MS. Low doses also induced autoimmuntiy in some species( 18 1.355342. Mercury inhibits macrophage and neutrophil defense against candida by its affects on Thl and Th2 cytokine effects( 18 1.425c). One study found that insertion of amalgam fillings or nickel dental materials causes a suppression of the number of T-lymphocytes(270).3 14. immunotoxicity.333). Low T4/T8 ratio has been found to be a factor in lupus. T-cells were susceptible to Hg induced cellular death (apoptosis).131.27.285. causing activation of glial cells to produce superoxide and nitric oxide. and generationof lipid peroxides or free radicals.272. impaired cellular respiration.which result in neurotoxicity. and impairs the T-4/T-8 ratio.129. gastrointestinal/metabolic effects.270.314.18l.60. toxicity. depleting the thiol reserves of cells. and inactivating or inhibiting enzyme or coenzyme systems or hormones involving the sulphydrol protein (SH)groups( 18 1. inhibition of enzymes. and low doses also induce aggregation of cell surface proteins and dramatic tyrosine phosporlation of cellular proteins related to asthma. .(226. changes in cellular membrane permeability.369).245). Mercury vapor exposure at very low levels adversely affects the immune system (17.424. hormonal effects. The inhibition of these tinctions by 50 % occurred rapidly at very low levels.118.129. and glomerulonephritis. and immune reactivity or autoimmunity. and Cl groups in proteins. Immune Thl cells inhibit candida by cytokine related activation of macrophages and neutrophils. inflammatory bowel disease.35). 2.369.405. and depressive symptoms(460).404). binding with mitochondria. inhibiting ability to secrete interleukin IL-1 and IL-2R.355) Interferon syntheses was reduced in a concentration dependent manner with either mercury or methyl mercury as well as other immune functions(l31).

355. Copper is an essential trace metal which plays a fundamental role in the biochemistry of the nervous system(489. Mutations in the copper/zinc enzyme superoxide dismustase(SOD) have been shown to be a major factor in the motor neuron degeneration in conditions like familial ALS and similar effects on Cu/Zn SOD to be a factor in other conditions such as autism.496.463). camosine.25 1. Both mercuric and methyl mercury were equally highly toxic at the cellular level and in causing cell volume reductions( 13 1). Amalgam fillings have also been found to be positively associated with mouth cancer(206. The low Zn levels result in deficient CuZnSuperoxide dismustase (CuZnSOD).52 I). Vit E. Some of the antioxidants were also found to have protective effects through increasing catalase and SOD action. Exposure to mercury vapor causes decreased zinc and methionine availability. whose deficiencies are known to cause significant neurological effects(461.283). lipoic acid. Body mercury burden was found to play a role in resistant infections such as Chlamydia trachomatis and herpes family viral infections.40.239.43.180).495.403). which in turn leads to increased levels of superoxide due to toxic metal exposure. 38% to Au and 40% to Pd They removed LST positive dental metals from the oral cavities of patients. White cell levels decline after total dental revision(TDR) and some have . gingko biloba.144. Mercury by its effect of weakening the immune system contributes to increased chronic diseases and cancer(91.). and non-familial ALS(489. However methyl mercury inhibits macrophage functions such as migration and phagocytosis at lower levels.143. Large numbers of people undergoing amalgam removal have clinically demonstrated significant improvements in the immune system parameters discussed here and recovery and significant improvement in immune system problems in most cases surveyed(Section VI). I 19) These effects can be reduced by zinc suppIementation(464. 5. Similar results have been found for treatment of cancer(35). This is in addition to mercury’s effect on metallothionein and copper homeostasis as previously discussed(477). it was found many cases can only be effectively treated by antibiotics after removal of body mercury burden(cilantro tablets were used with followup antibiotics)(25 1.237. Coenzyme QlO.464). Antigen specific LST-test was performed on a large number of patients with atopic eczema(323).180. Nacetylcysteine. Mercury from amalgam fillings has also been found to cause increase in white blood cells and in some cases to result in leukemia(35.38). depressesrates of methylation. Mercury from amalgam interferes with production of cytokines that activate macrophage and neutrophils. Similar results have been obtained at other cIinics(455). which have been found to affect glutamate mediated excitability and apoptosis of nerve cells and effects on mitochondria(495.38.495. as well as supplementation with antioxidants and nitric oxide-suppressing agents and peroxynitrite scavengers such as Vit C.180.494. etc. 4.234. Mercury also blocks the immune function of magnesium and zinc (198.489).464. Parkinson’s.(444.469. disabling early control of viruses and leading to enhanced infection(l31.495).etc.25 1. Ceruloplasmin in plasma can be similarly affected by copper metabolism disfunction.13 1).222. like SOD function.43. 87% showed LST positive reactions to Hg. 3.495.239. 87% to Ni. and increased free radicals-all factors in increased susceptibility to cancer(l4.1 I 1).496.237.25 1).35. This condition can result in zinc deficient SOD and oxidative damage involving nitric oxide. Animal studies have confirmed that mercury increases effects of the herpes simplex vet-is type 2 for example( 13 I).38.256. Several chronic neurological conditions involving copper metabolic disorders are well documented like Wilson’s Diseaseand Menkes Disease. Alzheimer’s. and is often a factor in neurodegeneration(489).34.using T-cells of peripheral blood. peroxynitrite.427.The increased white count usually normalizes after amalgam removal.464. Improvement of symptoms was obtained in 82% (160/l 96) of the patients within l-10 months. Several studies found adverse health effects at mercury vapor levels of 1 to 5 mcg/M3 (35). while reducing lipid peroxidations(494a). and lipid peroxidation(495.

and higher levels of excretion of choline. Similarly nickel crowns and gold crowns over amalgam have been found to be a factor in lupus(456. A high percentageof patients with oral mucosal problems along with other autoimmune problems such as CFS have significant immune reactions to mercury.232. 87. including to mercury preservatives such as thimerosal. toxic. and cause DNA malformations(35.82. cadmium(63%).119.456).468). and glycine in CFS. Toxic/allergic reactions to metals such as mercury often result in lichen planus lesions in oral mucosa or gums and play a roll in pathogenesis of periodontal disease.43. replacement of metal crowns over amalgam. A high correlation has been found between patients subjectively diagnosed with CNS & systemic symptoms suggestive of mercury intoxication and immune reactivity to inorganic mercury(MELISA test. This also results in inflammatory processes that cause muscle tissue damage and result in higher levels of urinary excretion of creatinine .3 13). including effects on vitro production of tumor necrosis factor TNF alfa and reductions in interleukin-1 .375. People with chronic and immune reactive problems are increasing finding dental materials are a factor in their problems and getting biocompatiblity tests run to test their immune reactivity to the various dental materials used.60.160) as well as with MRI positive patients for brain damage. antimony(36%). These effects along with reductions in red blood cells oxygen carrying capability often result in fatigue and reduced energy levels as well as neurological effects (35. extraction of root canaled teeth. Mercury also interrupts the cytochrome C oxidase system.90.140. mercury(93%). arsenic(86%). palladium(32%). 94% of such patients had significant immune reactions to inorganic mercury(MELISA test) and 72% had immune reactions to low concentrations of HgCl2(<0. lead(68%).5 ug/ml). 61% also had .212.V.235. 7. (13 I.1 I 8.84. Controls without CNS problems did not have such positive correlations.168. CFS and Fibromyalgia patients have also been found to commonly have abnormal enzymatic processes that affect among other things the sodium-potassium ATPase energy channels(473). nickel(98%). Among a group of patients testing positive as allergic to mercury.141.78. Mercury. Tests have found a significant portion of people to be in this category and thus more affected by exposure to amalgam than others(see section V).recovered from leukemia after removal of amalgam fillings in a very short time(35. blocking the ATP energy function (35. and treatment of cavitations where necessary(35).133. for which mercury is a known cause(43.130.288).1 52) Nickel and beryllium are 2 other metals commonly used in dentistry that are very carcinogenic. Nickel ceramic crowns and root canals have also been found to be a factor in some breast cancer and some have recovered after TDR. which includes amalgam replacement. the following percentages were immune reactive to the following metals that have very common exposures: aluminum(91%).182. ATCH indicative of hypothalamic deficiency such as relative glucocorticoid deficiency(472).212. tin(32%).342. and nickel(46.palladium.60.81. 6. chromium(83%).86. gold.338~).468).456. and trimethyl amine oxide in FM(474). palladium.nickel. taurine.313).101. choline.232.3 13. citrate.369.75.202. low level mercury exposure was found to causeadverse immune system response. silver(25%). beryllium(74%).229) and Belle’s Palsy from which some have recovered after TDR and Felderkrais exercises(35). nickel crowns. Removal of amalgam fillings usually results in cure of such lesions(60. and gold induce autoimmunity in genetically predisposed or highly exposed individuals(3 14. The majority of those with CFS having SPECT scans were found to have 5 times more areas of regional brain damage and reduced blood flow in the cerebral areas (47 1).342.118. zinc(33%).118.94. cobalt(78%).l SO).35.313. copper(32%). Of the many thousands who have had the Clifford immune reactivity test(445).90. The majority studied were also found to have increased Th2 inflammatory cytokine activity and a blunted DHEA response curve to I. A high percentage of such patients test immune reactive to many of the toxic metals.234.

gold.382. with most patients also reactive to one or more other metals such as palladium. Other studies have also found relatively high rates of allergic reactions to inorganic mercury and nickel(8 1. Such hypersensitivity has been found most common in those with genetic predisposition to heavy metal sensitivity(342. The improvement in symptoms and lymphocyte reactivity imply that most of the Hg-induced lymphocyte reactivity is allergenic in nature. Scleroderma. A significant portions of the population appear to fall in this category.I 68. lead. palladium. The rates of sensitization were even higher in some groups of CFS patients.382.118.35. Mercury has been found to impair conversion of thyroid T4 hormone to the active T3 form as well as causing autoimmune thyroiditis common to such patients(369. cadmium. Only 2% were worse.385.459. After amalgam removal the immune reactivity to all of these metals other than nickel declined significantly.369.1%. which has been commonly used in root canals and cosmetics(3 13.90. Of a group of 86 patients with CFS symptoms.86. palladium.000 patients tested for lymphocyte reactivity to metals(60. and methyl mercury.342. chemical sensitivities.456). sleep disturbances.453.168b. In general immune activation from toxics such as heavy metals resulting in cytokine release and abnormalities of the hypothalamus-pituitary-adrenal axis can cause changes in the brain.375).375). and autoimmune thyroidititis. 342. myalgia.369. Fibromyalgia.45g. Although patch tests for mercury allergy are often given for unresolved oral symptoms. cadmium. muscosketal pain. Hashimoto’s thyroiditis.35. also often recover or improve significantly after amalgam replacement (12.) Also using mercury in a patch test has resulted in some adverse health effects.I I 1 1 1 I D I I I I 1 I 1 I I 1 I I immune reaction to phenylHg.369. with over 20 % being highly reactive to each of these metals(375).375. The study concluded that immune reactivity to mercury and palladium is common and appears to be allergenic/immune related in nature since immune reactivity declines when exposure levels are reduced. 10% of controls had significant immune reactions to HgCl and 8. Conditions involving allergies.23%. and autoimmunity have been increasing rapidly in recent years(405).453.468). 8.468. gastrointestinal and neurological problems as are seen in CFS.etc.113. etc. fatigue. Of the over 3.3% to palladium.1 l%.369. and oral lichen planus.3 I 3. the patients reactivity to inorganic mercury.445.375. Such symptoms usually improve significantly after amalgam removal. silver. most of the patients tested positive to inorganic mercury and most of such patients health improved significantly and immune reactivity declined after amalgam removal. and severe psychological symptoms(379-382. In a group of patients tested by MELISA before and after amalgam removal at a clinic in Uppsala Sweden.2 12.383). 60) such as profound fatigue.323. epilepsy. Of 50 patients suffering from serious fatigue referred for MELISA test(369). eczema. lupus. inorganic mercury.34%. A group of patients that had amalgams removed because of chronic health problems.35.60. CFS.382. Patients with other systemic neurological or immune symptoms such as arthritis. CFS. this is not generally recommended as a high percentage of such problems are resolved irrespective of the outcome of a patch test(87. and 76% reported significant long term health improvements after 2 years.375).13%.12%.section VI). diabetes. ALS. Such studies have also found that .381. were able to detect subjectively when a patch test used mercury salts in a double blind study(373).50d). For groups with suspected autoimmune diseases such as neurological problems. MS.229. phenol mercury. Other studies of patients suffering from chronic fatigue found similar results(369. the following were the percentages testing positive: nickel.222.60). A high percentage were also reactive to nickel in both groups. such as found more frequently in patients with HLA-DRA antigens(375. gold and phenyl mercury all had highly significant differences from the control group. 78% reported significant health improvements after replacement of amalgam fillings within a relatively short period. and MELISA test found significant reduction in lymphocyte reactivity compared to pre removal tests(342.10 1.1 l%. over 70% had significant immune reaction to inorganic mercury and 50% to nickel.

383. 9. reaction to mercury.Chrons Disease.3 13.168.330.323.129. 13% tested positive for allergy to mercury.234.90. 270. but none in the controls. Tests have found a significant portion of people to be in this category and thus more affected by exposure to amalgam than others.426. Mercury.45. The authors concluded that immune reactions have an important role in development of brain lesions .113.35.234. 10.44.369.225.234. Low level mercury exposure(as well as other toxic metals) including exposure to amalgam fillings has been found to be associated with increased autoimmune diseases (19.33e.404). immune reactions and autoimmunity in animal studies (77.286).118)(270.I I 1 1 I I I I I I I I I B’ I I 1 I deficiencies in detoxification enzymes such as glutathione transfereases cause increased susceptibility to metals and other chemicals(384).342. In a population of dental students tested.35. For MS and lupus patients. which like mercury vapor crosses the blood-brain barrier.465. 44% were positive for allergy to mercury( 156). Such deficiencies can be due to genetic predisposition. Eating fish was not a significant factor between sensitive and non.342.234.269. and gold induce autoimmunity in genetically predisposed or highly exposed individuals(60. but are also known to be caused by acute or chronic toxic exposures. syndrome(CFS) through its effects on ATP and immune system(lymphocute reactivity.78. Medical Studies Finding Health Problems Related to Amalgam Fillings (other than immune) 1. including lupus( 12. lichen planus(86.1 18) as well as with MRI positive patients for brain damage. suicidal thoughts.60.87. Neurological problems are among the most common and serious and include memory loss. CFS patients usually improve and immune reactivity is reduced when amalgam fillings are replaced(342. A patch test was given to a large group of medical students to assess factors that lead to sensitization to mercury(l32).270.35). neutraphil activity. Mercury vapor or Inorganic mercury have been shown in animal studies to induce autoimmune reactions and disease through effects on immune system T cells(226.60.487). Silver also is released from amalgam fillings and stored in the body and has been shown to cause immune complex deposits.229).3 14.9. and also and weakens the damages immune (222. anger and sudden bursts of anger/rage(434. but the sensitized group had a significantly higher average number of amalgam fillings and higher hair mercury levels.) . etc.and amalgam fillings induce immune reactions in many patients (91 .270.33 l. depression.268. lack of strength/force to resolve doubts or resist obsessions or compulsions. a high percentage tested positive to nickel and/or inorganic mercury(MELISA). 293.405).34.233.3 13.480-483.60.226. A high correlation has been found between patients subjectively diagnosed with CNS & systemic symptoms suggestive of mercury intoxication and immune reactivity to inorganic mercury(MELISA test.38. Controls without CNS problems did not have such positive correlations. Chronic immune activation is common in CFS.314). effects on T-cells and B-cells) as well as its promotion of growth of candida albicans in the body and the methylation of inorganic mercury by candida and intestional bacteria to the extremely toxic methyl mercury form. 27.130. Many studies of patients with major neurological diseases have found evidence . 81% of the group with health complaints had pathological MRl results including signs of degeneration of the basal ganglia of the 60% of the symptom group tested positive for immune system brain.nickel.314.palladium.235.3 13). moodiness.sensitized students.3 14.234.425.229. with increase in activated CD8+ cytotoxic T-cells and decreased NK cells(5 18). selfeffacement. endometriosis (1. system 265.215. Mercury exposure through dental fillings appears to be a major factor in chronic fatigue 11. V.268.456).3 14).269.21~/272.

loss of sexual drive. nervousness. “Early manifestations are likely to be subtle and diagnosis difficult: Insomnia.503b) point out that chronic mercurialism is often not recognized by diagnosticians and misdiagnosed as dementia or neurosis or functional psychosis or just “nerves”.210.229.372. Other animal studies on rodents and monkeys have found brain cellular migration disturbances.294. Diagnois of mercury toxicity can be made based on exposure history and 3 or more of such symptoms mercury is known to cause(2 1.482). abnormal glucose tolerance(hypoglycemia). Low serotonin levels and/or hypoglycemia have also been found in the majority of those with impulsive and violent behavior(48 1.33. and Alzheimer’s(see # 25).320.465). Flu shots have mercury and aluminum which both are known to accumulate in the brain over time. (34. Thus chronic exposure to low level mercury vapor can inhibit polymerzation of brain tubulin and creatinine kinase which are essential to formation of microtubules. and low levels cause abnormal brain cell balance and neurological disturbances (280.254). which is a factor in neurological diseases such as depression and Alzheimer’s.305. One study(305) found prenatal mercury vapor exposure decreased NGF concentration in newborn rat’s forebrain at 4 parts per billion(ppb) tissue concentration.amalgam fillings may play a major role in development of conditions such as depression schizophrenia (94. behavioral changes. Epidemiological studies have found that human embryos are also highly susceptible to brain damage from prenatal exposure to mercury. Parkinson’s.212. depression. Another study(134) found general toxicity effects at 1 micromole levels in immature cell cultures.27.294.271. are often mistakenly ascribed to psychogenic causes”. Very high levels of mercury are found in brain memory areas such as the cerebral cortex and hippocampus of patients with diseases with memory related symptoms (l58.295). etc. increased immunoreactivity for glial fibrillary protein at 1 nanamole (0. The exposure levels in these studies are seen in the fetus and newborn babies of mother’s with amalgam fillings or who had work involving amalgam during pregnancy(61).317.453).27. which mercury has also been found to be a cause of. impaired judgment and coordination.222.} Mercury(as well as toxins from root canals and cavitations) interact with brain tubulin and disassemblesmicrotubules that maintain neurite structure(207b. Lithium protects brain cells against excess glutamate and calcium.295. and microglial response at even lower levels.285e. fatigue.264. mild tremor.465. along with reduced learning and adaption capacity after low levels of mercury vapor exposure (149. Studies have confirmed that there are vulnerable . and low folate levels(480-83). One mechanism by which mercury has been found to be a factor in aggressiveness and violence is its documented inhibition of the brain neurotransmitter acetylcholinesterase( 175.333.35.2 ppb) concentration.175.305).437).322.35. Animal studies of developmental effects of mercury on the brain have found significant effects at extremely low exposure levels. Some factors that have been documented in depression are low serotonin levels.109. and other more serious neurological diseases such as MS.107. ALS. Medical texts on neurology (21. decreased mental efficiency. The effects of mercury with other toxic metals have also been found to be synergistic.etc.233.222). A study of people who received flu shots regularly found that if an individual had five consecutive flu shots between 1970 and 1980 (the years studied) his/her chances of getting Alzheimer’s Disease is ten times higher than if they had one or no shots(475). emotional lability. Mercury causes decreased lithium levels. having much more effect than with individual exposure(35). headache.287.207.34. memory problems (212.45 1.212. excitability.56 ). Studies of mercury studies on animals give results similar to that found the Alzheimer brain. levels commonly seen in those with amalgam fillings or in dental staff working with amalgam.295.374.

erythism. Spatial and temporal changes in intracellular calcium concentrations are critical for controlling gene expression and neurotransmitter release in neurons(432.43.175. Some conditions found to be related to such toxic exposures include autism. These alterations are not mutually exclusive. Calcium plays a major role in the extreme neurotoxicity of mercury and methyl mercury.305. 2. Some of the resulting conditions include stomatitis.270. A Canadian study found that blood levels of five metals were able to predict with a 98% accuracy which children were learning disabled(3).305). Motor neuron dysfunction and loss in amyotrophic lateral sclerosis (ALS) have been attributed to several different mechanisms.288. Exposure to mercury and 4 other heavy metals tested for in a study of school children accounted for 23% of the variation in test scores for reading. Protein Kinase C (PKC) regulates intracellular and extra cellular signals across neuronal membranes.432. Prenatal/early postnatal exposure to mercury affects level of nerve growth eczema.84. but adverse effects such as increases in blood pressure and cognitive effects have been documented as low as 1 ug/L.K)ATPase in dose dependent manner and inhibits dopamine and noreprenephrine uptake by synaptosomes and nerve impulse transfer(288.56. and both forms of mercury inhibit PKC at micromolar levels.305.38. mitochondrial dysfunction. but neural development extends through adolescence. with impacts higher in low birth weight babies(39).232.285~. Metallic mercury is much more potent than methyl mercury in such actions.453). Mercury alters calcium homeostasis and calcium levels in the brain and affects gene expression and neurotransmitter release through its effects on calcium. Mercury vapor exposure causes impaired cell proliferation in the brain and organs. and increased calcium and altered calcium homeostatis apper to be a common denominator. ADD. Mercury inhibits sodium and potassium (N.210.181.329.338~).259. glutamate excitotoxicity.287.264.10). . schizophrenia. Mercury has an effect on the fetal nervous system at levels far below that considered toxic in adults. Both inhibit cellular calcium ATPase and calcium uptake by brain microsomes at very low levels of exposure (270. etc. 255.511). M ercury also interrupts the cytochrome oxidase system.149). The upper level of mercury exposure recommended by the German Commission on Human Biomonitoring is 10 micrograms per liter in the blood(39).50.The fetal period is most sensitive. lowering immune growth factor IGF-I levels and .279). ADD. resulting in reduced volume for cerebellum and organs and subtle deficiencies(38.I I I I I I I I I 1 I 1 I 1 I I I I I periods during brain and CNS development that are especially sensitive to neurotoxic exposures and affect development processes and results(429).4 12).333. Several studies found that mercury causes learning disabilities and impairment.508. etc. as well as inhibiting phorbal ester binding(43.110. factor(NGF) in the brain and causes brain damage and imbalances in development of the brain (38.175.24/ 39. tremor. oxidative stress and free radical damage.38.2 1. blocking the ATP energy function (35. with 50 % inhibitition in animal studies at 13 ppb(333. They also block or inhibit calcium Lchannel currents in the brain in an irreversible and concentration dependent manner. Exposure of developing neuroblastoma cells to sub-cytotoxic doses of mercuric oxide resulted in lower levels of neurofilament proteins than unexposed cells(305). and neurofilament aggregation and dysfunction of transport mechanisms(507). Mercury vapor or inorganic mercury exposure affects the posterior cingulate cortex and causes major neurological effects with sufficient exposure(428.35).).50.119. both chronically or as a transient condition(458. including increased intracellular calcium. dyslexia. and mercury is documented to commonly cause hypothyroidism. and reduction in lQ(3. and background levels of mercury in mothers correlate significantly with incidence of birth defects and still births (23.338~. Maternal hypothyroidism has been found to cause endocrine system abnormalities in the fetus. spelling and visual motor skills(3).329).432).509. etc.

increases in inflammatory cytokines such as caused by toxic metals trigger increased free radical activity and damage to astrocyte and astrocyte finrction( 152).5 15.343).416.impairing astrocyte fi.4 16. MS has also been found to commonly be related to inflamatory activity in the CNS such as that caused by the reactive oxygen species and cytokine generation caused by mercury and other toxic metals (405.516). and ALS(346. Metals like mercury bind to SH-groups(sulphydry1) in sulfur compounds like amino acids and proteins. which are affected in MS. Mercury lymphocyte reactivity and effects on glutamate in the CNS induce CFS type symptoms including profound tiredness.496) which are responsible for much of the Fibromyalgia symptoms and a factor in neural degeneration in MS and ALS. which results in nitration of tyrosine residues in neurofilaments and manganese Superoxide . and Fibromyalgia by protecting the astrocytes from this destructive process.333.515.496).5% of men(368). Studies have also found mercury and lead cause autoantibodies to neuronal proteins. hemoglobin. MS.496). another amino acid excitory neurotransmitter) cause increased sensitivity to pain . A group of metal exposed MS patients with amalgam fillings were found to have lower levels of red blood cells. This often results in the immune systems T-cells not recognizing them as appropriate nutrients and attacking them(226).369. a type of cell in the brain and CNS with the task of keeping clean the area around nerve cells. gastrointestinal (2 lc) and neurological problems along with other CFS symptoms and Fibromyalgia (342.both found in CFS/Fibromyalgia. and CD8-t supressor immune cells than a group of MS patients with amalgam replaced.152.496). which also causes inflow of calcium. have a function of neutralizing excess glutamate by transforming it to glutamic acid. Glutamate is the most abundant amino acid in the body and in the CNS acts as excitory neurotransmitter (346.226a. Mercury and increased glutamate activate free radical forming processes like xanthine oxidase which produce oxygen radicals and oxidative neurological damage(346. changing the structure of the compound that it is attached to. Mercury has been found to be a common cause of Fibromyalgia(293.478.346.496. This is also a factor in conditions such as CFS.333. hemocrit. and more excurbations of MS than those without(l02a).369. and myelin basic protein(MBP) (269ag. Mercury and cadmium also have been found to intefere with zinc binding to MBP(5 17b) which affects MS symptoms since zinc stabilizes the association of MBP with brain myelin(5 17a). Mercury and other toxic metals inhibit astrocyte function in the brain and CNS( 119.119). Metals by binding to SH radicals in proteins and other such groups can cause autoimmunity by modifying proteins which via T-cells activate B-cells that target the altered proteins inducing autoimmunity as well as causing aberrant MHC 11expression on altered target cells(425de.3 86.346. Parkinson’s.rnction(119. IGF-1 protects against brain and neuronal pathologies like ALS.4 12.497). causing increased glutamate and calcium related neurotoxicity(l19. Nitric oxide related toxicty causedby peroxynitrite formed by the reaction of NO with superoxide anions.375. Immune and autoimmune mechanisms are thus seen to be a major factor in neurotoxicity of metals. musculoskeletal pain.516). as well as higher body temperature. neurofilaments.405. T-cells. If astrocytes are not able to rapidly neutralize excess glutamate. causing swelling and neurotoxic effects( 119.416. Such binding and autoimmune damage has been documented in the fat-rich proteins of the myelin sheaths of the CNS(478) and collagen(405). sleep disturbances. Animal studies have confirmed that increased levels of glutamate(or aspartate. thyroxine.478. then a buildup of glutamate and calcium occurs. Astrocytes are common cells in the CNS involved in the feeding and detox of nerve cells.152.527) .13 l). Antioxidants like lipoic acid which counteract such free radical activity have been found to alleviate symptoms and decrease demyalination(494c). Astrocytes. which based on a Swedish survey occurs in about 12% of women over 35 and 5.142.13).

Some that have been found to be effective include CoQ10(444).333). ginseng.60. 182.160. 3.17. L-camitine. Mercury also accumulates in the heart and (35.199. Organic tin compounds formed from amalgam are even more Studies of groups of patients with amalgam fillings found neurotoxic than mercury (222. There is also evidence that fetal or infant exposure causes delayed neurotoxicity evidenced in serious effect at middle age(255. Vit B6. Extremely toxic anaerobic bacteria from root canals or cavitations formed at incompletely healed tooth extraction sites have also been found to be common factors in Fibromyalgia and other chronic neurological conditions such as Parkinson’s and ALS. and glutamate-induced neurotoxicity involved in ALS(524.000 people.2 12. levels commonly received by those with amalgam fillings(290). memory.494a). One of the studies at a German University( 199) assessed20.34.140. significantly more neurological.262).35. and at 100 ppb can destroy the membrane of red blood cells(35..222.107.43. and omega 3 fatty acids(fish and flaxseed oi1)(417.reducing blood supply to the tissues (34. chest pains.119.437).74. as well as reducing NK-cells in the blood and . and behavioral problems than the control groups. 108.3 10.494e).35 1.212. (3.257. Cavitations have been found in 85% of sites from wisdom tooth extractions tested and 55% of molar extraction sites tested(35.I I I I I I 1 I 1 I I I I I I I I 1 Dimustase(SOD) has been found to cause inhibition of the mitochondrial respiratory chain. sleep.232. Neurological effects have been documented at very low levels of exposure(urine Hg< 4 ug/L).453).338c) and impairing These effects often result in fatigue and reduced energy levels astrocyte mnction( 119).108.119.313). hemoglobin irregularities.222.290.370).140.2 12.453). NAC(54.(20 1. choline.201. behavior.202.141. One of the studies conclusions was that a likely major factor for the high ALS rates in Guam and similar areas in the past was chronic dietary deficiency since birth in Ca. nicotine.52 1). The incidence is likely somewhat less in the general population. etc.202.437).21.270c) and damage blood vessels. methyl cobalamine(B 12). Mercury’s effect on pituitary gland vasopressin is a factor in high blood pressure(35).290. Mercury binds to hemoglobin oxygen binding sites in the red blood cells thus reducing oxygen carrying capacity(332. and mood problems(3. memory.109. Mercury also interrupts the cytochrome oxidase system. damages myocardial and heart valves (Turpayev.22.lO7. tachycardia. Medical studies and doctors treating Fibromyalgia have found that supplements which cause a decreasein glutamate or protect against its effects have a positive effect on Fibromyalgia and other chronic neurologic conditions. 258.199.14 1.140.255.222.60.69.84.109.in (35)) & (59.235.306. ginkgo biloba and pycnogenol(494a).141.34. mood. Mercury also increases cytosolic free calcium levels in lymphocytes in a concentration-dependant manner causing influx from the extracellular medium(270c). vitamins C and E(444. 4. Mg and Zn induced excessive absorption of divalent metal cations which accelerates oxidant-mediated neuronal degenerations in a genetically susceptible population(466).232.205. Both mercury and methyl mercury have been shown to cause depletion of calcium from the heart muscle and to inhibit myosin ATPase activity by 50% at 30 ppb(59).17. blocking the ATP energy function(35. A recent study assessedthe large decrease in ALS incidence in Guam and similar areas to look for possible explanations in the cause of past high incidence and recent declines. with condensing osteitis which must be removed with a surgical burr along with 1 mm of bone around it(35.205. 282.71.306). inhibition of the glutamate transporter.495e).35) and adversely affects the vascular response to norepinephrine and potassium.212.70.306).306.202.16. Amalgam fillings have been found to be related to higher blood pressure.246.160.33. Numerous studies have found long term chronic low doses of mercury cause neurological. and blocks entry of calcium ions into the cytoplasm (1.35).

156. those testing positive had significantly higher average number of amalgam fillings than those not testing positive(and higher levels of mercury in urine( 132.437). and CFS. enzyme nerve growth inhibition.spleen.61.156). with pattern indicating likely source and the level extent of damage. cerebral hemorrhage. I 86. Mercury.154. developmental.305. 44% tested allergic. CFS.lead.38. etc. increasing as a protective measure against metals toxicity. with most cases seeing significant increase in oxyhemoglobin level and reduction in porphyrin levels along with 100% experiencing improved energy.357). and other toxics have different patterns of high levels for the 5 types of porphyrins. suicide. The problem occurs in extractions that are not cleaned out properly after extraction(437).267). cavitations.161. DNA mutations.all known to be affected by mercury effects(35). The average for those with amalgams is over 3 time that of those without. and is over 20 times normal for some severely poisoned people(232. Recent studies have found that drug resistant strains of bacteria causing ear infections.116. Supplements such as glucosamine sulfate and avoidance of orange juice and caffeine have been found to be beneficial in treating arthritic conditions as well(35). Patch tests for hypersensitivity to mercury have found from 2% to 44% to test positive (87. much higher for groups with more amalgam fillings and length of exposure than those with less. Mercury is extremely toxic and kills many beneficial bacterial. Of the dental students with 10 or more fillings at least 5 years old. People with amalgam fillings have an increased number of intestinal microorganisms resistant to mercury and many standard antibiotics(35. and (34.296. be much larger and patch tests do not measure the total population getting toxic reactions from mercury. These have been found to be factors along with amalgam in serious chronic conditions such as MS. I 17. The interruption of the ATP energy chemistry results in high levels of porphyrins in the urine(260). the total would vulnerable to increased immune system reactions to amalgam fillings.(35. violent deaths. and pneumonia more than doubled since 1996. The study also found that mercury has major adverse effects on red and white blood cells. tuberculosis. and root canals also can cause high porphyrins.264. A study funded by the Adolf Coors Foundation(232) found that toxicity such as mercury is a significant cause of abnormal cholesterol levels. and significant health problems to be related such as arthritis. Alzheimer’s.270. but some forms of bacteria can alter their form to avoid being killed by adding a plasmid to their DNA making the bacteria mercury resistant. systemic effects inhibition.161. and that cholesterol levels usually normalize after amalgam replacement.222.292. Tests by special equipment(Cavitat) found cavitations in over 90% of areas under root canals or extracted wisdom teeth that have been tested.260). cancer. The most sensitive reactions are immune reactions. and porphyrin leveIs(232). The FDA has approved a test measuring porphyrins as a test for mercury poisoning. and have found that after reducing mercury burden antibiotic . 5. But this transformation also increases antibiotic resistance and results in adversely altered populations of bacteria in the intestines. oxygen carrying capacity.369). the percent of Americans allergic to mercury just from this group would be about 17 million people especially However.389). However some other dental problems such as nickel crowns. sinusitis.272. 6. Based on these studies and statistics for the number with 10 or more fillings. and toxins such as anaerobic bacteria and other toxics which significantly inhibit body enzymatic processes in virtually all cavitations(437). However lowering cholesterol levels by other means below 160 correlates with much higher rates of depression. rivers(53).175.204. Studies have found a significant correlation between mercury resistance and multiple antibiotic resistance (I 16.263. In studies of medical and dental students.226. These toxins have been found to have serious systemic health effects in many cases.117. 178. MCS. and deaths.41O-412/l 49.149. Cavitations are diseased areas in bone under teeth or extracted teeth usually caused by lack of adequate blood supply to the area. MCS. ALS. and similar for strains of bacteria in U.S.

hormones. Richardson(Health Canada) has estimatedthat about 20% of the population suffers a subclinical impairment of kidney or CNS function related to amalgam mercury(209c). autism. Mercury also blocks the metabolic action of manganese and the entry of calcium ions into cytoplasm(333).35.40).etc. 9. The results of hormone tests. resulting in inactivation of sulfur and functions such as cysteine dioxygenase(CDO). Based on this finding.33. gammablocking of enzyme glutamyltraspeptidase(GGC) and sulfite oxidase. etc. These exist in almost every enzymatic process in the body. Levels of mercury in follicular fluid was significantly higher for those with amalgam fillings (9. etc(330.56. 68 % of the women then responded to treatment and alopecia was alleviated( 187).464. Another study in Japan found significantly higher levels of mercury in gray hair than in dark hair(402).194.389.35.228b35. In some cases. In other studies involving amalgam removal. which is normally quenched by pyruvate and catalase(203). Molybdenum. nerve tissue.ll I. The Government’s toxic level for mercury in urine is 30 mcg/L (189).2 1c. immune disturbances.9). along with a deficiency in sulfates required for many body functions.(21c. Blocked or inhibited sulfur oxidation at the cellular level has been found in most with many of the chronic degenerative diseases.33 I . A large study of 20. Inorganic mercury exposure has been found to exert a dosedependent cytotoxicity by generating extremely high levels of hydrogen peroxide. Mercury from amalgam thus has the potential to disturb all metabolic processes(25. and red blood cells.) 7. Allergies and hair-loss were found to be 2-3 times as high in a group with large number of amalgam fillings compared to controls( 199. 194). including Parkinson’s. Mercury from amalgam binds to the -SH (suhhydryl) groups.111. and recurrent fungal infections were also found in the amalgam group. 33. Alzheimer’s. Mercury accumulates in the kidneys with increasing levels over time. but adverse effects have been seen at lower levels and . ALS.60. and appears to be a major factor in these conditions.203.338. 8. The alteration of intestinal bacterial populations necessary for proper digestion along with other damage and membrane permeability effects of mercury are major factors in creating “leaky gut” conditions with poor digestion and absorption of nutrients and toxic incompletely digested compounds in the bloodstream(338.211.56. 35. MCS.1 I 1 I I I I I I I I I 1 I I I I resistance declines (251. Mercury is transported throughout the body in blood and can affect cells in the body and organs in different ways. A study of levels in kidney donors found an average of 3 times higher mercury level in those with amalgams versus those without( 14c).194. and to decreaseglutathione pcroxidase activity in the kidneys while upregulating heme oxidase function. B12-vitamin.317). One study found levels ranging from 2 1 to 8 10 ppb.438).000 subjects at a German university found a significant relation between the number of amalgam fillings with periodontal problems. 114. and also in those with more than average number of amalgam fillings(254).146). B 1-vitamin. lupus.180.3 17).5 14. diarrhea. an intervention studies agree(9. a Gynecological Clinic that sees a large number of women suffering from alopecia/hair loss that was not responding to treatment had amalgams replaced in 132 women who had not responded to treatment. HgC12 also has been found to impair function of other organelles such s lysomomes that maintain transmembrane proton gradient. infertility.405). rheumatoid arthritis. and gastrointestinal problems( 199). stomatis. wasting disease. Mercury exposure has been shown to adversely affect kidney function in occupational and animal studies (20. cell culture studies. Other clinics have also found alleviation of hair loss/alopecia after amalgam removal and detox(40. Sulfur is essential in enzymes.260. neurological problems. producing sulfur metabolites with extreme toxicity that the body is unable to properly detoxify(33. Higher levels of hormone disturbances. PSP-vitamin.146).21. Some of the gastrointestional problems caused by mercury include poor mineral absoroption.197}. and tetrahydrofolate supplementation has helped to boost the protective sulfite oxidase.).etc. the majority had significant improvement (40.222. bloating.

10. depression. with some measuredat over 4 micro amps.366).35.27.210. reproductive function and cause birth defects and developmental problems in chi1dren(2.35.146.194).365). ATSDR mercury health MRL of 0.197. causes aberrant numbers of chromosomes in cells. Mercury has been found to cause decreased sperm volume and motility . affects DNA in sperm. or epilepsy.3 1.29. Some studies have also found persons with chronic exposure to electromagnetic fields(EMF) to have higher levels of mercury exposure and excretion(28) and higher liklidhood of getting chronic conditions like ALS(526). Subfertile males in Hong Kong were found to have 40% more mercury in their hair than fertile controls(55). In studies of women having miscarriages or birth defects. The central nervous system operates on signals in the range of nano-amps. currently U.37.100.433.50.305.38.50.104.260.287.105.224.61.192).100.).19. birth defects.3 1. For these reasons it is important that no new gold dental work be placed in the mouth until at least 6 months after replacement. resulting in reduced volume for cerebellum and organs and subtle deticiencies(38.39.28. 12. Amalgam fillings produce electrical currents which increase mercury vapor release and may have other harmful effects( 19.361).etc.162) humans(9.146. Clinical evidence lead to hormone imbalances that can reduce indicates that amalgam fillings fertility(9. inhibits enzymes necessary for sperm production.255.338~.55. Abnormal sperm is also being blamed for a global increase in testicular cancer.38).3I . Mercury from amalgam fillings is transferred to the fetus of pregnant women and children who breast feed at levels often higher than those of the mother( 18.which is 1000 times less than a micro amp(28).183.61.19.9. 10.105.216.2 mcgA43 which is exceeded by any dental work involving amalgam(Section III).186.20. Studies indicate an increase in the rate of spontaneous abortions with an increasing concentration of mercury in the fathers’ urine before pregnancy(37)..61. increased infertility and abortions at low levels of methyl mercury( 162. Other protocols for amalgam removal are available from international dental associations like IAOMT( 153) and mercury poisoned patients organizations like DAMS(447).159. Studies in monkeys have found decreased sperm motility.61.4.182.37.458).38. and background levels of mercury in mothers correlate significantly with incidence of birth defects and still births( 10.10. Studies have found that mercury accumulates in the ovaries and testes.23.255.38.27.57.55. or birth defects( 10. These currents are measured in micro amps. 11.159. husbands were found to typically have low sperm counts and significantly more visually abnormal sperm(393).146.104.395. For this reason urine tests are not a reliable measure of mercury toxicity( 11.25.296).305).23. It’s now estimated that up to 85 per cent of the sperm produced by a healthy male is DNA-damaged(433).23. Negatively charged fillings or crowns push electrons into the oral cavity since saliva is a good electrolyte and cause higher mercury vapor losses(35.23. Patients with autoimmune conditions like MS.38. abnormal sperm. increased sperm abnormalities and spontaneous abortions.all of which can cause infertility.162. are often found to have a lot of high negative current fillings(35). spontaneous abortions. 186. and other reproductive conditions.224.38.20. Many governments have bans or restrictions on use of amalgam by women of child-bearing age.41.105.281).low levels in urine often mean high mercury retention and chronic toxicity problems. in animals(4. causes chromosome breaks.105. increased uterine and decreased fertility and in fibroids/endometritis.112.38l. . etc. Researcher’s advise pregnant women should not be exposed to mercury vapor levels above government health standards (2.287. etc.36.227. Mercury has an effect on the fetal nervous system at levels far below that considered toxic in adults.192.503).35.282. The Huggins total dental revision(TDR) protocol calls for teeth with the highest negative charge to be replaced first(35).4.31.30.24.S. Mercury vapor exposure causes impaired cell proliferation in the brain and organs.367). Since mercury(al1 forms) is documented from studies of humans and animals to be a reproductive mercury can reduce and developmental toxin(23.

221.250.35).244.442). Such hormonal secretions are affected at levels of mercury exposure much lower than the acute toxicity effects normally tested. MS. etc.289.98.170.56).160.363. Among those with chronic immune system problems with related immune antibodies.459).13.l g-24. ALS(92.41. which has been found to be a major factor in neurological . tyrosine(257). Low noncytotoxic levels of mercury induce dose dependent binding of mercury to DNA and significantly increased cell mutations (142.189.56.35).105).423.248.204.). Mercury and other toxic metals such as copper and lead cause breaks in DNA(4.163. Parkinson’s.238.369.346.207.504b). Low levels of mercuric chloride also inhibit ATPase activity in the thyroid.35). etc.46 l.257. Both types of mercury were found to cause denaturing of protein. Many studies of patients with major neurological or degenerative diseases have found evidence amalgam fillings may play a major role in development of conditions such as such as Alzheimers (66.369). Mercury exposure causes high levels of oxidative stress/reactive oxygen species(ROS)(13. These effects result commonly in a reduction in thyroid production(50) and an accumulation in the thyroid of radiation.197. 16. Low levels of mercury and toxic metals have been found to inhibit dihydroteridine reductase . ALS. Mercury depletes and weakens the immune system in many ways documented throughout this paper.30.166.412).285.l83.326.184. Mercury has been well documented to be an endocrine system disrupting chemical in animals and people.105. and many hormonal functions at very low levels of exposure (9.257. The hypothalamus regulates body temperature and many metabolic processes. Parkinson’s(98.194.302. 17.4) and birth defects(l97. enzyme production processes (111. MS(l02. 3 12. is significantly decreased in patients with Alzheimer’s’s’s. 18.300. 2 10. but inorganic mercury was more potent. hypothalamus.36-44.67.258.416. The level of mercury released by amalgam fillings is often more than the levels documented in medical studies to produce adverse effects and above the U.381). including the immune system and reproductive systems(105.186).122. In addition to effects on DNA.325.and autism.183.42.291. which is essential in production of neurotransmitters.229.405. There has been no evidence found that there is any safe level of mercury in the body that does not kill cells and harm body processes(WHO. 35).212.372. tyrosine and tryptophan transport into neurons(27.342. and 5-HTP(4 12). with methyl mercury inhibiting ATP function at even lower levels(50. the types showing the highest level of antibody reductions after amalgam removal include thyroglobulin and microsomal thyroid antigens(91) 15. Tetrahydrobiopterin. and some after 5-formyltetrahydrofolate. government health guidelines for mercury exposure(see previous text). ADD(285e. Such patients have abnormal inhibition of neurotransmitter production.382.295.242. thyroid gland(50. This is especially so for the pituitary gland of the developing fetus where mercury has been shown to accumulate and which is the most sensitive to mercury(2-4.33. which affects the neural system function by inhibiting transmitters through its effect on phenylalanine.372.3 1.35).61.3 12. mercury also promotes cancer in other ways.S. This was found to cause severe impaired amine synthesis and hypokinesis.462.324.158. Such symptoms improved for most patients after administration of R-tetrahydrobiopterin (4 12).272.97. Mercury also damages the blood brain barrier and facilitates penetration of the brain by other toxic metals and substances (311). disrupting function of the pituitary gland.38.169. in addition to many problems caused by hormonal imbalances. 14.146.296) and also have synergistic effects with x-rays(296) . 84. Mercury damage thus commonly results in poor bodily temperature control. Toxic metal exposure’s adverse influence on thyrocytes can play a major role in thyroid cancer etiology( 144) .38. The pituitary gland controls many of the body’s endocrine system functions and secretes hormones that control most bodily processes.

324.442). Such damage to the blood brain barrier’s function has been found to be a major factor in chronic neurological diseases such as MS(286. Clinical tests of patients with MND.329. Most recovered after mercury detox. with the average being 500% higher than controls(330. 4 16.184.287a).222. as well as multiple exposures to these and lead. Such conjugates are found to be highest in the brain substantia nigra with similar conjugates formed with L-Dopa and dopamine in Parkinson’s disease(56). Such patients have abnormal inhibition of neurotransmitter production. and anterior horn motor neurons. but noted that this effect was only seen for exposure of over 20 years. which affects the neural system function by inhibiting brain transmitters through its effect on phenylalanine.2 12. tyrosine and tryptophan transport into neurons( 122. Many studies of patients with major neurological or degenerative diseaseshave found evidence amalgam fillings play a major role in development of conditions such as such as ALS (48.disease(56.38. MS patients have been found to have much higher levels of mercury in cerebrospinal fluid compared to controls (163.325.33 1. is significantly decreased in patients with Alzheimer’s’s’s.207. which is necessaryto mitigate reactive damage.139). Tetrahydro-biopterin.(supplements which inhibit breach of the blood brain barrier such as bioflavonoids have been found to slow such neurological damage). Studieshave found mercury related mental effects to be indistinguishable from those of MS (207. This means that these patients have insufficient sulfates available to carry out .291.183. Mercury.ALS.271. which finally leads to neuronal cell death in the substantia nigra in PD(424).301.85. 324.162.33e). Parkinson’s.35.291.520.35). they can be considered part of a vicious cycle. with some requiring additional treatment for viruses and intestinal dysbiosis.302.442).3 I l/262).478).442. urine.302. and hair of Parkinson’s disease patients(363). which enervate the skeletal muscles(48.105.372). Mercury depletion of GSH and damage to cellular mitochondria and the increased lipid peroxidation in protein and DNA oxidation in the brain appear to be a major factor in Parkinson’s disease(33.327.92.423.289.289.229b. and the pattern of deposition is the same as that seen from morphological changes(327g.289. rheumatoid arthritis and autism have found that the patients generally have elevated plasma cysteine to sulphate ratios.470.469. cerebellum. Alzheimer’s’s. and MS.346). Another study (145) that reviewed occupational exposure data found that occupational exposure to manganeseand copper have high odds rations for relation to PD.326).244. This was found to cause severe impaired amine synthesis and hypokinesis.257. Lupus(SLE).326.97. Parkinson’s. Mercury penetrates and damages the blood brain barrier allowing penetration of the barrier by other substances that are neurotoxic (20. dorsal root ganglia. Another study( 169) found blood and urine mercury levels to be very strongly related to Parkinson’s with odds ratios of approx. Increased formation of reactive oxygen species(ROS) has also been found to increase formation of advancedglycation end products(AGEs) that have been found to cause activation of glial cells to produce superoxide and nitric oxide.56. which is essential in production of nerurotransmitters. rhombencephalon. 20 at high levels of Hg exposure. A Canadian study found those with 15 or more amalgam fillings to have more than 250% greater risk of MS than controls.291.327. with exposure either to vapor or organic mercury tends to accumulate in the glial cells in a similar pattern. with one study finding 300% higher than controls(271). and in general being poor sulphur oxidizers. and likewise higher risk for those who have had amalgam fillings more than 15 years(324) One study found higher than average levels of mercury in the blood. Mercury and quinones form conjugates with thiol compounds such as glutathione and cysteine and cause depletion of glutathione. Mercury has been found to accumulate preferentially in the primary motor function related areas such as the brain stem. Low levels of toxic metals have been found to inhibit dihydroteridine reductase . Large German studies including studies at German universities have found that MS patients usually have high levels of mercury body burden.

514). astigmatism. etc. black streaks on retina. In many cases(many thousand documented)removal of amalgam fillings and treatment for metal toxicity led to “cure’ or significant improvement in health(see Section V).232.56). are especially susceptible to this damage(207. This has been found to produce inflamatory cytokins sch as IL-I and TNF that contribute to cartilage and bone destruction.3 11).33e). blocked.43). damaged. while those with Apo-E2 which has extra cysteine and is a better mercury scavenger have less damage.33.338c.254). The majority have an intermediate form Apo-E3. Mercury and methyl mercury impair or inhibit all cell functions and deplete calcium stores(96). it is documented that the process thus involves free radical/reactive oxygen species effects. while high levels of free cysteine have been demonstrated to make toxicity due to inorganic mercury more severe(333. and low levels of zinc(363. cataracts.brain barrier. It has been documented that conditions like depression and other chronic neurological conditions often involve damage and nerve cell death in areas of the brain like the hippocampus. and to inhibit cytochrome C enzymes which affect energy supply to the brain(43. and to be effective in treating not only depressive conditions but degenerative conditions like Huntington’s Disease which are related to such damage.221. Less than lppm mercury in the blood stream can impair the blood. Lithium protects brain cells against excess glutamate induced excitability and calcium influx(280. Mercury was also found to accumulate in the mitochondria and interfere with their vital functions.194. In one subtype of ALS.111. This appears to be a factor in susceptibility to Alzheimer’s’s disease. Low levels of available glutathione have been shown to increase mercury retention and increase toxic effects(l1 I). Parkinson’s disease and multiple sclerosis.239). Persons with the Apo-E4 gene form of apolipoprotein E which transports cholesterol in the blood.84. with high levels of mercury in the brain (207). causing excess membrane permeability.33e). or faulty enzymatic superoxide Dismustase (SOD) processes appear to be a major factor in cell apoptosis involved in the condition(443). Mercury causes an increase in white blood cells. Mercury and the induced neurofibrillary tangles also appear to produce a functional zinc deficiency in the of AD sufferers(242)as well as causing reduced lithium levels which is another factor in such diseases. and removal of amalgam has led to remission very rapidly in some cases(35. This can be a major factor in bone loss of calcium(osteoporosis). 20. and lithium has been found to not only prevent such damage but also promote cell gray matter cell growth in such areas(280). There is evidence that some forms of leukemia are abnormal response to antigenic stimulation by mercury or other such toxics.Mercury has been shown to diminish and block sulphur oxidation and thus reducing glutathione levels which is the part of this process involved in detoxifying and excretion of toxics like mercury(33).macula degeneration.180. Ones susceptibility can be estimated by testing for this condition.necessarybodily processes.38. with more createdto try to react to a foreign toxic substance in the body. Mercury(like copper) also accumulates in areas of the eyes such as the endothelial layer of the cornea and macula and is a major factor in chronic and degenerative eye conditions such as iritis. Mercury has also been found to play a part in inducing intoleranceand neuronal problems through blockage of the P-450 enzymatic process(84. Mercury has been shown to be a factor that can cause rheumatoid arthritis by activating localized CD4+ T-cells which trigger production of immune macrophages and immunoglobulin(lg) producing cells in joints(405.56. 19. Also. and antioxidants have been found to have benefits in treatment(5 14). Mercury is known to damage or inhibit SOD activity(441. Most of these conditions have been found to improve after . myopia. especially in terms of the blood-brain barrier (I 55. Mercury at extremely low levels also interferes with formation of tubulin producing neurotibrillary tangles in the brain similar to those observed in Alzheimer’s patients. Also mercury binds with cell membranes interfering with sodium and potassium enzyme functions.346).35).207. Glutathione is produced through the sulphur oxidation side of this process.

anger(2 12.95.322.etc. On average those with 29 amalgam surfaces excreted over 3 times more mercury in urine after DMPS challange than those with 3 amalgam surfaces.222. depression (94.485.293.212.222.525).322.369.3 17.75.291.40. 222.229.82.470.87.222). endometriosis (229.2 12.91.212. autoimmune thyroiditis(382.322.349.107.485).222.94. Removal of amalgam fillings resulted in a significant reduction in body burden and body waste product load of mercury(75. insomnia(35.165.469. sinus problems (35.232.180.271.469.25 1.35.233. chronic eye conditions: inflamation/iritis/ astigmatism/myopia /cataracts/macula degeneration (35.115.271.35.etc.405. susceptibility to infections (35.248.271.469.271. PMS(35.229. but within 2 weeks levels fall significantly. 2 12. chron’s disease(222. Results of Removal of Amalgam Fillings 1.27 1. 3.27 1.310. Alzheimer’s’s(204.229.60.271.35).35. pain/Fibromyalgia (35.313.229).94.229.233.233. Chronic Fatigue Syndrome (8.323.60.95.etc.342.3 17. patients gold or nickel crowns over amalgam are replaced by biocompatible alternatives.229.354. tachycardia and heart problems .469).35).349).222.470.376.376.40.35.376.453).3 17.440.349.470).469.229.).94.35.523). but usually improve if adequate precautions are taken to reduce exposure during removal.3 17.465.222. 350.375. etc.358.1 15.293.294.86.etc.95.212.222.95.222.527.367).222.229.469.27 1.222.35.322.232.40). urinary/prostrate problems(2 12. Total reduction in mercury levels in blood and urine is often over 80% within a few months(79.3 13.470.27 1.212) (205.35.440.46.170.89.27 1.46.523).34.440.3 17.93.322.322.222.376).222. 229.271.404.60. muscular/joint infertility(9.82.222.322).229.40.35).35.) VI.233.102. The above over 60. (212.470.453.3 13.35.35).88.322.376).6.375.322). 229.94. For the week following amalgam removal.93.133.95.101.291. immune system/ autoimmune problems (8.271.271.317.228.232.452. cancer(breast. schizophrenia 376.115.423.91). eczema and psoriasis (168b.469.306.222.98.78.2 12.229.57).229. skin conditions (2 12. oral keratosis(pre cancer)(87.440.187.115.59.34.) diabetes(35.222.27 1.469.75.82.323).349.90.376. For the following case studies of amalgam replacement.).523.485.222.94. some clinics primarily replaced amalgam fillings using patient protective measures and supportive supplements.385.35).469.270. neuropathyfparesthesia (35.309.25 l).233.323.440.etc.232.35.228. epilepsy (5.285e.233.3 17.3 13./leukemia) (35.322).2 12. pain/ arthritis(35.317.222.271. There are extensive documented cases (many thousands)where removal of amalgam fillings led to cure or significant improvement of serious health problems such as periodontal diseases(35.94.35.2 12.271.35).369.102.26.35.38.322).94.94.95. vision disturbances(35. alopecia/hair loss (40. allergies(8.95. 222.(82.38). stomach problems lupus( 12. antibiotic resistant infection(25 1). hearing loss( 102. anxiety & mental confusion (94.113.2 12. whereas some clinics do something comparableto Hal Huggins total dental revision where in addition to amalgam replacement.322.3 13.523).440.blood conditions 212. body mercury levels increase significantly.95).233. 408.317.523.94.94.95.222.453) MS(94.453.35.212. asthma(8.88.212.233. joint dizzyness/vertigo(40.34.233.222.103. muscle tremor Parkinson’s/ ALS(97.323. (26.228.317.459).57).271. memory disorders (35.469.322.38.2 12. 2.233.486).470. (294. depending on protective measures taken. (222.2 12.35.302.222.321.89) Chronic conditions can worsen temporarily.453.342).212.222. tinnitus(35.168.485.523).322.349.222.212.233.000 cases of cure or significant .212.97.523).485.2 12.229.115.97.469.115).271.89.229.342. (35.222.322.35. headaches/migraines(5.100.440).40.271. root canals extracted and cavitations checked for and cleaned. candida(26.271.523.amalgam replacement(35.233.95.chronic sensitivities chemical multiple 317.271.322.322.35).376.271.57. and those with 45 amalgam surfaces more than 6 times as much mercury( 12b).222).94).

dizziness.). and the average was 54. in over 60% of cases for: allergies.87. muscle fatigue. head aches/migraines. the clinical studies indicated a large majority of most such type casestreated showed significant improvement.dementia. thyroglobulin. A Jerome meter was used to measure mercury vapor level in the mouth.359). poor memory.).(35).). skin reactions. For examaple. Lupus. and mouth sores.302). The Huggins Clinic using TDR has successfully treated over a thousand patients with chronic autoimmune conditions like MS. TDR and other measures used in metals detox have been found to increase T-cells and immune function in AIDS patients(35). CFS. and removal of the teeth with highest negative galvanic current first(35). fatigue. tender teeth. in over 80% of cases for: depression. bad breath. Interviews of a large population of Swedish patients that had amalgams removed due to health problems found that virtually all reported significant health improvements and that the health . diabetes. sciatic pain. and microsomal thyroid antigens(91). This appears to be due to migration of mercury into roots & gums that is not eliminated by simple filling replacement. Among those with chronic immune system problems with related immune antibodies. The Huggins TDR protocol includes testing teeth with metal for level of galvanic current caused by the mixed metals. watery eyes. That such mercury(and similarly bacteria) in the teeth and gums have direct routes to the brain and CNS has been documented by several medical studies(34. AD. 85%) who experienced significant improvement in MS. In a large German study of MS patients after amalgam revision. Other cases have found that recovery from serious autoimmune diseases.168. and leg cramps. 97% versus 37 to 88%(435). etc. poor concentration/ADD. bleeding gums. chest pain. as a high percentage of those testing negative also recovered from chronic conditions after replacement of fillings(86. in over 70% of cases for: bloating or intestinal cramps. Some of the above cases used chemical or natural chelation to reduce accumulated mercury body burden in addition to amalgam replacement. irrational fear. Other clinics reported similar success. etc.improvements were not isolated cases of cures. far above the Government health guideline for mercury(2 17). constipation. or cancer may require more aggressive mercury removal techniques than simple filling replacement due to body burden.etc. nasal congestion or discharge. cold hands/feet. Details are available and case histories.6 micrograms mercury per cubic meter of air. Clinical studies have found that patch testing is not a good predictor of success of amalgam removal. insomnia. This has been found to improve recovery rate for chronic conditions like epilepsy and autoimmune conditions. irratibility. extraction resulted in 85% recovery rate versus only 16% for filling replacement alone (222. related to mercury and other immunotoxics(60. including himself with the population of over 6OO(approx.325. But the recovery rate of those using dentists with special equipment and training in protecting the patient reported much higher success rates than those with standard training and equipment.etc. Some clinics using DMPS for chelation reported over 80% with chronic health problems were cured or significantly improved(222.MS. heart problems.etc. Swedish researchers have developed a sophisticated test for immune/autoimmune reactions that has proved successful in diagnosing and treating environmentally caused diseases such as lichen planus. throat irritation. the types showing the highest level of antibody reductions after amalgam removal include glomerular basal membrane.3 13.27 1. urinary disorders. one of the clinics(95) replacing amalgams in a large number of patients with chronic conditions had full recovery or significant improvement: in over 90% of casesfor: metallic taste. muscle tremor. ALS. Metals are being pushed into the body from negatively charged metal dental work with saliva as electrolyte and the highest charged teeth lose the most metal to the body(35).

having a higher correlation to systemic body burden than urine or blood.83.282). extrapolated to U.183.6b).278).25).21ab). For those with several fillings daily fecal mercury excretion levels range between 20 to 200 ug/day. etc. though still not totally reliable and may be a better indicator for organic mercury than inorganic. liver.80. and inhibiting excretion(503). but high levels of DMPS can be dangerous to some peopleespecially those still having amalgam fillings or those allergic to sulfur drugs or sulfites. A new test approved by the FDA for diagnosing damage that has been caused by toxic metals like mercury is the fractionated porphyrin test(260. Mercury vapor passes through the blood rapidly(half-life in blood is 10 seconds(370)) and accumulates in other parts of the body such as the brain.278.36. Kidneys have a lot of hydroxyl(SH) groups which mercury binds to causing accumulation in the kidneys.35.303).157. In the early stages of mercury exposure before major systemic damage other than slight fatigue results you usually see high hemoglobin. which tend to correlate with recent exposure level (6b. population this would represent over 17 million people who would benefit regarding allergies alone.503). (study period 17 years) A compilation of an even larger population found similar results(212. Many studies using chemical chelators such as DMPS or DMSA have found post chelation levels to be poorly correlated with prechelation blood or urine levels(57. The saliva test is another good test for daily mercury exposure.2 1abd.improvements were permanent(233).58). As damage occurs to kidneys over time. thyroid gland. as well as with occupational dental exposure and to be a good medium for monitoring internal mercury exposure.5 ppm. Mercury blocks enzymes needed to convert some types of porphyrins to hemoglobin and adenosine tri phosphate(ATP). mercury is less efficiently eliminated (11. Feces is the major path of excretion of mercury from the body. plus low oxyhemoglobin(35).335. Hair mercury levels did not have a significant correlation with urine mercury in one study(340) and did not have a significant correlation to number of fillings(350). hemocrit. with significant numbers of those with several filings having over 10 ppm and 170 times those without fillings(80).260. that measures amount of damage as well as likely source.1 I . Tests for Mercury Level or Toxicity and Treatment 1.115.80.21abd. Mercury hair level in a population sampled in Madrid Spain ranged from I . in later states you usually see marginal hemoglobin.386. alkatline phosphatase.S. The pattern of which porphyrins are high gives an indication of likely toxic exposure. body burden or level in a target organ(36. Thus blood test measures mostly recent exposure.79.2 16.36. One researcher suggests that mercury levels in hair of greater than 5 ppm are indicative of mercury intoxication.57.528.35). so urine tests are not reliable for body burden after long term exposure. kidneys. except that external occupational exposure can also affect hair levels. The average level of mercury in feces of populations with amalgam fillings is as much as 1 ppm and approx. 10 times that of a similar group without fillings (79. Some researchers suggest hair offers a better indicator of mercury body burden than blood or urine(279. Provocation challenge tests after use of chemical chelators such as DMPS or DMSA also are effective at measuringbody burden(57. and lactic dehydroganese.183. For example 89% of those reporting allergies had significant improvements or total elimination.3 to 92. done commonly in Europe and representing one of the largest sources There is only a weak correlation between blood or urine mercury levels and of mercury exposure.183. but one study (340) found a significant . VII. This study found a significant positive correlation between maternal hair mercury and mercury level in nursing infants. For this reason many researchers consider feces to be the most reliable indicator of daily exposure level to mercury or other toxics. with high precoproporphyrin almost always high with mercury toxicity and often coproporphyrin. pituitary gland. Hair was found to be significantly correlated with fish consumption. hemocrit.

Use of EDTA may need to be restricted in those with high Hg levels.292. Zinc induces metallothionein which protects against oxidative damage and increases protective enzyme activities and glutathione which tend to inhibit lipid peroxidation and suppress mercury toxicity(430. Lipoic acid has a protective effect regarding lead or inorganic mercury toxicity through its antioxidant properties(494).173. often mercury toxic(35) (e) fractionated porphyrin(note test results sensitive to light.495e.< 1.273.Vitamins C & E.54). gingko biloba.However one study(290) found significant effects at lower levels. has been found to dramatically increase excretion of inorganic mercury(over 12 fold). average mercury level is 3 to 4 ppm. diabetic neuropathy(494). Note: during initial exposure to mercury the body marshals immune system and other measures to . so thus have an additional neuroprotective effect(494ab. Experienced doctors have also found additional zinc to be useful when chelating mercury(222) as well as counteracting mercury’s oxidative damage(43). EDTA. Another chelator used for clogged arteries.On average those with 29 amalgam surfaces excreted over 3 times more mercury in urine after DMPS challange than those with 3 amalgam surfaces. Several doctors use 16 ug/L as the upper bound for mercury after DMPS challenge. and motor deficits(290). temperature.303).g. forms toxic compounds with mercury and can damage brain function(307). but to cause decreasedexcretion of organic mercury(494d) and copper.222. Also lipoic acid. Tests suggestedby HugginslLevy(35) for evaluation and treatment of mercury toxicity: (a) hair element test(386) (low hair mercury level does not indicate low body level)(more than 3 essential minerals out of normal range indicates likely metals toxicity) (b) CBC blood test with differential and platelet count 0 blood serum profile (d) urinary mercury (for person with average exposure with amalgam fillings. excitotoxic amino acid(glutamate) brain injury. 444).521. s. Some studies have also found DMSA as more effective at removing mercury from the brain(58). Lipoic acid has been found to have protective effects against cerebral ischemic-reperfusion. and pycnogenol have also been found protective against degenerative neurological conditions(494. A common protocol for DMSA(developed to avoid redistribution effects) is 50 mg orally every 4 hours for 3 days and then off 11 days. N-acetylcysteine(NAC) has been found to be effective at increasing cellular glutathione levels and chelating mercury(54).464). Coenzyme QlO. lower test level than this likely means person is poor excreter and accumulating mercury. Zinc is a mercury and copper antagonist and can be used to lower copper levels and protect against mercury damage. and consider anyone with higher levels to have excessbody burden(222. Some researchers believe DMSA has less adverse side effects than DMPS and prefer to use DMSA for chelation for this reason. memory.correlation between pre and post chelation values when using DMPS.008 consistent with and suicidal tendencies(35)) depression 3.g> 1. mitochondrial dysfunction.290.172. shaking) (f) individual tooth electric currents(replace high negative current teeth first) (g) patient questionnaire on exposure and symptom history (h) specific gravity of urine(test for pituitary function.022 normal. Challenge tests using DMPS or DMSA appear to have a better correlation with body burden and toxicity symptoms such as concentration . s.352). but should not be used with high copper.LA. Other antioxidants such as carnosine(495a). Lipoic acid and N-acetylcysteine(NAC) also increase glutathione levels and protect againstsuperoxide radical/peroxynitrite damage.with many studies finding a significant correlation amalgam level the number of chelation mercury and between post surfaces(57. 2. and those with 45 amalgam surfaces more than 6 times as much mercury( 12b).

zinc.4 ppm (h) oxyhemoglobin level < 55% saturated (1) carboxyhemoglubin > 2. high mercury exposures with low hair mercury or urine mercury level usually indicates body is retaining mercury and likely toxicity problem(35). (f) avoid acute exposures/challengeto the immune system on a weekly 7/l 4/2 I day pattern. and antioxidants have been found to have benefits in treatment(5 14).5 ppm or < . ALS. Rheumatoid Arthritis. supplementation of calcium AEP(448) and alpha lipoic acid(494). with supportive vitamin/mineral supplements. periodic monitoring tests.5 gm/lOO ml (e) triglycerides > 150 mg %ml (f)BUN>18or<12 (g) hair mercury > 1. (d) test and treat cavitations and amalgam tattoos where relevant (e) supportive supplementation. it is documented that the process is inflamatory involving free radical/reactive oxygen species effects. and most with these conditions improve after TDR if protocol is followed carefUlly(35). mercury toxicity likely and hard to treat since retaining mercury. after prolonged exposure the body inevitably lose the battle and measures to combat the challenge decreaseand immune system Chronic conditions are common during this phase.manganese. VIII. with low/marginal hemoglobin and hemocrit plus low oxyhemoglobin during long term chronic fatigue phase. In such cases where (calcium> 1100 or < 300 ppm) and low test mercury.potassium. Other measures in addition to TDR that have been found to help in treatment of MS in clinical experience are avoidance of milk products. CFS. etc. (b) replace amalgam fillings starting with filling with highest negative current or highest negative quadrant. nickel. Lupus.. Health Effects from Dental Personnel Exposure to Mercury Vapor . Also so some test indicator scores decline. 0 extract all root canaled teeth using proper finish protocol. Parkinson’s. Progesterone creme has been found to promote regrowth of myelin sheaths in animals(448c). Alzheimer’s’s. Huggins Total Dental Revision Protocol(35): (a) history questionnaire and panel of tests. Test results indicating mercury/metals toxicity(35): (a) white blood cell count >7500 or < 4500 (b) hemocrit > 50% or < 40% 0 lymphocyte count > 2800 or < 1800 (d) blood protein level > 7. Also. 4.5% saturated (j) T lymphocyte count < 2000 (k) DNA damage/cancer (1) TSH > I ug (m) hair aluminum > 10 ppm (n) hair nickel > 1.5 ppm (0) hair manganese> 0. evaluate need for further treatment(not usually needed).3 ppm (p) immune reactive to mercury. so many test indicators will be high. note: after treatmentof many casesof chronic autoimmune conditions such as MS. get lots of sunlight.try to deal with the challenge. aluminum. it has been observed that often mercury along with root canal toxicity or cavitation toxicity are major factors in these conditions. (q) high hemoglobin and hemocrit and high alkaline phosphatase(alk phos) and lactic dehydrogenese(LDA) during initial phases of exposure. etc.

national sample of dentists provided by the American Dental Association had an average of 5. with women having higher levels than men in general.249.172. Allergy tests given to another group of dental students found 44% of them were allergic to mercury( 156). A group of dental students taking a course involving work with amalgam had their urine tested before and after the course was over. p287-288.222. though the relationship was nonlinear and increased more with larger number of fiIlings(124).363.& 10.34 to 9.040 ppb.290. with excretion levels after a dose of a chelator as high as 10 times the corresponding levels for controls(57.8 q/L with approx. It is well documented that dentists and dental personnel who work with amalgam are chronically exposed to mercury vapor. Autopsies of former dental staff found levels of mercury in the pituitary gland averaged as high as 4. Mercury levels of dental personnel average at least 2 times that of controls for hair(397-40 I).8 q/L (124.000 ppb. Sweden.S.249. Studies have found that the longer time exposed. 3.249).6ug/L.138.l56.290). the number of amalgams polished each week.253. with study averages ranging from 1.16. The total lymphocyte count.195. 173.6 q/L with approx.7 to 6. The Swedish safety guideline for Study averages for other countries ranged from mercury in urine is 5. which accumulates in their bodies to much higher levels than for most nonoccupationally exposed. the sensitivity rate increased 5 fold to over 10%( 154~).253. 10% of dentists had urine mercury levels over 10.4 q/L and 1% had levels over 33. A review of several studies of mercury level in hair or nails of dentists and dental workers found median levels were 50 to 300% more than those of controls(38.2 ug/L (124.1 ug/L with study averages from 3. each filling was found to increase mercury in the urine approx.195. Another group of dental studentshad similar results(362). meeting(171) found that the mean mercury level in 1986 was 7.6 nmol Hg/nmoI(l 1.397-399) and for blood (124. 16% above 13.397).303. One study found that over a 4 year period of dental school.173. with levels in pituitary gland and thyroid over 10 times controls and levels in renal cortex 7 times controls(99.6 q/L). T helper/ inducer(CD4+CDS-).124.362).3 to 36 microgram/liter(ug/L)(69.6 to 57 ugL.64. Dental offices are known to be one of the largest users of inorganic mercury(71 b. They also found much higher levels in the brain occipital cortex(as high as 300 ppb). the more likely to be allergic and the more effects(6b.99.38).362.17 I.17 1.70. Urinary porphyrin profiles were found to be an excellent biomarker of level of body mercury level . 290. A large survey of dentists at the Norwegian Dental Assoc. which has banned use of mercury in fillings.etc. The average urine level increased by 500% during the course(63).123. In that large sample of dentists.8 to 30.2 ug/L (70. urine (25d.57.397).303). while another group of dental student showed compromised immune systems compared to medical students. and with the number of fillings in the dentist(l71. Mercury excretion levels were found to have a positive correlation with the number of amalgams placed or replaced per week. and urine levels in dental professionals from Swedish and European studies ranged from 0. and T suppressor/cytotoxic(CD4-CD8+) numbers were significantly elevated in the dental students compared to the matched control group(408). and for 1987 found an average of 8. indicating daily exposure levels of over 100 ug/day.173). Autopsy studies have found similar high body accumulation in dental workers.290. renal cortex(as high as 2110 ppb) and thyroid(as high as 28.64.172. Adverse health effects of this exposure including subtle neurological effects have also been well documented that affect most dentists and dental assistants.178).8 ug/L.253.68). Much higher accumulated body burden levels in dental personnel were found based on challenge tests than for controls(303).69.253. 3%. 15% above 15.). Mercury levels in blood of dental professionals ranged from 0.503a) .25c).1. In one study. is the country with the most exposure and health effects studies regarding amalgam.4ug/L(290.with measurable effects among those in the lowest levels of exposure. Similar results have been seen in other studies as well(408).69. total T cell numbers(CD3).154c. In general dental assistants and women dental workers showed higher levels of mercury than male dentists (171.172. A U.

7 to over 300 micrograms per cubic meter(ugIM3) (120. In addition to these measures researchers also advise all dental staff should wear face masks and patients be supplied with outside air( 120.10.153). This produces high levels of exposure to patient and dental staff.395c.395.138. and emotional/mood tests(70:249.7.69.171. with coproporphyrin significantly higher in those with higher mercury exposure and urine levels(70. neurobehavioral tests of motor speed. mercury vapour concentrations of ten times the current occupational exposure limit of 25 microg/m3 were recorded after 20 minutes of continuous aspirator operation(219). It was found that the bacterial air exhaust filter (designed to clean the contaminated waste air entering the surgery) offered no protection to mercury vapour.S. but care should be taken regarding challenge tests as the high levels of mercury released can cause serious health effects in some.123.209). 2.) The level of mercury at breathing point in offices measured ranged form 0.70.7.290.1 b).249. OSHA surveys find 6-16% of U. and visuomotor coordination(69. visual memory(68.71 b. Another study found spot readings as high as 200 ug/M3 in offices with few controls that only used saliva extractor( 120). as seen in previous discussion.S.2 ug/M3 (217) (giving approx.5 to 3. similar to U.503) For offrice’s using an aspirator. and dental masks to only filter out about 40 % of such particles (2 19.1 b). Screening test that are less burdensome and less expensive are now available as first morning void urine samples have been found to be highly correlations to 24 hour urine test for mercury level or porphyrins(73).3O3). Coproporphyrin levels have a higher correlation with symptoms and body mercury levels as tested by challenge test(69.260). mercury vapour emissions increased.124.395. The U.70. The average levels in offices with reasonable controls ranged from 1. This study was for dental personnel having mercury excretion levels below the 10th percentile of the overall dental population. dental offices exceed the OSHA dental office standard of 50 ug/M3.dental personnel with several fillings.249. Some studies note that carpeting and rugs in dental offices should be avoided as it is a major repository of mercury(6.and mercury damage neurological effects.6 ug/M3.290. Thus most offrce mercury levels were found to far exceed the U.l88. Amalgam dust generated by high speed drilling is absorbed rapidly into the blood through the lungs and major organs such as the heart receive a high dose within minutes(2 19a. etc. Use of water spray.303). Dentists were found to score significantly worse than a comparable control group on 3.395.S. 0. but even in Sweden which has had more office environmental controls than others spot levels of over 150 ug/M3 were found in 8 offrces(l72).S. especially those who still have amalgam fillings or high accumulations of mercury.249). A build up of amalgam contamination within the internal corrugated tubing of the aspirator was found to be the main source of mercury vapour emissions followed by particulate amalgam trapped within the vacuummotor. guidelines for chronic mercury exposure. Many surveys have been made of office exposure levels( I . Test performance was found to be proportional to exposure/body levels of mercury(68.70. The average dental office exposure affects the body mercury level at least as much as the workers on fillings(57.173). This study used .6.2 1d.395. with several studies finding levels approximately the same as having 19 amalgam fillings( 123. Use of such measures along with a Clean-Upm aspirator tip was found to reduce exposure to patient and staff approximately 90%(397).290.173.1b).172.253. concentration verbal memory.64.123.1b). EPA and Health Canada guidelines(2.249. 4 ug/day exposure). Significant adverse neurobehavioral effects were found even for dental personnel receiving low exposurelevels(lessthan 4 ug/l Hg in urine)(290). Such levels are also common among the general population of non. As the vacuum motor heated up with run time. ATSDR mercury vapor exposure MRL for chronic exposure is much lower.503c).395c.290. visual scanning. high velocity evacuationand rubber dam reduce exposure to patient and dentai staff significantly.247). and residual levels in equipment sterilizers often exceed this level(454).69. at the dentist’s breathing zone. Use of high speed drill in removal or replacement has been found to create high volume of mercury vapor and respirable particles.

etc. immune reactivity. Another study using DMPS challenge test found over 20 times higher mercury excretion in dentists than in controls.word).400.lack of ability to concentrate. stomach problems. Mercury exposure has been found to often cause disability in dental workers(230b.193. chronic muscular pain.377. memory(vocabulary. In a study in Brazi1(492).246. motor effects. muscle pains. dentists and dental assistants with chronic exposure to mercury vapor and anestheticsfound increased health problems compared to controls. The most common problems were related to the central nervous system. and motor function correlated more strongly with post-chelation mercury levels.72. tremors. 46% arthritic pains. and 45% headaches(490a). DMPS. One dentist with severe symptoms similar to ALS improved after treatment for mercury poisoning(246). Both dental hygienists and patients get high doses of mercury vapor when dental hygienists polish or use ultrasonic scalers on amalgam surfaces(240.503c). and indications of mild to moderate mercury poisoning in 62% of workers. One of the common effects of chronic mercury exposure is chronic fatigue due to immune system overload and activation.369).490). Mood scores including anger were found to correlate more strongly with pre chelation urine mercury levels. Many studies have found this occurs frequently in dentists and dental staff along with other related symptoms.etc. burnout. have from dentists been documented to suffer mercury Many poisoning(6f.S.503.247.74.while another study found selective atrophy of muscle fibre in women dental workers(490b). Thirty percent of dentists with more than average exposure were found to have neuropathies and visuographic dysfunction(395). concentration. to measure body burden mercury levels. Those with higher levels of mercury had deficits in both memory. indicating high body burden of mercury compared to controls(491). In another study nearly 50 % of dental staff in a group tested had positive autoimmune ANA titers compared to less than 1 % of the general population(35).193). and motor function compared to those with lower exposure levels. other than the documented neurological effects such as chronic fatigue. and another with Parkinson’s disease recovered after reduction of exposure and chelation(248). while toxicity symptoms. 50% reported significant irritability.193).369. Even at the low levels of exposure of the subjects of this study. 4. Pregnant women or pregnant hygienist especially should avoid these practices during pregnancy or while nursing since maternal mercury . Dental workers and other workers exposed to mercury vapor were found to have a shortening of visual evoked potential latency and a decreasein amplitude. Other studies reviewed found increased rates of brain cancer and aIlergies(99.(249.a new methodology which used standard urine mercury levels as a measure of recent exposure. This method was found to give enhanced precision and power to the results of the tests and correlations. mood. including significantly higher liver.490. and neurological diseases(99. with magnitudes correlated with urine excretion levels( 190). And the plotted test results gave no indication of there existing a threshold below effects were not measurable.000 U. and urine levels after chelation with a chemical. there were clear demonstrated differences in test scores involving memory. 50% had autoimmune reaction to inorganic mercury and immune reactions to other metals used in dentistry were also common(369).395.71.378. Similar cases among those with other occupational exposure have been seen. Tests of controls did not find such immune reactions common. Dentists were also found to have a high incidence of radicular muscular neuralgia and peripheral sensory degradation( 190. 62% of dental workers had urine mercury levels over 10 mg/L. and motor skills related to the level of exposure pre and post chelation(290).1 b).) Chelators like DMPS have been found after a fast to release mercury from cells in tissue to be available for excretion. In a group of dentists and dental workers suffering from extreme fatigue and tested by the immune test MELISA. In one study of dentists and dental assistants. etc.395c. mood.248. kidney. A survey of over 60. Swedish male dentists were found to have an elevated standardized mortality ratio compared to other male academic groups(284).504a.

88.38.112.490.504b).247.173. A large U.401.68-74.70. I 10.23. but one study found rates in same range as doctors. memory. and congenital defects than for the control group(394). 69.19. and very little mercury vapor(247). survey also found higher spontaneousabortion rate among dental assistantsand wives of dentists( 193).1 88. Most studies find dentists have increased levels of irritability and tension( l. atopic dermatitis.S.38. stillbirths. A study of dentist and dental assistantsin the Netherlands found 50% higher ratesof spontaneous abortions.290.123. A study in Poland also found a significant positive association between mercury levels and occurrence of reproductive failures and menstrual cycle disorders.6873. and higher suicide rates than the general white population (284.369. and which behavioral problems.287).I 0.142. visiomotor.3 I c. and contact urticaria(247.40 1. it can be seen that dental nurse/assistants have a clearly increased risk of having a deformed child or spontaneous abortion(433). 6.l72. Some studies .31.34.348) dental hygienist are advised not to polish dental amalgams when cleaning teeth. with unusually high occurrence of spina bifida. high rates of drug dependancy and disability due to psychological problems(l5.exposure has been shown to affect the fetus and to be related to birth defects.156. Face masks worn by dental workers filter out only about 40% of small dislodged amalgam particles from drilling or polishing.34.249. significantly reduced fertility and lowered probability of conception (10.24.37. Female dentists have increased rates of spontaneous abortion and perinatal mortality (193.222. A study in Poland found a much higher incidence of birth defects among female dentist and dental assistants than norrnal(l0).50). conjunctivitis. as well as higher brain and body burdens( 1. and another study found an increased risk of spontaneous abortions and other pregnancy complications among women working in dental surgeries(277b).433).12 l). Populations with only slightly increased levels of mercury in hair had decreases in academic ability(3).38.l b). Female dental technicians who work with amalgam tend to have increased menstrual disturbances (275. Dental staff have been found to have significantly higher prevalence of eye problems.1b). musculoskeletal.74).433)) .38).99). which often contain higher mercury levels than in the mother’s blood (20.279. Dentists and dental personnel experience significantly higher levels of neurological. The level of mercury excreted in urine is significantly higher for female dental assistantsthan dentists due to biological factors (17 l. 5.246.248.146. Even dental personnel with relatively low exposure(urine Hg<4 ug/l) were found to have significant neurological ef’fects(290) and was found to be correlated with body burden of mercury. increased spontaneous abortions (lo.110). SIDS. Body burden increases with time and older dentists have median mercury urine levels about 4 times those of controls. and their children have significantly lower average IQ compared to the general population (1. Because of high documented exposure levels when amalgam fillings are brushed( 182. A chronically ill dental nurse diagnosedwith mercury sensitivity recovered after replacement of fillings and changing jobs(60).38. Amalgam has been shown to be the main source of mercury in most infants and breast milk.38.248).compared to controls.61 . and poor performance on memory tests(68.395).249.( 10.124a). etc. Effects are directly related to length of time on the job(277).290) Some older dentists have mercury levels in some parts of the brain as much as 80 times higher than normal levels( 14. From the medical register of births since 1967 in Norway.3 1.99).493. and concluded dental work to be an occupational hazard with respect to reproductive processes(401).277.245.247. Several dental assistants have been diagnosed with mercury toxicity and some have died of related health effects(32.186. An epidemiological survey conducted in Lithuania on women working in dental offices(where Hg concentrations were < 80 ug/M3) had increased incidence of spontaneous abortions and breast pathologies that were directly related to the length of time on the job(277a). and a female dentist recovered from Parkinson’s after mercury detox(248).246.10. increase with years of exposure (1.247.34. mood.

S. Studies have found significant measurable adverse health effects at levels far below current government regulatory levels for mercury(290). etc. The use of mercury amalgams has been banned for children and women of child-bearing age or put on a schedulefor phase out by several European countries. Scientists and Government Panels or Bodies That Have Found Amalgam Fillings to be Unsafe.19. that requires all dentists in the state to discuss the safety of dental materials with all patients and to post the following warning about use of amalgam on the wall of their office: “This office usesamalgam filling materials which contain and expose you to a chemical known of California to cause birth defects and other reproductive harm”. REFERENCES (1) Denton S(MD) & ButlerJ. Caulk Inc.Ott 1990. advisesthat amalgam should not be used as a base for crowns or for retrograde root fillings as is commonly done in some countries(387). The Chairman of the panel.Univ. A major amalgam manufacturer. 1.94. 36. Proceedings of the First International Conference on Biocompatability. cardiovascular.38. Japan. and found no threshold level below which effects were not measurable. (2)U.435).170. Sweden.1999.189.S. Proposition 65.236. and reproductive systems from common levels of exposure(Section IV)..208.18.212. Many of those researching amalgam related health effects including several very prominent scientists have concluded that the health effects are widespread and serious so that mercury should not be used as a filling material (1. and motor function related to mercury exposure level as measured by excretion levels(290).61. and CNS system cancers among dental workers( 14..222. A World Health Organization Scientific Panel concluded that there is no safe level of mercury exposure( 183.have found increased risk of lung.164. 7. A study of dental personnel having very low levels of mercury excretion found measurable neurological effects including memory. hormonal.209. EnvironmentalProtectionAgency(EPA). kidney. including Canada. mood. Great Britain. Switzerland.20.88.238.( 164. NationalCenterfor . Both countries have indicated plans to ban or phase out use of amalgam. IX.p 133-I45. 183. of Health in Germany issued an advisory warning against use of dental amalgam in pregnant women(61). A Canadian Government study for Health Canada concluded that any person with any number of amalgam fillings receives exposure beyond that recommended by the USPHS Standard(209). have similar or more extensive bans or health warnings regarding the use of amalgam. 3. Austria. Many homes of dentists have been found to have high levels of mercury contamination used by dentists bringing mercury home on shoes and clothes( 188). Australia.60. EPA found that removed amalgam fillings are hazardous and must be sealed airtight and exposed of as hazardous waste(214).34.435) A Swedish National Mercury Amalgam Review Panel and a similar Norwegian panel found that “from a toxicological point of view. Lars Friberg stated that “dental amalgam is not safe for everyone to use(208238).Life SciencesPress.Of Psychology. Norway. In 1987 the Federal Dept. A Swedish medical panel unanimously recommended to the government “discontinuing the use of amalgam as a dental material”(282). to the State 4.143.208). The use of amalgam is declining in Europe and Germany’s largest producer of amalgam has ceased production. The U.S. Most European countries require controls on dental waste amalgam emissions to sewers or air.99.153. 227. The director of the U.99.S. brain. New Zealand. Most major countries other than the U. Other studies have found measurable effects to the immune. “IntegratedRisk InformationSystem. Of North Texas.210.1 15.283). The Legislature of the State of California passed a law.57. Federal program overseeing dental safety advises against using mercury amalgam for new fillings. 2. mercury is too toxic to use as a filling material”(l64. Dept.282).148. France.

Runnebaum B “Heavy Metals and Fertility”. J Can. Dent. “Main and interactive Effect of Metallic Pollutants on Cognitive Functioning”. Dent. & Pihl RO et al. & 0 Chang YC. Sept 24. & A. Dr. (5) D. & U.Yeh CY. Bagchi D. sixth Ed. Roydhouse et al. 1984. 1985.1981.Skuba. 4906:378-395. Wissenschaftliche Produktmonographie. Daniel V. & Gowdy JM et al.gov/ncea/iris. (10) Editorial. 1983. 54(8):593-611. Mercury poisoning. Arch Occup Environ Health.Chop et al. (4) Lee IP. Jones et al. Reduction in mercury vapor levels in Seattle dental offices.Roller.Environmental Assessment.57(2):19-2 1. Glasgow Scot. 1993. Office of Water.“Effects of Mercury on Spermatogenisis”. “Subclinical neurotoxicity of mercury vapor revealed by a multimodality potential study of chloralkali workers”.Part A. 1977. Sweden(lOO cases). J. 1997. Of Clinical Physics and Bio-Engineering. Miller et a1. 1998. Johann Dimaval (DMPS). Mutat Res 1996 Jun. Button. Bains et al. Runnebaum B.. [olle.24:237-243. IOO(I): 6-9. “Oxidative stress induces programmed cell death in neuronal cells”. & National lnst of Dental Research. 71(1):95-l 05. Neurotoxicol Teratol 1998.32(3):395-409.“Mercury in dental offices” J Can Dent Assoc.25(3):335-58. JD Kruse-Jarres(Ed.“Repot-ton Independent survey taken of Austin dental offices for mercury contamination”. & S.38:4044 11. page 119 Ruprecht. & (b) Dr. Gynecological Clinic. Waibel S.C. J. Nov 1979. & United States Environmental Advisories: Protection Agency. Tubingen Univ. Frejavagen 33. 194(1). JADA Sept 1984. Future Medicine Publishing. Cordon LD. “Subclinical effects of exposure to inorganic mercury revealed by somatosensory-evoked potentials.42(3): 100-l 06. ~617.epa. Seizures. Sick From Amalaam R-Dental Ab.Olle Redhe . (8) Redhe. 199. & G.“Survey of Des Moines area dental offices for Mercury vapor”. J Abnormal Child Psycho]. ADA News.117(3):482-8. Waldbrenner A.198l. & R. 1977. “Mercury Contamination in the Dental Offtce: A Review”.. Erfahrungsheilkunde. & (b)Gerhard I.I. p5 l-68.l996.57A:347. Workshop: Biocompatibility of metals in dentistry. Diagnosis of heavy metal loading by the oral DMPS and chewing gum tests. April. Dent. 50(7):5 17-522. & Recommendations in dental mercury hygine. Dr Johann Ruprecht. & Stohs SJ. Oxidative mechanisms in the .(Gordon . Science. EPA-823-F-00-20. JADA and to floor 103(9):402-407. Thuro H. 1978. Hey1 Corporation.Kantor et al.epa. Vol 198. J California Dental Assoc. & Gordon HP. Wang JD.198 1 . Oguraet al.181.219:205-8. EPA. Diagnose und Therapie von Umwelterkrankungen.J Environ Sci Health B 1997 May.S. (I I) Lamm 0 et al. E. 1985. Visual evoked potentials in 6 year old children in relation to mercury and lead levels. Assoc. l35( I): 115-7. “Ganzheitiche Diagnostik un Therapie bie Infertilitat”. “Survey for Mercury vapor in Manitoba dental offices”. Jan 1997. ~457-458. Virginia Dental J. & (d) Gerhard I. ‘Neurodegenerative disorders in humans and role of glutathione in oxidative stress mediated neuronal death”. 1998.Schulein et al. 1980. (12) Dimaval Scientific monograph. 1998. & H.4(3):301-309.Pregnancy in Female Dentists. Mercury Update: Impact on Fish Advisories-Fact Sheet. JADA. 8(1):23-27.1983. Monga B. 20( 1):9-17. & J.et al. 1999.171. 1997. 13(2):185-98. & D. S-79133 Falun. & Proceedings of Intl Conference on Mercury Hazards in Dental Practice. & G.F.Iowa Dent.Oper.Tan et al. Sveinsson K.). 12:37. Brain Res Rev. Waldbrenner P. Ott.com] (9)9)(a) Dr. J Pharmacol Exp Thera 1975. Hum Reprod Update 1998 May. “Activity of Gpx and SOD in workers occupationally exposed to mercury”.Klinghardt(MD). Runnebaum B “Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages”.H.M. “Migraines.Battistone et al.O. 5 l(2): 156-l 58. http://www. 1984.gov/ostifish/advisories/general. Assoc. (6) T. Clinical Chemistry and Chemical Toxicity of Metals. “Mercuric chloride-induced reactive oxygen species and its effect on antioxidant enzymes in different regions of rat brain”. Sept.Can.htm. Journal of Learning Disabilities. 70( 1):35-36 1984. “Mercury as Occupational Hazard in Dentistry”. Immunol.html . Texas Dent.“Mercury vapor in the dental of&e-does carpeting make a difference?“. & Moon C et al. (13)SHussain et al. & Mercury in the OfIice.340(2-3):175-82. Nov 2 1.redhe@telia. & (c) Gerhard I. “Mercury vapor related to manipulation of amalgam surfaces” . & (f) Gerhard I. 1983. The National Listing of Fish and Wildlife Summary of 1999 Data.Bulat. 1984.epa. “Whole blood mercury in mental hospital patients”.Gerhard. 71 Suppl:S37-9. Office of Water. Ohio. Dept.. & P.W. J Neurochem. NY S Dental Journal. http://www. and Mercury Toxicity”. & RT McNemey et al.html (3) Marlowe M et al. “A comparison of chromosome aberrations and micronucleus techniques for the assessmentof the genotoxicity of mercury compounds in human blood lymphocytes.S.W. Eur Neural. “Survey of Mercury vapor in dental o&es in Atlantic Canada”.gov/ost/fish/mercury.a Mercury Hazard)& (several survey studies comparing level of mercury in hair of dental staff vs controls). “Main and interactive effects of metallic toxins on classroom behavior”. Am J Psychiatry. 1985. & R. J. “Hair element content in Learning Disabled Children”. Heidelberg. J of Toxicology and Environmental Health. & (b)AItmann L. 1985. Klinisches Labor 1992. J Dent Res Abstract 1092.204-6. Cincinnati. & (c)“Hormonal conditions affecting women caused by environmental poisons” in Pravention. 1993. http://www.1983.. (7) L. November 2000.

(a)Magnus Nylander.” Mercury horn dental Canada. Safety and Review Board of North Carolina. Longitudinal surveillance”.. & Wang Chen CP and Greener EH. & F. & Res.4:5536 (21) R.Vimy. Stand J Dent Res.Ag. The Pharmacological Basis of Therapeutics. Peterson LC.& L.ibiblio.Y. 107( 11):867871.64(S): 1072-5. FASEB J. “The contribution of dental amalgam to mercury in blood”. Ott et.Abraham. al. Am.“Toxic effects of metals%: Caserett and Doull’s Toxicolow. 198 1. J Prosthet Dent.L. et al. J. Am J Obstet and Gynecol.58(6). 1981. “Amalgam hazards in your teeth”. & b)Momoi Y.Kuhnert et al. 1982. 1977. & Lichtenberg H. Mac Millan Publishing Company.Physiol. II 1986.68(5):780-5 (18) M. J Dent Res 1989 May. &(c) Encyclopedia of Occumpational Health and Safety.84(2): 186-94. 1984. J.toxicity of metal ions. 30):RlOlO-R1014. FASEB J. Dent.Hahn et al. Boyer DB. “Comparison of mercury levels in maternal blood fetal cord blood and placental tissue”. Stockholm May . Fifth Edition.. 58:704-707. Implant Dent. Univ. (20) M. 1985. ICBM 1988.“hnra oral Mercury released from dental amalgams and estimation of daily dose” J. “Mercurv Concentrations in the human brain and kidnevs in relation to exposure 6om dental amalgam fillings”.D.1444.J.Lorscheider et al. Berglund M. Dept of Medicine and Medical Physiology .Takahashi. 4:23-7.. et al.Hansson. 1980.J. et al. “ the mercury concentration in humans from amalgam fillings”. 1984. 1992. Correlation of dental amalgam with mercury in brain tissue. breast milk.Nylander et al. Swed Dent J 1987. Environ Res 2000 Oct.Malmstrdm.Dt. Drew. M. & “Silver tooth fillings impairs sheep kidney function”. Dalisay C. Toxicology-Symptoms-Treatment. Environ Health Perspect 1999 Nov. 1990. &(b) Schupp. & Prosth Dent 1987. Measurement of galvanic current and electrical potential in extracted human teeth”.& (c)Barregard L. n. of Iowa.Y. University of Lund. &(b) Goodman. 143(4): 440443. l(2): 107112..64(S): 1069-I 075.al. “The effects of dental amalgam on Mercury levels in expired air” J.Sn . Lauderback CM. Svalander C.. “Occupational exposure to Mercury in dentistry and pregnancy outcome”. 1985 (25) C. Brodsky.D. Pediatrics 2000 Oct. 258:R939-945. intraoral corrosion resulting from coupling dental implants and restorative metallic systems. & Lemons JE et al. & Vahter M. 1985. “Longitudinal study of methyl mercury and inorganic mercury in blood and urine of pregnant and lactating women. Akesson A. Schutz A. faculty of Medicine. Cruz MC. Svare CW.167 I . Obstet and Gyneco1.. N. JADAl 11(11):779-780. “Evaluation of the safety issue of mercury releasefrom amalgam fillings”. 2(3): 194-20 1. of Calgary. 0rganen. Poisoning. J Orthomol Med (1996) vl 1. Sallsten G. Dent. Boyd.Cu. J.lO6(4):774-81. Calgary Alberta N. & (d) D. Springfield. Nylander.TheBasic Science of Poisons.88:269-72. 63( 1):7 l-73.. The Tagum study I: analysis and clinical correlates of mercury in maternal and cord blood. Distribution of mercury released from amalgam fillings into monkey tissues”. 1993. 3rd Edition. Galvanic currents between gold and amalgam.2.Z. Dept of Zoophysiology. (23) W. Pagulayan 0. Thomas-Publisher. & (b) Jackson GH.J. Lind B. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. as well as in umbilical cord blood”.Eggleston et al. Lorscheider. Gillman. 7:1432-33.. J. 1985.Lorscheider. Vol 2.Vimy.J.C.W. Racine CL. & Pocemich CB.L.Kuntz “Maternal and chord blood mercury background levels.FL Maternal -Fetal Distribution of Mercury Released From Dental Amalgam Fillings. & Patterson JE. Bjors U. “Mercury vapor in the oral cavity in relation to number of amalgam surfaces and the classic symptoms of chronic mercury poisoning”. Res. Journal of Oral Rehabilitation. Allan Butterfield D. “Mercury in human breath from dental amalgams”. www. Cardin AL. M. Orthomolecular Psychiatry 1983. Conference on Trace Elements in Health and Disease.87-94 (17) J. “The effects of dental amalgam restorations on Blood Mercury levels”. Bull Env Contam Toxic01 34 1985 459 (16) K. Am. Univ. Blohm.A.&(d) Arena. and Lead in Kidney Cortex of the General Swedish Population: A Study of Biopsies from Living Kidney Donors”. Charles C.Res. Mercury. 11:179-l 87.MolneJ.B. 261 (Regulatory lntegrative Comp Physiol. (24) J.Zn and trace elements in amalgam removed from an abutmenttooth underneath a gold alloy bridge that had been in vivo for nine plus years. (15) Svare CW et. 1g(2): 321-36. “Cadmium.Svare. Sweden. meconium. & Holland RI.139:209-212.. J Dent Res. Westberg G.Goyer. and infants’hair. 1993.. 1990 & Amer. & Ramirez GB. “Mercury burden due to amalgam fillings” Dtsch. “Mercury concentrations in the human brain and kidneys and exposure from amalgam fillings”. Schutz A. Physiol. 1992. Attman PO. Haglind P. Riedel et al.Vimy.. Quantitative analysis of Hg. (22) P. 65( 12): I44 1. Neurochem Int (14) 2001 Aug. N. Free Radic Biol Med 1995.org/amalgam/ (I 9) Matts Hanson. Geneva.Zahnarztl.Proceedings. McGrawHill Inc. 47:490-496.704-7.F.39(2):141-9. A galvanic study of different amalgams. & Snapp KR. & M. 60(9): 1668.Y. Zahnarztl Z 39(9):199-205. 1987.1991. Ostrea E. International Labour Office.l990. Dent Res.

Chronic Mercury Toxicity. 1969. “Fatal mercury intoxication in a dental surgery assistant”.Zamm. Anttila et al. 117(2): 199-202. Emory et al. 1992. Danscher G. Uniformed Consent: the hidden dangers in dental care.com. & Sheppard AR and EisenbudM.25(2): 207-2 1O. 1973.I I 1 I 1 I I I I 1 1 1 I I I 1 I I I 25-1992. “Simulated crevice corrosion experiment for ph and solution chemistry determinations”. 1CBM conference Colorado Springs. Stockholm Mercurv Poisoning. 1999. Update Health Issue Assessment. “Xenobiotic metabolism and adverse environmental response: sulfurdependent detox pathways”. & Mareck and Hockman. 1997. 55:l l-15.Malmstrom. EPA.E. Co. 1977. & (d)S. & Trivedi and Talim. Of Occupational Health. (28) F. 114(2):89-98. 1984. & Hal Huggins. J Orthomolecular Med. & Health damage due to exposure to mercury vapor (Mercury) Szkody zdrowotne wywolane narazeniem na pary rteci (Mercury). Shannon. 5 l(3): 3 18-20. Its All in Your Head. 1984. 1974.com.5(53):138-142.. 1976 . 1999. Tidsskr Nor Laegeforen. 29:73-81. Pirrone P.Hoos.197 1.POLISH. 127:533555. 1997. (33) S. Corrosion. ISBN: O-94 1011001-1 & Dental Caries as a Cause of Nervous Disorders. “Mercury in urine of employees exposed to magnetic fields”. MaImstrom et al.l 1:399-405. “Removal of dental mercury: often an effective treatment for very sensitive patients”. Mercury Health Effects. & H.com (36) Sam Queen. 42: 1183-l 197. N. http://www. from Dental amalgam-A Hazard to the Human Brains. Dentinal and pulpal uptake of mercury from lined and unlined amalgam restorations.1988. Assoc Dean for Research. J CDA 37:255-256..F. JADA. Periodo. J. Langley-Evans et al. FASEB J 9:504-508. Res. 33(6): 300(35) Huggins HA. 1998. & 1 Mandel. (37) A. p668-. Psychiatr Clin North Am 1998. 42(4): 233-8 1989. (30) T. Williams and Wilkins.C. Toxic01 Appl Pharmacol.207-2 10. “Mercury in gingival tissues adjacent to amalgam fillings”. (Abs 122). MCS. Roman0 C. 73:33-43.& H Reden. New York university press.bioprobe. “Mercury exposure from silver tooth fillings: emerging evidence questions a paradigm”. 11:108-l 15. Moszczynski-P Jr. http://www. Waring RI-I.867 Donated by The ADA.hugnet. & (e)Alberti A. School of Dental and Oral Surgery. Moszczynski-P Czas-Stomatol.. Biol Psychiatry 1999. Final Report.1000-1006.New Hope Against an Endemic Disease.S. & S. Philadelphia. Hampton Roads Publishing Company Inc.Inc. & Hartman DE. & SanchesSotres et al. Bioprobe. Holland RP.Till et al. J. Sulphation deficit in “low-functioning” autistic children. 1964. Swedish paper translated in Bio-Probe Newsletter. 1993 & C. JADA Vol 115 December 1987.Cd) inhibit the activity of the liver and kidney sulfate transporter Sat-l”. British Dent Journal. Office of Health and Environmental Assessment.Cook et al. Biological Effects of electric and magnetic fields of extremely low frequency.Fan. & (b)P. 1999.TE. & App . “Mercury Release from Amalgam Fillings and Oral Dysbacteriosis as a Cause of Resorption Phenomena” Zahnarztl Welt/Reform(ZWR). “Amalgam derived mercury in feces”..” Why is Mercury toxic ?: Basic chemical and biochemical properties of Mercury/amalgam in relation to biological effects”. Comp Biochem Physiol Pharmocol Toxic01 Endocrinol. 3rd Ed. Vol 122.Schmidt et al.. “Release of elements due to electrochemical corrosion of dental amalgam” J of Dental Research. EOA-600/8-84f. 140: 543-546. Stortebecker Foundation for Research. & Zander JADA.(p753) Haddad.A. “Heavy metals (Hg... Aug 1991. “Mercury vapor release from dental amalgam in vitro caused by magnetic fields generated by CRTs”. Finnish Inst. Perio. 1992. 1994. Odontal Revy. Fourth international symposium Elements in Experimental Medicine. 1972. 9th Ed. Proceedings. Olsson et al. Swed Dent J 1991 p 3 1 Abstract 22 (29) Fisher et al.Lorscheider et al. 1974:23.bioprobe.Fusayama et al. “Effects of paternal occupation exposure to lead or mercury . McFadden. 1990. Eur J Oral Sci 1997. J Oral Rehab. 1961. (34) PatrickSt&tebecker. W. Saunders and Company. (3 1) Langan.154(2): 18 l-7. Journal of Trace Nylander et al. & C. & Ortendahl T W.Y. J Dental Res. & Horsted-Binslev P. & Q Markovich et al.J Prosth Dent 11:522-532.B. J CDA. Vol 9( 1):5-6. 1969. (22 patients) (27) Matts Hanson. Baltimore.. Hogstedt P. & F.A.2 I (3):659& Merritt’s Textbook of Neurology. 25. 1996. Prosth. & U. and Winchester. & Trott and Sherkat.Freden et al. “Increased Prevalence of poor sulphuoxidation in patients with Rheumatoid Arthritis”.http://www. Epidemiology in Occupational Health. Levy. Como ltaly Sept 1985 (26) A.. 1978:87. Dentistry. 1995. 1989 Apr. & Clinical 70. 5. & Goldschmidt et al. (32) T.1130-1134.1995. Ann Rheum Dis. & Turgeon et al. 1963. 1957. Odontal Revy. “SO2: a potent glutathione depleting agent”. Jan. 105: 338-43. The use of Mercury in dentistry: a critical review of the literature. Missed diagoses and misdiagnoses of environmental toxicant exposure.Associate Professor of Neurology. & T. “Silver amalgam: an unstable material”. 30:766-770. 111 (l-3):43-65. 1988: & J Canadian Dental Assoc. & NeuroloW for Barefoot Doctors. Karolinska Institute. Elia M. & Center for Progressive Medicine. Columbia Univ.L. Management of Poisoning. J.Toxicology.46(3):420-4.

1993.Biochem Mol Biol Int 1996 Aug.H.Ed.. “Lazer Light Scattering Study of the Toxic Effects of Methyl mercury on sperm motility”..Saunders Co. 37:7687. et al. 1985: 157. 1990. Teratogenic and genetic effects of Mercury toxicity. Forsell et al..A. “Mechanisms of neurotoxicity and their relationships to behavioral changes”. J Biol Buccale.I 8 8 8 8 8 8 8 8 8 8 1 8 8 8 8 I 8 :I on spontaneous abortion”.Inouye et al. (43) Knapp LT. 1992. Sonnenfeld NL. Swed. in KomDendiu der Reeulationspatholocie und Therapie.Perger. ISBN: o-94101 l-03-8. 77(3):461-7 1. 1986 : 14. J Pharmacobiodyn. Surg Oral Med Oral Pathol.Hansen et al A survey of metal induced mutagenicity in vitro and in vivo. 1995. Int Arch Allera Immunol. 4th Ed. Dtsche Zahnarztliche Zeit. 22:3-9. 1990. “Generalized allergic reaction from silver amalgam fillings”. 8c K.Strassburg et al.D.nl . & Natura Med 1992...B.7(4): 295-306. Am J Epidemiol.‘% -viva self reactivity of mononuclear cells to T cells and macrophages exposed to Hg CI2” Eur. “MeHg and neurotoxicity in children”. 10:370-375. military population”. “Autoimmune disease induced by mercuric chloride”. Mercury content in amalgam tattoos of human oral mucosa and its relation to local tissue reactions.. (50) Allan W. 1999.“.227-232. 1993. The mediation of mutagenicity and clastogenicity of heavy metals by physiochemical factors. Allgemeine Homoopathische zeitschrifi. & M. 2000. School of Public Health. Comparative in vitro cytogenetic studies in Mercury exposed human lymphocytes. lnfertilitv and Birth Defects: IS Mercury from Dental Fillings a Hidden Cause?. 1980. Blackbum. 253.28: 1278-91. & PGrandjean et al. Euro J Oral Sci 1998.37(8):9 15-2 1. EW. 184-I 87. JADA. Klann E. & “Amalgamtherapie fur Arzte und Zahnarzte”. Panta 3. Thyrotoxicity of cadmium and mercury. Toxic01 Lett. “Homoopathische B$adlrg Allg.Toxicol Teratol. Buchner et al. Environ Res. Amalgamtherape.Kawada et al. J of Occup & Environ Med. Paternal exposure to mercury and spontaneous abortions. K.l986 137(8):2548-54 8c Stand J of Immunology. Int Arch Allergy. J Dermatol 1992.25(3):361-83. & K.Vanay et al. 8: 293-304. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. Souder W.20(8):1125-38.Caron et al. Philadelphia.7( 1): 11-l 5.. & J.239(6): 225-233 . Harrison et al. 1985:7. Amalgam tattoos: light and microscopy and electron-probe micro-analysis. & S. & B.& Homoopathische Behandlung de Amalgamvergiftung & “Polemik und Wirklichkeit”. Prenatal mercury exposure raises blood pressure.Kingman et al.Veprintsev. “Autoreactive T cells in mercury induced autoimmune disease”. J Immun.1984.3 1:65-74 & M. Dent Res. 1994. “CNS arylsulfatases inhibited by methyl mercury”. Hemon D. 19(8):487-92.Arvidson. Therapeutikon. (42) Babich et al . 1988.Badou et al.49(2):139-47. Bio-Probe. (47) A. 1980. & “Schnupfen-Was tun?“. & T. 1996.& J.39(6): 1255-65 (44) L. J 68: 135-139.Ziff and M. & Savitz DA. 241(5). v4 1. & D. Mutation Res. 1995. “Amalgam Dentaires et Allergies”. 83-l 00 Swartzendruber.& M. Corrosion of dental alloys. “Modulation of protein kinase C by heavy metals”. Amsterdam.. In vitro testing of dental materials by means of macrophage cultures. Biomed Environ Sci 1992. J. “Lymphocyte transformation induced .Friese. (38) S. Inc. 1985:37. & Ghosh N.. Br J Ind Med 1991 Jun. Journal of Medical .135(8): 13. Toxicology. & D.1987 (39) M. 3(3):149-59.. Behavioral and neuropathological effects of prenatal methyl mercury exposure in mice”. 199 1.. (40) F. 109( 1): 1 l-20 . Homoopathische Z.1979. 1998.1957. The Effect of Mercuric Chloride on . (46) Veron et al. 1984:3. Neurobehav. J Immunol.E. (48) & Skinner. (45) L. 503-l 8. Olshan AF. Review of epidemiologic studies of paternal occupational exposure and spontaneous abortion.(total:over 1200 cases) (41) Khera et al. Nilner et al.S.Verchaeve et al. “Mercury concentrations in urine and blood associated with amalgam exposure in the U.87(2): 157-63.. & Goldman.. Electron microscopic Xray microanalysis of metals deposited in oral mucosa. Kanzaki et al. & G. Elsevier.B. Kubicka et al. 1994. & Cordier S. 106( 1):582-7.381-430. J Amer Co11Toxicol . & Sorensen N. 150(3):301-5: & Z. Sonntag-Verlag. (41 cases).15. & “Belastungen durch toxische Schwermetalle”. Pb2+ and Hg2+ binding to alpha-lactalbumin”. “HgCl2-induced IL-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels”. Russian Academy of Sciences. The biochemistry of Mercury in the environment Nriagu.69( I):7 1-4. Epidemiology 1999.(MD). J Biomed Mater Res 1986. Dent. National Institute of Dental Research.O. Deplan F. Med Hypotheses. 22 l-226. (4): 25 lder Amalgamvergiftung”. Am J Ind Med 1994 Mar. Haug-Verlag.1970. & “Amalgamvergiflung_moglicher”Der Naturazt. & Pelletier et al.1986. Mandereau L. W. & Mohamed et al.253-286.“Corrosion studies of dental gold alloy in contact with amalgam”. 194 1. & Schoonover IC.Annau et al.D.48(6):375-81. “Amalgam tattoo of the oral mucosa: a clinicopatholigic study of 268 cases”.Pelletier et al. Institute for Biological Instrumentation. & K.revised.Rajanna et al. Johns Hopkins Univ. 8 1(2-3): 197-203: & A. Screening. p3 l-34.. 8~ Teratology. 5(3): 236-40. Pharmacol Toxicol.. 8(3): 62-68.. 1967. p284285. J Androl. Jan 1996. 1995. (49) A.Ziff. &Erfahrungsheikunde. J Biol Chem 2000 May 22.l985:460-465.49(2): 219-25. “Effects of inorganic and methyl mercury on thyroidal function”. 1996. The Science of Dental Materials.

Sweden LYMPHOCYTE IMMUNO-STIMULATION ASSAY -MELISA” & VDM Stejskal et al..K. “New aspects of murine coxsackie B3 mycocarditis: focus on heavy metals”. Toxicol and Applied Pharm 1979.D. Decreased Hg retention with DMSA.“In viva mercury and methyl mercury levels in patients at different intervals after amalgam . 1996. “Hong Kong subfertility links to mercury in human hair and fish”. & Chem Res Toxicol.l995.E. & USA Today. Davies “The Methylafon of Mercuric Chloride by Human Intestinal Bacteria”. Med Sci.Scan. Biomed Pharmacother. Columbia Univ. App Microbial. Ann NY Acad Sci.l995. J Toxicol Clin Toxicol.Owen et al. & J. Toxicology 1991 Mar 11. “Trace elements linked to cardiomyopathy”. “Direct evidence for glutathione as mediator of apoptosis in neuronal cells”. & Assoc.44(9):7 14(64) Steinberg D. Otzenhausen. Niv Y.Godfrey. Lancet 1999. & M. Dept.48: 49-55.37(5):991-1015 (56) X. Jaeger A. “MELISA: tool for the study ofmetal allergy”. Lund et al. 1984. & Science News. Prescription for Nutritional Healing”. Leung KM. Of Clinical Chemistry. Base1 1975 . Aug.. 11(7):824-37.melisa. 192(5): 447-54( 12 cases). April 1994 Sydney Australia. Dent. & (c) Stejskal V. 1996. J Neurosci. Amer J of Cardiology.Nicole et al. J Neurochem.9 1:150-l 52: & Rowland.Drasch et al.G.“Qxidative mechanisms in PD”. (59) A. (57) N. Niedersachsisches Umwehministerium. Mov Disord. Orstavic.1994. Sci Total Environ. 199 1. & G. 9(7):1117-26. of Neurology. & Butterworth RF et al.Peiper et al. Term. 14(7): 4385-92.Ferrari et al. & Livardjani F. Ncurobehavioral effects of NAC conjugates of dopamine: possible relevance for Parkinson’sDisease”. mechanisms involving ROS”.Shen et al.Stejskal. J of American College of Cardiology. Hebrew Univ. Germany. Ratan et al. Chem Res Toxicol. & A. Dept.. “Mercury mobilization by DMPS in subjects with and without amalgams”? Zentralbl Hyg Umwehmed. & Kostyniak PJ. March 2001... J Appl Toxicol. “Mercury Burden of Human Fetal and Infant Tissues”.K.M. 1994. Mercury among dental personnel in Israel. European Heart J.Zander et al. “Formation of methyl mercury by bacteria”. Offen et al. & N.Spencer et al. (60) V.39:267-274 (53) C. 786:2 17-33. “Concentrations of mercury in brain and kidney of fetuses and infants”. Exp Neurol. 13(5):321-5. 1978. 7(I) 1994. http://www. Proceedings of Infectious Diseases Sot. ~356. Immunological effects of amalgam components: MELISA-a new test for the diagnosis of mercury allergy.“Confirmation of Mercury Retention and Toxicity using DMPS provocation” .. Acta Odontol. & RR. & (b)D.“Methylation of Mercury from dental amalgam and mercuric chloride by oral Streptococci”. Frustaci et al. Valderhaug (52) “Bacteria1 Growth on Dental Restorative Materials in Mucosal Contact”. (65) Y. 52(9):349-55. for Birth Defect Children. in Quecksilber in der Umwelt-Hearing zur Amalgamprolematik.P. Of Pathology. I996. Kostler.Campbell & M. (54) M. Franklin. Grauer F. 156(2): 113-8. & J.22( 1):3 l-49. 1998. 1998. 1996. “Study of mercury uptake in dental students”. 1998. 1997. 1999. (62) W. Karolinska Institute. 1964.J. 8(5):991-1000. 1994. 1993.198 1. Scand. Balch et al. Eur J Pediatr 153:607-6 10. 1999.Effects of mercury on the isolated heart muscle are prevented by DTT and cysteine”. Grasso. J Appl Toxicol. & Husten L.Dtsch Zahnarzt Z 1989.66(3):289-95. Toxicology in Vitro. 1996. April. President of the Austrian Oncology Society.2 1(1):35-39. Kopolivic K. Ameberg.3 1: 1064-1065. 33(6):1578-83. “Use of thiols in treatment of PD”.141(1):32-9.Lutz et al.Thyroid Function of the Rat.. Dahlet M. Perlyte M.org (61) E. Paper presented at the World Congress on Cancer. 1975. & A. 1994. (63) K. (51) Heintze et al. Journal of Trace Elements in Medicine and Biology. & G. June 5. 1997. Vassalo.(80 cases). April 29-May 14. 15(4):2857-66. Lung and blood superoxide dismustase activity in mercury vapor exposed rats: effect of N-acetylcysteine treatment. J Neurosci. 1992. Johns Hopkins Univ.V. Soiefer AL. 5(4):397-400. Experientia. Toxicol Appl Pharmacol 1999 Apr 15. Thornsberry. 16: supp 0: 20-4. “Treatment of acute MeHg poisoning by NAC”.J of Advancement in Medicine. & Dahhan. MRL Services. Neurochem Res. Sept. & JJ Heales et al.1999.Fung et al. & D. (58) Kostial K et al. “Marked elevation of myocardial trace elements in Idiopathic Dilated Cardiomyopathy”. “Cysteine & GSH in PD”. Dept.Hamdy et al.3 1(7):428-32. 1998. & D. Can J Neurol Sci.Birth Defect News.Forth. Ledig M. 1983. (55) Dickman MD. Electrocardiogrphic Changes in Mercury Poisoning. Orfaly. Dept.4(4):206-10. Ilblack et al. 71(5):2 I 12-22: & P. Stockholm.F. Chemosphere 1998 Aug. “Toxikologie von Quecksilberverbindungen”. Of Oral Biology.Vol 155.Jenner. & Mercury and organochlorine exposure from fish consumption in Hong Kong.D. 1995.10:6 I-67. 13(Suppl):24-34. Proceedings of the International Symposium Status Quo and Perspectives of Amalgam and other Dental Materials. San Francisco. & W. Of America. Kopp P. Res. 1984. 353(9164): 1594. 19982 14: 165-74. Ca.M. 2nd Ed. Leroy M.

Adv Neural. 49(5):384-394. 1997. (67) A search for longitudinal variations in trace element levels in nails of Alzheimer’s’s disease patients. “Resolution of lichen planus following removal of amalgam restorations”. _ Of Chemistry. Annals of Allergy. Air. “Behavior effects of low level mercury exposure among dental professionals”.Drouet et al.“Psychomotor testing of dentists with chronic low level mercury (68) exposure”. M. JADA. 1997.MThompson&W. 1995.A. K. Batelle Center for Public Health Research.“The relationship between mercury concentration in human organs and predictor (85) variables”.30:37-39. ~156-62.1993.E.Ritchie et al. (73) Toxicol Eniviron Health. J Sot Occup Med. J Pharmacology and Experimental Therapeutics. Water.Weiner et al. “Allergy to Silver Amalgams”. Zamm. & “An estimation of the uptake of mercury fi-om amalgam fillings in Swedish subjects”.G. 60(2): (71) 267-273. and Soil pollution. 1976. Sci Tot Environ.Smart et al.Bjorkman et al. 144(l). C. lnt Arch Occup (82) Health 66:209-2 12. porphyrins. Neurotoxicology & Teratology. 1986. Allerg Immunol(Paris).20(4):429-39.52( 12): 8 13-7 D Gonzalez-Ramirez et al. Schulte et al.L. 29(10): 1412-4. 70(3) 23-6 “Regional brain trace-element studies in Alzheimer’s’s disease”. Arch Biochem Biophys. 1998. E.Carlson-MP College of Northwest-Dent. LSkare. Of Glasgow.Bittner et al. Orthmol. Lincoln. 1988. Univ.Smith. 9: 1-7. & M.I. (72) M.” Silver Concentrations in Human Tissues: the Dependence on Dental Amalgam”.Veltman et al. Neurotoxicolgy. & A. Seattle.J Trace (78) Elements in Medicine and Biology. (80) Antimicrobial Agents and Chem. 1998. “Mass Balance and Systemic Uptake of Mercury Released fi-om Dental Fillings”. & Thompson et al. LSkare et al.248(2):467-78. 1986. “Imbalances of trace elements related to oxidative damage in Alzheimer’s’s diseased brain”. “Neurobehavioral effects in Occupational Chemical Exposure”.Osterblad et al. “Human Exposure to Hg and Ag (83) Released f?om Dental Amalgam Restorations”. Vance DE Ehmann WD Markesbery WR In: Biol Trace Elem Res (1990 Jul-Dec)26-27:461-70. Neurotoxicology. and neurobehavioral changes of dental workers in (69) Monterrey. G. 138( l-3): 10 l-115. Environmental Research. “Mercury Concentrations in Children with and without Amalgam Restorations”.52( 1): 19-33. ‘:Epidemiologic assessment of measures used to indicate exposure to mercury vapor”.Drasch et al. SO:27l-86. “P450 and hemeoxygenase enzymes in the basal ganglia and their role’s in Parkinson’s disease”. 199 1 May-Jun. & Schweiz Monatsschr Zahnmed. & A case of mercury contamination of a dental suite.A. “Increased blood mercury levels in Alzheimer’s’s patients”. University of Nebraska Medical Center. L. A.“Mental effects of mercury poisoning”. Br Dent J 036) .9(2):82-7. IADR Abstract 165. J. “Antimicrobial and Mercury Resistance among Persons with and without Amalgam Fillings”. Neural. “Mercury reactions in the human mouth with dental amalgams” Water.C.197s.1998. Neurotoxicology (1988 Spring) 9( 1):1-7 & Hock et al. Katsunuma et al. 92:1189-l 194. D.C. 22(3):8 1.Liang et al. IADR Abstract 160( 1995): & Occup Environ Med. Mantyla et al. (66) Of Kentucky. J. “Behavioral Effects of Low Level (70) Exposure to Hg vapor Among Dentists”. (75) 64(5):472-75.Echeverria et al. Amalgam allergy associated with exacerbation of aspirin-intolerant asthma.Dentistry. “Alterations of heme. 1990. 1993. “Mercury in Saliva and Feces after Removal of Amalgam Fillings”. 1995. Mexico”. cytochrome P-450. 19:339-345. (81) 80:103-107. 10559-68 & Comet-t et al. et al. Med.Dent Res (76) 73(4): 980 A-334.J. v6#2 ~~67-77 (199 1). 1999. 17(2): 16 l-i 68( 1995). Swedish National Board of Occupational Safety and Health. (74) Neurotoxicology & Teratology. Air. Mercury poisoning in dentists. J. Neurodegenerative Disease Research Center. Amayasu H.Dept.Begerow et al. S. Calsakis et al. Clin Exp Allergy 1999. 1994. 1980. Archives of Environmental Health 1994. J.R. 7: 195-206.Foo et al. Dental Mercury: A Factor that Aggravates and Induces Xenobiotic Intolerance.Cianciola et al. Toxicology and Applied (79) Pharmacology.C. Univ. 1976. Vol92. Science of the Total Environment. Nakagawa H. vl68. JADA.1996. 39( 11):2499.1995 D. “Mercury toxicity in the dental office: a neglected problem”. & (b) J Dent Res 75: 38-.“Long-term mercury excretion in urine after removal of amalgam fillings”.G. 272( 1): 264-274. 8~ Yoshida S. 1995. “Is mercury a respiratory tract allergen?“. and steroid metabolism by mercury in rat adrenal (84) gland”.104( 11): 1336-40. 1994.197s. King’s College.South Med J 71:904-5. D. “Anaphylaxis improvement after removal of amalgam fillings”. 80( l-4):59-67.Oral Surg. 1990. Neurotoxicology.R. A. Markesbery. and Soil (77) Pollution. ~255-265. UK.n3. Al6ed V.46:371-5. & Ehmann et al.1995 L. restorations”. “Uninary mercury. Mikami H.Riedl et al. Transm.1995. J Dent Res 74:420. & Symington D. & L. J.

1990. M.1984. & H. 6l(Suppl 3): 6468650s.Molin et al. Stand J Dent Res 102(4): 2 16-222. Possible environmental factors for Parkinson’s disease”. Dental amalgam. J Radioanal Nuclear Chem (92) 195( 1): 13. “Elemental imbalance studies by INAA on ALS patients”. “Mercurial neurosis resulting ti-om amalgam fillings”.1652.33(5): S..1998. Med Sci Res 24(5): 355-356. & amalgam” European J Oral Sci 1996. “Oral lichenoid lesions caused by allergy to mercury in amalgam”. Toxic and essential metal interactions. n. Greer M. & G.12. Tandon et al. selenium. & R. 1 l(4): 195-203. L. & Adams CR.Fl. 1996.160: 434-437. 1998. Stand J. (97) Redhe 0. & Khare et al. 1995.48: 189202. Metal exposure from amalgam alters the distribution of trace elements in blood cells and plasma. & Vroom FO. 1989. “Mercury vapor intoxication”. 1972. v. 95: 305-3 18.44(3): 246-8. & lichenoid lesions. 23 Dee. 1990. 1995. Tandlakartidningen 88( IO): 570-572. 1943: 1648. p. Vol7. Skoghmd. and (88) Feek. and Endodontics. Dermatol. “Recovery from ALS and from asthma after removal of dental amalgam fillings”. Rinsho Shinkeigaku 30: 1275-1277. Cutis. Contact Dermatitis.Seidler et al. J Dent Res 74:420.Jolly et al. Occup Envir (93) S. Lin JT. 4:229-236. & P. 102(4): 390-394. 111.1SBN O-94 lOOIl-14-3(245 cured). . Vol.F.Lindqvist et al. Clin Chem Lab Med 2001 Feb.Koch et al. “Chronic ailments related to amalgams”. & “Oral (90) 323-328. 1986. Dent Mater 1997 Sep.178(3):108-l 12. Contact Dermatitis. Am J Clin Nutr 1995. I 996. “Mercury in the hair of ALS patients”. Stromberg et al. 1996. Cohn. & K. J Allergy Clin Immunol95( l)(Pt 2): 145 F. Carlmark B. Of Work Environment Health. “Effect of Replacement of Dental Amalgam on OLR”.Mobacken et al. M.1990. Int J Risk & Safety in Med 1994. and methyl mercury on gap junctions and [Ca2+]1 in bone cells”. 1996. The Brooklyn Medical Journal. ~725-742 Lichtenberg.39(2): 134-142. & (b) M. (98) A. (95) J Orthomol Med 8:145-148. 1995. “Effects of removing amalgam fillings from patients with diseases affecting the immune system”. “Three cases of oral lichenosis caused by metallic fillings”.1995. 1994. 326 Berglund A. Sasaki et al. 134(3):420-3. No. Journal of Orthomolecular Medicine. “Mercury. Annu Rev Nutr 1997. (119 cases) (96) Goyer RA. & Goyer RA et al. & Y . Intravenous gamma globulin (IVIG) treatment of autoimmune kidney disease associated with mercury ( Hg++) toxicity. .1993. & 33(6):423-7.. 1994. 1996.4 1(3):422-430. 1996. Case renorts suanning 150 Years on the adverse effects of dental amalzam. M. 1999.Ostman et (87) al. “Symptoms before and after proper amalgam removal in relation to serum-globulin reaction to metals”. Lindvall A. & C. August 28. (94) Inc.Mano et al.O. Acta Odontol Stand. New Zealand Medical Journal. Ziegler DK..Orlando.19.Freeman et al.Neurology 46(5): 12751284.Gen Dent. 12:890-892. “Parkinson’s Disease and Occupational Exposure to Mercury”.E. “Kinetics of mercury in blood and urine after amalgam removal”.Schirrmacher. “Contact hypersensitivity to mercury”.Molin et al. “People with high mercury uptake from their own dental amalgam fillings”. “Effects of lead. A. IO:1 l-15. Neurotoxicology.Goldberg et al. 17:37-50. And GPX before & after amalgam removal”. 1999. “A case of unusually high mercury exposure from amalgam fillings”. & Nutrition and metal toxicity.H. Molin M.Ibbotson et al. Bio-Probe. Dermatol.Markow. Rinsho Shinkeigaku. “Mercury intoxication simulating ALS”. Gronquist SO. & Ohlson et al. Envir Health Perspectives. Dee 1995 (Denmark) 8~ H. 1990. “A case of high mercury exposure from dental Med 52: 124-128. British Journal of Dermatology.3:247.Camisa et al. “Trace element imbalances in ALS”. J.1995( 12 cases). Environmental Risk Factors for Osteoporosis. JAMA. “Mercury levels in plasma and urine after removal of all amalgam restorations: the (8% effect of using rubber dams”. National Institute of Environmental Health Sciences.] 991(40 cases). J. 29(7): 844-848. “Oral lesions and symptoms related to metals”.. 1983. “The relevance of amalgam replacement on (270 cases) oral lichenoid reactions”.4: 252- . HJ “Elimination of symptoms by removal of dental amalgam from mercury poisoned patients”. 1996. December 1898.Langworth et al. 81(4):459-465. 13(5):297-304 . & A. Calcif Tissue lnt 1998 Aug.” Regression from orticaria following dental filling removal:. & S. and 99(4):320-g.New York State J Med.E. & Godfiey.Berglund. Oral Surgery. & M.24( l-2):4 l-45( 161 cases).1996.12. JADR Abstract 159.11:52 I-532. & Lichtenberg H.Godfrey. 1990. mercury. & J. & Mano et al. L. “Amalgam related chronic ulceration of oral mucosa”. . & Lindh U.‘I.Barregard et al. Br Dent J. mercury hypersensitivity.63(2): 134-9. Oral Medicine. Contact Dermatitis.63(3): 189(91) B. . P. & Tuthill JY. 104(3):320-32 1. “Clinical & histologic changes after removal of amalgam”.Adv Med. 1996. Journal of Dentistry.Bratel et al. 250(5):642-5. Pleva J. & McCann et al. “Effect of Amalgam restorations on whole body potassium and bone mineral content in older men”.1995.

Oskarsson et al. 16( 1):3 I-40. amalgam fillings. & M. “The dental amalgam issue: a review”.“Defensive characteristics in individuals with amalgam illness”.R. V 10 1.610-611.1993 (106) R.F. Br J Ind Med 50(10): 945-954. 1139-51.442. 1995.“Amalgam Removal for Treatment of Arthritis”. “Mercury in human colostrum and early breast milk”.lation in tissues from dental staff and controls”. Arch environ Health. E. Weihe P. 13:235-243. and MS”. & Amer.P.Glavinskiaia et al.l998. 1989.53.& A.Clarkson et al.Leikin & Palouchek. 1980.J Appl Toxicol.“Psychometric evidence that mercury from dental fillings may be a factor in (107) depression. & A. Keiding N. & D. A.“Cytotoxicity of retrofil materials”. Arch Dermatol47. 1993. M. 1998. (113) 12: 24-28. “Mercury in breast milk in relation to fish consumption and amalgam”.Trace Elem.” Das Deutsche Zahn rztebl. Orthomol. Zh. 1980. R.Larsson et al.12:23-27. & Giwercman A. Bemdt et al. Merc&y acc. “The histopathology of oral mucosal lesions associated with amalgam”. Vet Hung I995.anger. Envir. 1998. “Health. 1993. 1996. “Personality traits of adolescents with intact and repaired 60(2): 320-327. “The distribution of HgC12 in rat body and its effect on fetus”. Analyst. Swedish Dental (99) Journal. Y. 1974. Environ Health Perspect 1993.Weiner et al. 14(3): 20 I-.‘Nylander et aI.Quig.Siblerud et al. “Healing of Lichenoid Reactions following Removal of Amalgam”. Lancet. Med Pr.Henningsson et al.v42. 10 1 Suppl(2): 65-7 1.). 123( 1): 19-23.M. Skakkabaek NE. NYLANDER et al. July 1994.5. Role of gammaglutamyltraspeptidase(GGC) and extracellular glutathione in disposition of inorganic mercury”. Med. & A.& Siblerud R.. Dermatol Venerol.Jay.A. Lexi-Comp. & “Mercury in pituitary glands of dentists”.n6.43(2): 109-2 1. Windham. “Korrosionserscheinungen an Amalgamf llungen und Deren Auswirkungen auf den Menschlichen Organismus. J Endodont. “Mental retardation and parental occupation”. Feb 26. Pub1 74-473. “Renal glutathione and mercury uptake”.Oct 1993. and Welfare.I 994. Altem Med Rev. V22. Doctors Data Lab. Carlsen E. & R. Annotated Bibliography .l995. (109) & T. 1985.and anxiety”.Colbom(Ed. and Kienholz E.1996.Yang et al.Biol. Health Perspect. & J. . p354(103) C. & Trachtenberg IM. Fundam Appl Toxicol. Journal of Clinical Immunology. Hormonal.S. Jan 1996.5(5):8 16-3 1. “Effect of mercury on the epithelium of the fowl testis”.1992.nl .Sikora et al. & B.3:4..5 1(3):234-4 I. “Biliary secretion of glutathione-metal complexes”.48( 11):729-34.197O .l992.70(3 Pt2). Acta Stand 54(3): 176-181.n4.“Psychological effects of low exposure to mercury vapor”. & J.117 and 170. 99( l-2): l22. Evidence for increasing incidence of abnormalities of the human testis: a review.43( 1): 153-6. D.m. & J. 1994. & R. Arch Inst cardiol Mex. 47:9-22. T. J.Forsbec et al. Zulups et al. 1990. G. 1992.p705 Odont (108) M. vl9. v74. & W. 1998. 58: 57587. J Toxicol Environ Health. 103 (104) (Supp4):79-86.Bruce. Experientia. M. (1 IO> T.Henriksson et al.“Evidence that mercury from silver fillings may be an etiological factor in multiple (102) sclerosis”. 1998. Dept. T.1989. Evidence That Mercury From Dental Amalgam May Cause Hearomg Loss In Multiple Sclerosis Patoemts. ~262-270. Education. Milk as a Source of Methyl mercury Exposure in Infants. & ” Developmental Effects of Endocrine-Disrupting Chemicals”. 24. & “Risk assessmentin relation to neonatal metal exposure”. Psycho1 Rep. M. Med.199 1.L. Psycho1 Rep. “Reproductive impairment in the Florida Panther”.K.Facemire et al.. J. 1981: L.9(4): 437-42.Maretta et al. & R. J Clinical (101) Periodontol. 1(3):152-8. Oral Dis 1995.L. v12#4 pp 240-4 (1997).256.Kishi et al. & Drasch et al. Environ Health Perspect 1994 Jan. Of Psychotherapy.Acta Odont Scand. Gen Dent.Environmental Med Research. & Grandjean P. J. “Theraoeutic properties of Unitihiol” Farm.1995 & M. “Glutathione inhibits SOD activity of Hg”. 102( 1):74-7.de Ceaurriz et al.44(4): 385-99. Residual neurobehavioral effects of chronic exposure to mercury vapor”.A. and Reproductive Effects of Endocrine Disrupting Chemicals” (including mercury). dentitions”.Environ Heath Perspectives. N. 1985. Golota.Marxkors. Sci Total Environ.“Cysteine metabolism and metal toxicity”.N4.Hall. 1996. p287-94. 142(3): I9 I-205 . Fundam Appl (111) Toxicol. Of Health.p288-92. 1994. “Complexons in the treatment of lupus erghematousus”. & “Mental health. Med. Occupat.X.. Environ Sci .1996. “Evaluation of mental functions in workers exposed to metallic mercury”. 1943. 1986.F. (1 12) A.5(5):832-9. 1: 18-22. Br J Ind Med 1991. Siblerud et al. Princeton Scientific Press. Poisoning and Toxicolow comDendium.O.W.5 1:35-41.Chemically Induced Alterations in Functional Develonment.G.L.Kampe et al.Roeleveld et al.44:95-. (100) “Does mercury from amalgam restorations constitute a health hazard”. Liang et al.68(6):457-61. Chronic effects of mercun/ in organisms.. Sci Total Environ. U. 1986. 1994. No.Tanchyk. Jurgensen PJ.Hanson et al.

“The Effect of Occupational Exposure to mercury vapor on the fertility of female dental assistants”. 2001.199O.. & K.” Changes in the nervous system due to occupational metallic mercury poisoning” Neurol Neurochir Pol 1997 Sep-Oct. & Examination of blood levels of mercurials in practicing dentists. v55. 1992. & Grewal JS.Santos.1993. hydrophobicity and klebocinogeny of Klebsiella pneumoniae isolated 6om foods. 1994 1B. 1996.Ono et al. &(b) H. “Resistance of the Normal Human Microflora to mercury and antimicrobials”.Hall. Toxicological Effects of Methyl mercury (2000). Immunopharmacol Immunotoxicol. Centers for Disease Control. Dept. pp. Cell Struct Funct 1995. “Immunoglobulin E in mercury . 1993.l( I): 1995.Int J Occup Med Environ Health.L. of Occupational Medicine. Antimicrobial Agents and Chemotherapy. 1987. Stand J Work Environ Health. Kagen R Toxic heavy metal ions inhibit reduction of disulfide bonds. Sweden.S. 143(2):269-g]. National Report on Human Exposure to Environmental Chemicals. “Mechanisms of dopamine-induced cell death and differences corn glutamate Induced cell death”. Umea Univ. 1997. In vitro evidence for the role of glutatmate in the CNS toxicity of mercury. 1987. 37(4):825-834. Summers AO. Resistance to antibiotics. 266(19): 12695-702. “Metallothionein induction in fetal rat brain by in utero exposure to elemental mercury vapor”. Troost D. dec 5. April 29 .Froissard et al. 1 l(4): 149-53.Vol.p44-48. &(c) Kim P. Med Lav 85(3):239-241. Apr 1996. & The Physiologist 33(4). Clin Infect Dis 22(6):944-950. & Baauweegers HG.PovlncehMdls’renorlilijnhlich~s.cdc.nl .Hoyt et al. “Selective inhibition of glutamate uptake by mercury in cultured mouse astrocytes”. & U. & Brookes N. Arch Environ Health. “The behavior of T-Cells in the blood of workers exposed to mercury”.. A.Rowland et al. C. National Center for Environmental Health. Skare et al. IAkesson et al. “Mercury exposure of different origins among dentists and dental nurses”.S. Science. “The impact of mercury released from dental “silver” fillings on antibiotic resistance in the primate oral and intestinal bacterial flora”. Schatz JR. II:1 75-84. et al. Mar 2. 1994.A. Wireman J. metals. Acta Odontol Scand.May 1. 36(3): 299-305. (127) (128) Moszczynski et al. & T.778( 1):222-32. Matyja E. 1997. “Chronic encephalopaties induced by low doses of mercury or lead”.S.26 1(5 I22):7 15-25. A-l 16.” Silver dental fillings provoke an increase in mercury and antibiotic resistant bacteria in the mouth and intestines of primates”.Queiroz et al. of Dental Materials Science.31(5):905-13.1995. 199 1 & Chang SB et al. L. “Immunoglobulin Levels in Workers Exposed to Inorganic Mercury”.S. 76(3):245-56.Vimy et al. 1991. 20(3): 233-8. T and NK cells in men exposed to mercury”. “Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal cells” Eur J Pharmacol. Appl Environ Microbial.v53. 1990. “Status of mercury and selenium in dental personnel”. & Matts RL. 236( 1): 93-99. Br J Ind Med 49: 233-240.1994. Int J Occup Med Toxic01 4(2):285-294. 1994. Fall. Metab Brain Dis 1996. Brain Research. “Transition metals in control Of gene expression”. Met Ions Biol Syst 1997. Dent Res.cdc. J Biol Chem 1991. O’Halloran. Toxicology 1992. Nat’1 Academy Press 2000. Immunological and brain MRI changes in patients with suspected metal intoxication”. APUA Newsletter. M. Tiwari RP. Boot JH. (a) L. 1999. Yonsei Med J 1995. Mercury levels excreted after Vit C IV as chelator. Cytobios 1999. Effects of SH-blocking compounds on the energy metabolism in isolated rat hepatocytes. Exp Neurol 1997.Edlund et al. 16:340-347. Universite de Caen. Glutamate: a potential mediator of inorganic mercury toxicity. 7 1(1):66-74.3: 18 l-7. 21(1):141-50.3. Qstzenhausen/Germany.V. & J. & D. & P.Pohl.Occupational & Environmental Medicine.O.R.63(11):4494-503. CDC. ~6-8 (200 cured or significantly improved) Liebert CA. & National Research Council.Aschner et al.nl.gov/mmwr/preview/mmwrhtml/mm5008a2. U. & “Presence of Micronuclei in lymphocytes of mercury exposed workers’.2001. Biol Signals 1994. Genet.11(5):3991. Stejskal VDM.by number of fillings Int Symposium “Status Quo and Perspectives of Amalgam and Other Dental Materials” European Academy. & M. V-TOX. Dept.Ronnback et al. 98(388):113-23 Tibbling L.htm1.Issue 1.htm .Langauer-Lewowicka.34:44 l-60 . Hurst R. Localization of metallothionein in the mammilian central nervous system. Choi BH. Pharmacol Toxic01 74:72-75. Wireman et al. G. & “Lymphocytes.(114) (115) (116) (117) (118) (119) (120) (121) (122) (123) (124) (125) (126) M. Morbidity and Mortality Weekly Report. & Heavy Metal Bulletin. Smith T. Factors affecting blood mercury concentrations in practicing dentists. Anal Toxic01 . 304-332: Risk Characterization and Public Health Implications. & Albrecht J. www. “Reduced tyrosine uptake in strains sensitive to inorganic mercury”.1995. 46(2): 102-I 09.Summers et al. “The dentist’s exposure to elemental mercury during clinical work”. vvww.C. 1997. 1992.

1974. 1988. (140) RL. J Fert Reprod. lead. Arch Toxicol. 1994. “Mercury sensitization caused by environmental factors”.3. “Studies on the Mercury Release from Dental Amalgam Fillings”. Ubl Hyg. A. Avery Publishing Group. “Occupational exposure to mercury.E. Zander et aI. (134) L.1996. Science News. 1997.M.Y. 1994. Sharma et al.67(3):205-l 1. Gore11et al.1989. (136) B.S. & U. Zentralbl Gynakol. & G. copper. 1988. “Toxicological profile of Mercury”. “Mercury mutagenesis”. (146) Gerhard et al. J Fert Reprod 1995. Ellermann-Eriksen S.199( 1):69-75 . Sweden. & L. 190: 325(138) G.p307. Swed J Biol Med No. 1999. Neurotoxicology. Environ Mol Mutagen 1998. Christensen MM.. (137) ~~8-15 & Summers.52(4):661-6. Ariza et al.2:25-30. Toxicology. Neurology. 1993. Plenum (147) Publishing Corp. S.n3. N. “Health Effects AAer Dental Amalgam Removal”. Environmental (13% Research.M.Roller et al.478-91. 1996. Enestrom et al.Sallsten et al.. Vol37. superoxide (142) dismustase. Sallsten et al. & M. 65: 195-206. 13(2): 107.L.3 1. . & “Study of workers compensated for mercury intoxication”.12. Therapeutikon. & J Occup Med.Ariza et al.Boffetta et al. InVivo 8(4):559-63.M.3 1(4):352-61. 198 1. “Abnormal neuronal migration of human fetal brain”.M.“Methyl mercury induced alterations in the nerve growth factor level in the developing brain ‘I. 120(3). Lancet.R. 4-10-93. R. 48:3. (143) P. 1995. “Chewing releases mercury”. & M. Ariza ME.1994. 1987.J Occup Med.Wood.M. Williams MV. Toxicology 1996.Y Zaichick et al. Influence of mercury chloride on resistance to (131) generalized infection with herpes simplex virus type 2 in mice.Siblerud. manganese. Bijur GN.Choi et al. 1991. D. & J. “Does amalgam affect the Immune System?” lnt Arch Allergy Immunol 106:180(130) 203. Stand J (135) Dent Res.1 B B I 1 I I 1 I I I I I I B I I. 1992.62(2). Lead and mercury mutagenesis: role of H202. I I exposed workers”.36( 11): 1260-4. 113(2):199-208. . “Mutagenic effect of mercury”.1994. Of Pathology.Siblerud et al.Bjorkman et el. (132) 1995. . in Organotransitional Metal Chemistry.Larkfors et aI. Arerugi 44(2): 86-92.“Occupational exposures to metals as risk factors for Parkinson’s disease”. “Carciagenocity of mercury”. &(b) T. N. (144) (145) J. 20(2-3):239-47. “Factors Influencing mercury evaporation rate from dental amalgam fillings”. 114( 1): 57-66. &M. & T. Journal of Neurophalogy. 1978.3. J Dent Res 75( 1):598. “Long term use of nicotine chewing gum and mercury exposure f?om dental amalgam”. (141) Toxic01 Lett.3. and therisk of Parkinson’s disease”. 1995.HuItman et al. “Influence of Chewing Gum on Urine Mercury Content”. “Effect of mercuric chloride on macrophage-mediated resistance mechanisms against infection”.“Trace Elements and thyroid cancer”. Gay et al.650-8. 36( 11): 1260-64. Zentralbl Hyg Umweltmed.Christensen et al.Gebel et al. “Mercury in plasma in patients allegedly subject to oral galvanism”.Analyst. 1992.& v69(3):305. 19(3):383-92. & J. J Orthomolecular Med 5(2): 95 -106. . & E. p7 19733. Stand J of Dental Res.287(1 50) U. Stand J Dent Res (133) 951328-334. Res Dev Res. “Cytotoxity of Silver amalgam”.Vallon et al.Casdorph. Mogensen SC.E. 100(6): 354-360.P. “Comparison of interaction of meHgC12 and HgC12 with murine macrophages”.Gerhard. Institute of Medical Microbiology. (149) B. “An epidemiological study of factors relating to mercury sensitization”. 1995. “Evidence that mercury from dental fillings may be an etiological factor in smoking”.593-602: & I.“Mechanisms for the Neurotoxicity of Mercury”.v68. (129) P. Nippon Eiseigaku Zasshi.Gorell et al.3 l-33. Biol Metals. Public Health Service. 1992. Toxic Metal Svndrome. D. 1993. “Mercury in cerebrospinal fluid in subjects exposed to mercury vapor”.114. 1979.Dept.Leiskir. 1993.Ellermann-Eriksen et al. M. 1999.Aronsson et al. 8123:985-98. Vo19 1. & Toxic01 Appl Pharmacol. 1990.“Studies on Human Exposure to Mercury Amalgam Fillings”. (148) H. and xanthine oxidase. 93:269-297.Fredin.19( 1): l-7. 1998.“Adverse immunological effects and immunity induced by dental amalgam” FASEB J 81183-l 190. J of Comp Pathology. K. “Dental amalgam and mercury”.Sato et al. 1987.7.Mori et al.Y. Linkoping Univ. Biochem Mot Toxicol. 1994.Molin et al.1993.1995. & R. & S. 1994. “Metals and Neurotoxic Effects”. Stand J Work Environ Health. 1997 Mar.

“Effects of low exposure to inorganic mercury on the human immune system”.htm (154) K.Robinson et al. & J.p12513 I . & Kerkhoff H.3 13(7048): 44.R. JADA.Mohamed et al. “Epidemiologic Study of occupational Contact Dermatitis in the Dental Clinic”. 117(37): 13 83-9(German). p338.D. Gig Sanit. 199 1. 1987.1993. Dtsch Med Wochenschr . & F. POB 608531. 66(6): (153) . & Nutrition Research.. Multiple Sclerosis and mercury in cerebrospinal fluid.tumpike. Dee 2000.. 64:Abstract 1472.B. (156) E. Contact Dermatitis due to Amalgam fillings”. Aug 1987. Smith RG.p1457-. Cognitive and Behavioral Effects of Toxic Metals. Adv Neurol 1995. Protocol for Mercury/Silver Filling Removal.1985. Mercury hypersensitivity among dental students.Basun et al. Int J of Immunopharm. “Health Effects of Toxic Metals: An Annotated Bibliography”. “Toxicology of Inorganic Mercury”.65(5):3 17-32 1.9(4):522(162) N. “Patch test reactions to metal salts in patients with oral mucosal lesions associated with amalgam fillings”. FASEB J. & A. “Inorganic mercury and the CNS: genetic linkage of mercury and antibiotic resistance”. Annals: NY Acad Sci. 1993. Vol28.et al. 12: 48-5 1.Djerasci et al.32860-853 1. J Dent Res. Louwerse ES. Johansson I. & R. http://emporium. (over 150 medical study references) www. “Mercury vapor inhibits tubulin binding “. “Comprehensive Medical Examination of patients with alleged adverse effects from dental amalgams”. 65:498-503.K.2. 1994.Health Perspect.Miller et al. & M.1985.netiP/PDHA/mercury/asr.Nordlind et al. Autoimmunity as an etiological factor in amyotrophic lateral sclerosis. 2001.1 949.I 990. 9: 197-208.L.9(4):A3485.Lorscheider et al. 1957. Dept.l995.l999. Mohamed et al.” Evaluation of effect of mercury on reproductive function of animals”.Lorscheider. (163) Ahlrot-Westerlund B. “Health Risks from Increases in Methyl mercury Exposure”.F.1976.275(49):38620-5. “Immunotoxicology of Heavy Metals”. Odense. Infammatory cells in the peripheral nervous system in motro neuron Acta Neuropathol 1993.Roberts. “Evaluation of Mercury in Hair & Blood as Biomarkers for Methyl mercury Exposure”. 2:269-279. “Antibiotic resistance in oral/respiratory bacteria”. 1992. April 1990. & D. J Dent Res. No. & J Biol Chem 2000 Dee 8.L. Mercury Amalgam Review Panel. Contact Dermatitis.27:3.G. & A. J Neural Transm Park Dis Dement Sect. Second Nordic Symposium on Trace Elements and Human Health. Vol533. & B. 1987. & M. “Correlation between amalgam restorations and mercury in urine”. International Academy of oral Medicine and Toxicology. Ericson T. “A Scientific Response to the American Dental Association Special Report and Statement of Confidence in Dental Amalgam. Univ. Langworth et al.Emst et al.Toxicol.Windham. Neurotoxicology. Use of primary cultures to sutdy astrocytic regulatory functions. & E. & N. “Effect of heavy metals on in vitro interaction between human sperm and cervical mucus”. & M. 22:284-7. “Metals in plasma and cerebrospinal fluid in normal aging and Alzheimer’s’s disease”. http://emporium. Orlando. 1992. Clin Exp Pharmoacol Physiol 1995. 85:560-5. 68:47-57. E. (166) H. Skoglund A .(15 I) (152) Electric Power Research Institute.White et al.Koller. Momstad H. EPRI Technical Brief:“Mercury in the Environment”.B. 59:pll68. Int Dent J 19:48 l-8.198O. Ivanitskaia. & de Saint-Georges et al. IAOMT. (155) L. “Trace element imbalances in the brains of Alzheimer’s patients”. 157-l 60.K. (157) L. “Declining sperm count: evidence that Young’s syndrome is associated with mercury”. 60( 1):29-36.tumpike.Eggert-Kntse et al. & Walum E et al. Stand J Work Environ Health. “Effect of mercury on human sperm motility”. Crit Rev Oral biol Med. Issue 3.earthlink. Troost D. BMJ. 19(6): 405-413. 1988. Contact Dermatitis. of Health. (158) Wenstrup et al. (165) Anneroth G.home.Mottet et al.Arch Dermatol Syphilol.97( 1): 19-22. Of Washington. Research.1995 & Vance et al.J Goldwater.58(3):2 19-24.1993.] 992.neti-bemiewl (161) F. 1991. “Inhibition by mercuric chloride of the in vitro polymerization of microtubules”.htm. disease. (160) B. ~0163 :I 33140. & IAOMT.1973.1 969. Toxic01 1991. Windham. Arch of Toxicology.L Olsted et al. CR Seances Sot Biol Fil. Denmark.Daily et al. “Effects of methyl mercury on testicular functions in monkeys”. & Heavy Metal Bulletin. 1998. ppll4-5.C. 178(5):562-6. & EPRI Journal. (159) W. Acta Odontal Stand. vol34.net/P/PDHA/mercu~/iaomt. 1996. & Appel Sh.Nielsen et al.50(2):101-11. 1986. Toxicol(Copenhagen).M. “Prevalence of Mercury Hypersensitivity among Dental Students”. 1985 Supplement (164) Swedish National Dept. 92: 124-7. Vol 6. & Amer J Vet Res. Of Pathobiology.Kawahara et al.3(4):23 l-58 (167) M.68(6):440-4.K.Haley.Toxicology. 1984.

H. 1992. 1992.W.a public health hazard”. & Mercury poisoning from dental amalgam. 18(3): 143-8. “mercury exposure from dental amalgam”.193(4):318-28. March 1985. 1983.. & Schimpff SC.Jokstad et al. 1973. Dept. Int Arch Allergy Appl Immunol I986 80: 405-I I . Swed Dent J. Monnet-Tschudi et al. “Cancer mortality in patients exposed to methyl mercury through fish diet”. Schweiz Monatsschr Zahnmed. Pinto OF et al. DZander et al. female dentists. Maggi E.Reviews on Environmental Health. Genetic and Environmental Factors Contributing to the Onset of Allergic Disorders.Pt2. “Mercury excretion and occupational exposure of dental personnel”. I I7:46. der Kassenarzt 4. 28(3): I 17-21.. and dental aides”. “Mercury in the mouth mucosa of patients with amalgam fillings”. & Vimy M.Willershausen et al.64: 1069-107 1 &” Serial Measurements of Intra Oral Mercury” Journal Dental Research 1985. 70(3). & Science of the Total Environment. “Mercury exposure of male dentists. 1989. A.199O.I I I 1 1 D I I 1179-I 182. “Dental amalgam and mercury”. Rev Environ Health 1O(I): I-27 (1994) . Lead differentially modifies cytokine production in vitro and in vivo. University of Calgary ” Intra oral Mercury Released from Dental Amalgam” Journal of Dental Research 1985. Hartmann HA. & L. Toxic01 Appl Pharmacol. . 64:1072-1075. 1139-51. “An Assessment of Mercury in Mouth Air”. I 1:84-93.Laine et al.6(3): 134-8.35-40 A. & Huggins HA. & Gelbier S.S. B.Lenihan et al. Enhancement of antibody and IgE production by mercury and platinum salts.77:707-7 11. & Adachi A. “Mercury hazards in dental practice”.Kinjo et al. & J Orthomol Psych. “Mercury: god of TH2 cells”. Mathieson.10(6):221-32. J Epidemiol.I 993. Horikawa T. 1992. “Daily dose calculations from measurements of intra-oral mercury vapor”. Medicine 1989. Int Arch Allergy Immuno12OOO Jan. 8(3): 128-41. (182) Pleva J. Brugnolo F. F.1992. Public Health (1989). C. Oral Roberts Univ. 1997.2. 1989.. Zinecker S. 1997. Dtsch Med (174) Wochenschr. Zentralbl Hyg (173) Umweltmed.Lussi. Young WH.308-13.74 1: 52-59. & “Resolution of OLL after replacement of amalgam restorations”. Brain Research. 1976. Contact Dermatitis.“Epidemiologic study on the association between body burden (169) mercury level and idiopathic Parkinson’s disease”. A. J Dent Res. Pharmacol Toxicol. (179) & Kind1 A. Origin of infections in acute nonlymphocytic leukemia.& (d) Parronchi P. Br Dent J. “Quantitative cytochemical studies of RNA in experimental mercury poisoning”. 4(3):141. “A comparison of mental health of multiple sclerosis patients with silver dental fillings (170) and those with fillings removed”. Oral (168) Pathol Med 1999.23. Psycho1 Rep. 196. & “Mercury. lO(I-2):1-14. 13 8: 149-57. B. Br J Dermatol. 135: 363-376. International J of Biosocial and Medical Research. Clinical Exp Immunol. 3: l-22. (181) Parsons PJ. and Lorschieder. J Intl Acad Prev Med. Ingram J.36:3. (177) 71(2):414-23. & (b)“Contact allergy to dental restorative materials in patients with oral lichenoid lesions”. Vol3.L.118( 1):58-62 S. Pepys J. 1990. “Dental mercury .Siblerud. J. 24(1). Greene WI-I.3. “Efficacy of dental metal elimination in the management of atopic dermatitis”.Barregard et (176) I. & G. 1986. 1994. Acta Neruopathol(Berlin).J Pleva.14 I-6. 103(6):722-29.1 995. & Emler & Cardone. Univ.1987. J Dermatology.Ngim et al.Jokstad. & Swed Dent J. & (c) Murdoch RD. Of Umea. Proposed role of dental amalgam (180) toxicity in leukemia and hemotopoietic dyscrasias. of Environmental Medicine. 1965. “Comparison of the developmental effects of 2 mercury compounds on glial cells (175) and neurons in the rat telencephalon”. J. Tidsskr Nor Laegeforen.23(1):77-83. 1986. J (178) Oral Ther Pharm. Int J Risk & Safety in Med.148. “Amalgam: Quecksilberdamfe bis ins Gehrin”. 1992. & Y. “lmmunocompetent cells in amalgam-associated oral licheinoid contact lesions”. 1996. IO3. Sampognaro S. Of Orthomol.A Public Health Hazard”. & Chang LW. 10: l-27. I996. 1992. Neuroepidemiology. “Urinary mercury excretion in dental (172) personnel”. & (b) Heo Y. 1992. 1992.Nilsson et al. 1973. P.12-19.Nixon et al.I 02(2):229-30. “Possible fetotoxic effects of mercury vapor: a case report”. 94(3): 179-85.126( 1): I O-I 5(20 cases).Community Dent Oral (171) Epidemiology. Annals of International Medicine 1972. R.“Mercury release from amalgam into saliva”. No. Vol 12. Journal of Dental Research. J. I2 1(1):2-9. Mercury from dental amalgams: exposure and effects. 1: 5 12.Olsson et al. 70(4). No. Lawrence DA. I998. 1743-7.

Ong et al. Amer J Forensic Med Path01 1989..63(2):202-3. Br Dent J 1998. “Heavy elements in root tips from teeth with amalgam fillings”. AtIanta. B. Atlanta. 10: 213-5. 16(5):334-9.“Effect of mercury on corrosion of eta’CuSn phase in dental amalgams”. National Naval Dental Center. “Electric current around dental metals as a factor producing allergic metal ions in the oral cavity”. Environmental Health Criteria 118. and WHO. 1993. G. “Sensory perception in the hands of dentists” J Work Environ Health. (192) Nippon Hifuka Gakkai Zasshi. 202(652 1):662. “Localized galvanic shock after insertion of an amalgam restoration”.J. “Mercury in human amniotic . 38:469. Runnebaum B.1. 1970. 1996. Mercury in biological fluids after amalgam removal. Box 535. (185) L. Clustering of multiple sclerosis in Galion.l985. & “Metal release from dental materials”. 18(4):482-489. 1993.Prosthet Dent. 1996.60(3): 15 lKlobusch J. (189) P.Jones. & B. Sweden E.7.. 1980. Methyl Mercury. & S.Soong et al. 1993.. Of Tokyo.N.(183) World Health Organization(WHO). Liliefors T. 11 l(8): 948-50. Biomaterials.Meyer et al. A. & M. Sept. Am J. Environmental Health Criteria 101 . “Mercury concentrations in blood of Danish dentists”. 1982-1985.. & Y. 1986. & Epidemiology. Medical School Dissertation (196) Dept.Am J Fors Med & Pathology.A.476. School of Materials Science.N.91:66-71 & Sci Tot Envir. “Alopecia and environmental pollution” Klinisches Labor (187) 1992. 14( 10). :Dentists. & R. School of Medicine.L.185(9):436. 163-175.69(2): 14 l-3.H. 455-61. “Comparison of heavy metal concentrations in human umbilical cord blood in 1980 and 1990:. Of Human Ecology.Cohen et al.D. Lu SC.1977. 1953. No I.. School of Dental Research. “Concentrations of heavy metal in maternal and umbilical cord blood”. Obstet. 1997.Ogletree et al. “Occupational disease in dentistry”. “Neurological Assessment of Health Status in Dentists”. Parsons.Urban et al.Zalups et al. Biometals.K. Obstet.1304. 3:32-35. 1993. & R.Moller-Madsen et al. (184) T. 29(4):595-602. Gerhard I.Gronla et al.199O. WHO. 1995.B. N.. JADA. Dent Mater.lngalls. Vol 4. Eur J (190) Neurology. & B. “Arch Gynecol. Spencer et al. & R.Rose et al. Suzuki et al. 11(5):332-6.l999. of Penn. (186)Yang J. “Maternal-fetal transfer of metallic mercury via the placenta and milk”. Comparative epidemiology of multiple sclerosis and dental caries”. Toxicology. 81:923-25. Dent Assoc.(Stockholm). Univ. etiology and prevention of MS”. Ohio. Amer. 1990. J of Epidemiological and Community Health 32: 155-65. “Health outcomes following amalgam removal”. Dept. 1999.CDC.254:277-g. 1999.44(4):324-6. 6( 1):61-66. 1989. 1983. Univ. Gastrointestinal and in vitro release of metals from conventional and copper-rich amalgams. 109(l): 15-29. 1991. & D. 1986. 1994. & L.. “Mercury Concentration in Cord Blood”. 1991.K. & Environ metal Health. D.Ekenvall et al.A.27(2):135-41. & “Schwem~etallbelastungen bei Patientinnen mit Alopezie” Arch Gynecol. J. Ann Neural. Tidsski Nor Laegeforen.254(14):278-80. Br Med J. Polakowska. Perry et al.Scand J Work Environ & Health. 1998.45(3):22 l-5.99( 12): 1243-54. J Hepatol.44:. 13( 10): I 169-83.S. Of Basal Oral Sciences. (191) Stand J Dent Res. Ga. 1988.1302. & Johansson E.75 1 2 I Uppsala. “Regulation of hepatic glutathione synthesis: current concepts (194) and controversies”. & R. 1990. J of Formosa Medical Assoc. 1983. Department of Radiation Sciences. 1. Japan.Nogi. 90(l): fluid” 59-65. Mar 1983. “Risk evaluation of the occupational environment in dental care”. Arch Dis Child. 10 l(1): 2 l-3 1. Pharmakinetics of mercury corn dental amalgam”. 1989.6(5): 57 l-7. Stand J Dent Res.Sikorski et al. Kunzel et al. GIT. & G. “Neurological examination on 3 groups of workers exposed to mercury vapor”. J Dental Res. Geneva.“The intrapartum content of toxic metals in maternal and umbilical cord blood”. New Zealand Psychology Journal. & (188) P. Osaka. & J. Rabe T. Toxicology Division.Fors Med Path.Owens et al. “The tarnished history of a posteria restoration”. Division of Physical Biology. & (193) G. Karolinska Institute.Bjorklund.Brune et al. Inorganic Mercury. 1985. & R.H. FASEB J.Taylor. & J Forsenic Medicine and Pathology.77(4): 615-24. and brain tumors”. 1988. Eastman Dental Institute. I-49. Bergdahl. Sandborgh-Englund. “Oral Electricity”. & T. U.7:3-g.1306-7.“Nephrotoxicity of inorganic mercury co-administered with L-cysteine”. Sandborgh-Englund et al. “Hallevorden-Spatz Disease: cysteine accumulation and cysteine dioxygenase deficiency”. A Complete Guide to Mercurv Toxicitv from Dental Fillinsrs Scripps Publishing.Sugiyama et al.. 1998. 1998. “lntraoral galvanic corrosion”. Compendium. Gen Dent. 101.& G. (197) . (195) 96( 1): 56-9. & “Endemic clustering of multiple sclerosis in time and place”.Certosimo et al. 1986. 1993. & AAhlbom et al. Criterion. 1991. Ginekol Pol.M. & C. Med Pr. & Craelius W.Ship et al. dental nurses. & T. Annals of Clin & Lab Sci. Kinki Univ.D. Wang Yl.

.R. Lancer 1995. T. & (e) G.. Lakartidningen.34:461L. 5(3): 102-109. & (c)Ware RA et al. 86 Colorado patients. G. 1996.L. I 00:3 I-8.Thieme Verlag Struttgart.W. 1995.273(3/2): 1199. Trace Elem. Part B. & Met Ions Biol Syst. 1997. 10.L. “Autoimmune Disorders”. International symposium proceedings.ApriI. H. Biol Res Preg Perinatal. in: Swedish Council for Coordinating and Planning Research. p 1. 1995. & SZiff.Friberg. in Bioloaical Monitorina of Toxic Metals. M. Clarkson et al. 1: 7(?) & M. Dent. RSiblerud. Sehnert. p47-48. pp.R.A. J.& K. Kidney Int.Nath et al.F. Vol.“Ferotoxicity of inorganic mercury: distribution and effects of nutrient uptake by placenta and fetus”.. 1993.Kishimoto et al. “The prediction of intake of mercury vapor 6om amalgams”. 1999. 3 15-23 Tom Warren. A. Neurotoxicol. PKraub & M. Beating Alzheimer’s’s. Dentistry Today. Journal of Trace Elements in Experimental Medicine. 2(4): 709-761. M.-Similarity to Lesions in Alzheimer’s Diseased Brains”. 22 patients(see (26)) Dr. . N. I 989.. M.1984. Avery Publishing Group. Pendergrass JC. October 1997. J Biochem Toxicol 1991 .? Dr. Inc. 1957. M.Zamm. ADV. & G. 346(8966):7-l 1: & Riometals.Vimy et al. “Localized cellular inflammatory response to subcutaneously implanted dental mercury”. 18(2)::3 15-24. & (b) Miller DM.p853. 1995. Assessment of Mercurv Exposure and Risks from Dental Amalaam.Deyhle.“A Monte Carlo Assessment of Mercury Exposure and Risks from Dental Amalgam”. Intravenous inorganic mercury intoxication”. Univ. l993.T. Environmental Health Perspective. Of Calgary. 1 I I-123. Lorscheider. K. Of Minnesota.000 people tested for mercury level in saliva and health status/symptoms compiled) V.T.de/KRAUSS/amalgarn. Dept. & F. Jan 1995. & Richardson M. 10(1):121-40. Inc.Berlin. “New occupational risk factors for chronic renal failure”. Kousmine.G. Bio-Probe. Dr.F. Ultrastructural changes in renal proximal tubules after chronic organic and & (d) McCann et al.(198) (199) (200) WI) (202) (203) (204) (205) (206) (207) (208) (209) (2101 (211) (212) (213) (214) (215) (21’3 E. “Documented Clinical Side Effects to Dental Amalgams”.6(4):293-8. J Toxicol Environ Health. Environ Res. July 1991. & “Prenatal exposure to mercury vapor: Effects on brain development”. Circulation.. 8th Edition. 1995.Larose. ~~1578-1583. 6(4): 155-l 63. Ott 11: 49(2):113-25. Of Medicine. Lance& 1991. IAOMT Symposium paper.. Ziff et al. 18:129-l 34. Dr. C. 1992. “Intake of mercury from fish and the risk of myocardial infarction and cardiovascular disease in eastern Finnish men”. Dr. Universitat Tubingen. 1997. ISBN O-94 101 I-08-9. Bio-Probe. http://www.Institut fur Organische Chemie. Human and Ecological Risk Assessment. 91(3):645-55.Health Canada. (20. 1988. (Study findings) & 1. Richardson et al. Multiple Sclerosis is Curable. Dr.J. West et al. Oral Oncology. FRN.environmental medicine risk analysis”. Fundamental and Applied Toxicology.V. Res.Hanson-Swedish patients-519(incIudes many MS). Haley BE. Faculty of Medicine.com.& B. 1990.Plenum Press. P. Mark Richardson.. Reactivity of Hg(I1) with superoxide: evidence for the catalytic dismutation of superoxide by Hg(II). February. Exper.. Teratol. Lorscheider et al. Neurotoxicology 1997. 1995.J.. & Dental Mercuq m. ISBN O-94 101 I-04-6. Salonen et al. Amer J Physiol. 1996. Woods IS. “Renal oxidant injury induced by mercury”. Univ. Environmental Health Directorate.. 1991. 1997 http://wvw. 3 1B(4): 232-4. “Status Quo and perspectives of amalgam and other dental materials”.80 Canadian patients.Vimy and F. Of Kentucky Dept. Final Report.pl99-246 & ~247-260. European Journal of Cancer. of American College of Cardiology V33.Danielsson et al.. “Is amalgam in dental fillings hazardous to health?“. A Persuasive New Look at Heart Disease As It Relates to Mercurv. Lund BO.112. 1999 Mats Berlin.50(3): 103243. Inc.Nadarajah et al.S. Ma et al. 1992. “Association between dental restorations and carcinoma of the tongue”. T.M. Advance.pI 103. March 1997 & “Mercury Vapor Inhalation Inhibits Binding of GTP . Amalgam and Health. Med. 1. MacMillan Co. (cases:FDA Patient Adverse Reaction Reports-762. Of Chemistry “ The Toxic Effects of Mercury on CNS Proteins: Similarity to Observations in Alzheimer’s’s Disease”.#6. & J.337. Ziff. 89(37):29 18-23.. “Amalgam declared hazardous”.html. Dr. Amalgam and Health.bioprobe. I(6): 13 I 134. Nuyts et al.3. Univ. & Danielsson et al. Lichtenberg-100 Danish patients. Dentistrv without Mercury.uni-tuebingen. in: [Swedish Council for Coordinating and Planning Research. “Mercury in dental filling materials. R.D. FRN. gamma globulin (IVIG) treatment of autoimmune kidney disease associated with mercury ( Hg++) toxicity. J Allergy Clin Immunol95( l)(Pt 2): 145. 1975. “Field Study on the Mercury Content of Saliva”. “Methyl mercury injury of Cultured Human Vascular Endothelial Cells”. Textbook of Biochemistry.l999] M.W.Y. Bio-Probe. “Renal function and amalgam mercury”.

Univ. Quarterly J. Chemical Sensitivitv.Viviani B. & Ridley WP. 29(S): 2 13-4. Of Texas Southwestern Medical School “Methyl mercury in dental amalgams in the human mouth”. & http://www. 199 1. 1982. “Dementia and Alzheimer’s’s Disease”. The Allergy Center. & “Besserung von Nerven. & Bauer. Golden et al. M. 105(3): 183-95. & “Amalgamtest”. Dept. Clostridium Tonomura”Formation of methyl Mercury Compounds from inorganic Mercury by cochlearium” J Ferment Technoll972 50: 159-I 660 (a)B. 1992.(217) (218) (21% (220) (221) (222) (223) (224) (225) (226) (227) (228) (22% (230) Agency for Toxic Substances and Disease Registry. Amer.“Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes: Alterations in cell viability” Immunopharmacologicol Immunotoxical.Arzt. over 5. Of Obstetrics and Gynecology. 1983. Feb 1997 (TV. & N.und Immunschaden nach Amalgamsanierung”. Dept. Rojko JL. vol 143. 63(2): 1990 Feb. 1992. Of Probiotic Dentistry and Medicine. Mercuric chloride-induced apoptosis is dependent on protein synthesis. & Friberg et al. 1990. Wood JM. Shenker et al “Immune suppression of human T-cell activation”.Lash. 1995.& Rossi AD.Miller et al. Mercury vapour release from a dental aspirator. Thomas D. Journal of Nutritional & Environmental Medicine 1996. 1967. 19.47(2): 167-73. Biologische Zahnmedzin.102( I 1).E.“Systemic mercury levels caused by inhaling mist during high-speed amalgam grinding”. “ A relationship between Vit B-12. Switzerland. 78:p25-29. The toxicity of mercury in Dental . Phoenix. Landsberg. editor. and methylation”. “Mercury Nephrotoxicity”. 1973. “Kidney injury after chronic exposure to inorganic mercury”.891-905. Daunderer. & Kazantis et al. Environ Health Perspect 1977 Aug. 1962. Toxicol Lett 1999.J.A.S. Dizikes L. 1976 & Discovery. Biochem Biophys Acta. 1994(case histories documented).DeSimone et al. & C Arch Environmental Health. T.gov:8080/97list. & 1993. Handbuch der Amalcamverziftung. 190( 10):558-60 & http://atsdrl . U. & E. No 4:440. Yannai et al. Cutler.atsdr.Davis. “Mercuric chloride induces apoptosis in human T lymphocytes”. 1990. Toxic01 Appl Pharmacol.S. 1991. & Goering PL.J. Shenker et al.H.gov/mrls. 7:245-247.Aschr. Pierre Blaise. F. Amer. Landsberg 1998. & “Amalgam”. Archives of Environ Health. S. “Nephrotic Syndrome Following Exposure to Mercury”. Of Medicine. M. “Inhalation during removal of amalgam restorations”. Applied Envir Microbiology. 4(4):317-24. B. Cheh A.1973 .E. Neurology 11:639-644 (1961) S. Of Penn.. Environmental Health Perspective. Toxicological Profile for Mercury 1999. & Dr.Allgen. & M.1999 Media Advisory. SelIars R. & 14(3):539-53. Ecomed-Verlag. ATSDR ToxFAQ CAS# 7349-97-6. Newman AP. Duke Univ. & Kantarjian A. Sellars WA. 6( 1): 33-37. 228-33. Recent studies on biomethylation and demethylation of toxic elements. 15(2-3):273-90. Hughes. Minnesota Medicine.Nimmo et al. Lustmuhle. Of Prosthodontics. 14(3):555-77. Paracelsus Allergy Clinic. 6(4): 152-7.D.cdc. & A.S. Jan 1991. “A syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism”. “Transformations of inorganic mercury by candida albicans and Saccharomyces cerevisiae”. &(b) B. & “Improvement of Nerve and Immunological Damages after Amalgam Removal”. Quecksilber in der umwelf-hearing zum amalgamproblem”. . Vol3 1: 403-4 18. 1. Shelton. Dee 1969. Inorganic mercury modifies Ca2+ signals. & L. 1990.l9:43-6 & R. Public Health Service. 1994. & Apr 19. mercury uptake.html U.cdc. Ecomed Verlag. Rau. Of Health. Immunopharmacologicol Immunotoxical. 14(3):555-77. in (293). Temple Univ. Keats Publishing. Dr. Rogers. Arizona. & March.E.. Univ. Cell Death and Differentiation 1997. Cutright et al. & Yamada.F. 1995. Nature Vol304: 633. ISBN 3-609-7 1750-5 (in German). Lucas AD. & Toxicologische erfahrungen am menchen.atsdr.Niedersachsiscles Umweltministerium.. Winning the War against Asthma & Allergies. Dept.May 28. Director. & Stonehouse CA. Of Pathology. Vahter M.. MRL:elemental mercury ~apor/inhalation/chronic & MRL: methyl mercury/ oral/acute. Vol 15:p64. M. D.Dtsch.Zom et al. Health Canada. and potentiates NMDA toxicity in cerebral granule neurons. Forum Prakt. Life Sci. R. J Oral Med 28(4):100-104. Defense Against Mvsterv Svndromes”.Quebec) Dr.000 cases) Nicholson et al. J Prosthet Dent. Br Dent J 2001 May 26. 1996(www). Chek Printing Co. 153(2):250-7 1998. School of Dental Med.html. J. New MRLs for toxic substances. DAMS(SOO-3 1 l-6265) M. ( amalgam removal & DMPS. triggers apoptosis.443.

June 1994.Ripa. CDA Journal.71(2): 269-274. Archives of Environmental Health. The calcium-selenium-mercury connection in cancer and heart disease”. 1994. removing. Issue 2. (www.Klock.8. “Improved Health after Removal of dental amalgam fillings”. FDI World Dental Congress.1996 and No. Ripa U.Momstad. Univ. and respiratory tract among dental personnel in .J. 5 1(4):335337. Lupus-prone mice as model to study xenobiotic-induced autoimmunity.Hamre.Foster. J Neural Transm Park Dis Dement Sect 1991. Univ.M. Bjorklund. H. Dr. Jan 1996: 86( l-4): 93-99 .R. “Effects of aluminum and mercury on the structure of chromatin”. Blomgren J. Augl9. Biochemistry.Schoeny.Basun et al. p44-47.A. D. National Research Council of Canada. 1995.3. J Biomed Mater Res 1990 Nov.Lokken. “Genotoxicity of phenylHg acetate in humans as compared to other mercury compounds”. JConstantinidis et al. p7. Of Geneva Medical School. 1988. & Pollard KM. 1973.H. Univ. J Dent Res. Pearson Dl.nu) (over 1000 cases) (Sweden has banned amalgam fillings & Gov’t maintains health records on all citizens) . U. The CFIDS Chronicle. 5( I):3 l-35 & G. et al. Univ. Bigazzi. Fall 1994. Tandl&utidn 81(23):1297-1302 (1989) . “Lethal mercury poisoning in a dental assistant”. Spring 1997. Professor of Oral Biology and Dental Medicine. Dept. Hinkleman et al. 1996.Ostlin). 1997. Jul.Bjemer~elm. Murray Vimy. Dept.G.13. Alzheimer’s’s Dis Assoc Disord . David Eggleston.Murphy. Environ Health Perspect. Voegel JC. 392(3):269-76.J.C. “Trace metals in plasma and cerebrospinal fluid in Alzheimer’s’s disease”. & Heavy Metal Bulletin. Lars Friburg.21(3-4):343-8.H. & C. 1995. 48(4):335-60. Larsen.l976.Lonnroth et al. Of Kentucky researcher on mercury in the brain and Alzheimer’s’s Disease ( http://www. Fritz Lorscheider. Molecular and Cellular Biology. Of Dental Mercury Patients. Goteborg. P. Clinical and Exper Immunology.“Mercut-yDischarge in Waste Water from Dental Clinics” Water Air and Soil Pollution.W. Supp 3: 663-73. No. 1. Of Calgary Medical School.Varga et al. 104.1993. J Nat! Cancer Inst. BBC Panorama Program on Dental Amalgam:“The Poison in Your Mouth”. 108(2): 196-9. researcher on mercury in brains of dead infants and fehises. May 2 1989. Ren Fail 1999 May-Jul. Hultman P. American Academy of Head. Arch Neurol. Dr. J.Tidsskr Nor Laegeforen. Mar 1977. “Exposure to mercury vapor during setting. 3: 449-453. (3 1 cases) Sven Langworth et al. & F. “Coors Amalgam Study: Effects of placement and removal of amalgam fillings”.H. Apr 1971.Gainer. 1997 and Svenska Dogbladet.Swe Adolph Coors Foundation. “Mercury release during ultrasonic scaling of amalgam”.tf. 3(4):23 lP.“Amalgamnews and Amalgamkadefonden. researcher on mercury in the brain. Dr. Mercury induced antinuclear antibodies in mice. Of Arizona. “Autoimmunity and Heavy Metals”. “Mercury in the Dental Practice: Contamination of Ambient Air and Waste Water. K. Lindvall et al.chairman. “Activation of Rauscher leukemia virus by metals”.Lee et al. Salek P. K. Of Calgary. and polishing amalgam restorations”. 199 1. Dr. (23 8) (23% (240) (241) (242) (243) (244) (245) (246) (247) World Health Organization Scientific Panel Members( Dr. Professor of Medical Physiology. “High incidence of cross stimulation by natural allergens of rat basophilic leukemia cells sensitized with IgE antibodies”. Hultman P. Mercury from Dental Amalgam and Chronic Fatigue Syndrom”.Walker et al. p 17. Int Arch Allergy 1mmuno1.altcorp. EPA risk assessment:the mercury study”.l997 (286 cases).Berglund. Abstract 960. Nor Tannlaegeforen Tid. 1996. Univ. Gustav Drasch. Ott 2 1. Boyd Haley. Dr. 33:788-790. et a1. Lupus. Echeverria. Dr. G.Iyer et al. Hypotheses. “Mercury Poisoning in a dentist”.l99 1 P. Environ Health Perspect 1999.(231) (232) (233) (234 (23% (236) P-37) Amalgam. Sweden. 1999. & Rubin.S. Huddinge Hospital. researcher on reproductive problems and birth defects in dental workers. and Facial Pain. P.24( 11): 155 l-8.609.E. “Effekt av amalgamavl%gsnandepB patienter som misstanker att de lider eller har lidit av amalgamfdrgiftning”. “Adverse health reactions in skin. H. & A. 1998. June 1982. Swedish Assoc. R. 102(9):323-325.EPA.5 1(2). Univ. “A case of panarteritis nodoa associated with chronic mercury poisoning”.28(9):391 l-3915. “Use of genetic toxicology data in U. “Hypothesis regarding amyloid and zinc in the pathogenisis of Alzheimer’s Disease”. Univ. E. 8 1(4):275288 & R. Of Geriatric Medicine. 1994 H. Vasken Aposhian. & Haikel Y. Of Munich. Dtsch Med Wohenschr. 74(SE): 13 1. & Hultman P. 107(Suppl 5): 729-735. Andrup B. Neck. eyes. & Klock B. “Can mercury cause Alzheimer’s’s”. Neuro-Toxicologist.S.com/). & J. *** Dr. Gasser P. & Nielsen JB. Enestrom S. Experimental studies on genetically determined susceptibility to mercury-induced autoimmune response. (www) & International DAMS Newsletter. Vol VII. Head.Lindforss. Wronski et al. Of California.D. 1995.

1992.Sweden”. and Neurotoxicology and Teratology. The activity of 1997.13(2): I7 I-85.Oct 1986.S. 14l:I.87-92. Neurotoxicol Teratol. J. Woods et al.“Prenatal exposure to metallic mercury vapor and methyl mercury produce interactive behavioral changes in adult rats”.B. & A. Rutowski J.Lohmann et al.“Occupational contact urticaria”. & M. Shinwari N. Vol 19. 1997. of Pennsylvania.Mittal et al. Immunopharmacol Immunotoxicol 1993. Dabrowski Z.S. “Cerebrospinal fluid biopterin is decreased in Alzheimer’s’s disease”. 43( 10): 996-9. Arch Neural. mercury (255) D. B. p4 (and editorial). 10(4): 315-23. and Jan 10. Urinary mercury levels in females: influence of dental amalgam fillings.Nagatsu et al. 1987. “Multiple Chemical Sensitivity Disorder in patients with neurotoxic illnesses”. 133(252) B.Bolanos et al. Heart Disease Research Foundation. MOV (250) Disord.“Parkinson’s disease mortality and the industrial use of heavy metals in Michigan”. J Pharmacol Exp Ther.“Chronic neurobehavioral effects of elemental mercury in dentists”. of Occupational Medicine. 17(3-4). 1995.40: 467-73. 1982. 6:13-I 5. 1996.NY. Tokhoku J Exp Med. Chemother.J. organolead. 1992.& A. 8c T. & T. 1998.Rybicki et al. J (260) Toxicol Environ Health. Vol97. 49(11):782-790.Ngim et al.H. Dept.P. 74(2-3):151-160. Nov 22.D.Langworth et al. Of Singapore. (248) Y. (265) K. Environ Res 1977.M. Nippon sanka Fujinka Gakkai Zasshi. Med Tr Prom Ekol. British Journal of Industrial Medicine. Spring. Neurotoxicology. Aug 1995. 2 19(4580):75-77. 1986. 18(2): 129-34. (254) al-Saleh I. Apr 1996 & J. Smith et al. (256) D.Omura et al. 1996.39(2): 202-6. “Effects of tyrosine ’ administration on serum bipterin In patients with Parkinson’s Disease and normal controls”. 1996. Danielsson et al. Mol Cell Biochem. Dept. “lmmunotoxic effects of mercuric compounds on human lymphocytes and monocytes: Alterations in cellular glutathione content”. 13-22 (25 1) Y. Swed Dent J. Moszczynski P. Toxicology. Rice.l6(2):58-64.Alymbaevaet al. 1993. “Heavy metals and antibiotic resistance in Escherichia coli isolates f%omambulatory patients”. (257) 62(724): 113-123. 183-I 90. Jan 1998. Fredriksson et al. “Catecholoamine-related enzymes and the biopterin cofactor in Parkinson’s”. (26 1) New Scientist: This Week. ‘& “Behavioral effects of prenatal metallic mercury inhalation exposure in rats”.Iioka et al. & “Altered porphyrin metabolites as a biomarker of mercury exposure and toxicity”. 20(3): 195-229. “The effect of inorganic mercury on placental amino acid transport”. Univ. & “Mercury exposure from silver fillings”. . of Pathology. Univ. Neurotoxicol Teratol. & “Behavioral effects of neonatal metallic mercury exposure in rats”. 1990. “Evidence of delayed neurotoxicity produced by methyl mercury developmental exposure”.Kanerva et al. & J.“The enigma of parkinsonism in chronic borderline mercury intoxication. 40(2-3): 1993. Acupuncture & Electro-Therapeutics Research. 15 SuppI 4: 125-5 1. (259) C.Shenker et al. p235-.D. “Role of mercury in resistant infections and recovery after Hg detox with cilanh-o”. 1996. “Exposure to mercury vapor and impact on health in the dental profession in Sweden”. 1989.A.2(4):238-40. 1997. & Yamanaga H. 1998. “Nitric Oxide mediated mitochondrial damage in the brain”. 8: 1. J Dent Res. Treatment of Mercury Intoxication in a Dentist with penicilamine. enzymes and basic indices of peripheral blood erythrocytes from workers chronically exposed to erythrocyte vapors.22( l-2): 33-45. 1996. 15(2-3):273-90. NY. resolved by challenge with penicillamine. Physiol Pharmocol.35(4): 229-33. J Toxicol Clin Toxicol. & Canadian J Physiology and Pharmacology.C. & L. 1984. (258) J. Acupuncture & Electrotherapy Res. 15(6): 391-6.Aguiar et al. ~583-96.K. and organotin” J Toxicol Sci. Science. “Effects of Porphyrinogenic Metals on Coproporphrinogen Oxidase in Liver and Kidney” Toxicology and Applied Pharmacology. Fall 1996.l49150:263-5. (253) S. Biometals & Zabinski Z. (264) B. Toxicol Ind Health 2000 Feb. Postgrad Med J. “Urinary porphyrin profiles as biomarker of mercury exposure: studies on dentists”. “Quantitative analysis of tremor in Minamata disease”. 1993.76(7): 1397-404. 1990.Martin et al. “The Neurotoxicology and pathology of organomercury. Woods et al. (263) H. “Validity of urine samples for low-level mercury exposure assessmentand relationship to porphyrin and creatinine excretion rates”. Contact Dermatitis.Kay et al. Neurotoxicology. Jan 1983. “Pteridines and mono-amines: relevance to neurological damage”. & “Latent effects of methyl mercury on the nervous system after prenatal exposure”. Neural. 19(4):401(249) C. 1983 Sep. (262) Chang LW.R. Feb 1996. “Interaction of heavy metals with the nitric oxide synthase”. 1995 (Russian) I.Finkelstein.Yamiguchi et al. p4 17. 17( 1): 29 l-5: & Hryhorczuk E et al.74(2):21 O-l 5.

& U. N. Myers GJ. & T. Germany.html.J. Monitoring methyl mercury during pregnancy: maternal hair predicts fetal brain exposure. “Mercury in the brain and CNS in relation to amalgam fillings”. Sept 1984..Symposium paper.Hirsch et al. 1996. Institute of Occupational Medicine. Stuttgart.Institute for Naturopathic Medicine.Schiele et al. Tumor.Weber. Vol 1. “Mercuric chloride induced anitnuclear antibodies In mice”.de/home/Institut_f. Contact Dermatitis. & P.“Hazardous burden by country” R.58(6):322-3 1. and loss of reductive reserve”. Environmental Protection Agency. & Tan XX. & “Low-level MeHg exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial disfunction”. L.77(2):149-l 59. “Influence of occupational factors on disease of reproductive organs”. (270) 5 1(5):6 17-623. 1995. . Department of Health and Human Services.48(4):22 l-9. “Induction of apoptosis in human T-cells by methyl mercury”.htm” BJ Shenker. p3. Toxicol Appl Pharmacol.t-online.S.. & T. Costa Lg. Environ Res. “Study on the normal mercury concentrations of human organs”. . 1996. p 6 l-69. Institute for Naturopathic Medicine. 109(3): 469471. “Beneficial effect of human therapeutic IV-Ig in mercury induced autoimmune disease”Clin Exp Immunol.cdc.lmmun. 1995.Epidemiology of .Kleber. Sept 96. & Immunotoxicol.Suzuki et al. Biocompatibility of Metals in Dentistry. “Effect of dental amalgam and nickel alloys on T-lymphocytes”.1986(Swedish Medical Journal). Of Erlamgem.Duuet et al. Suzuki et al. “The Marburg Amalgam Study”.J. & O. 8~ U.Robinson et al.157( 1):23-35. Zentralbl Bakteriol Mikrobiol Hyg (B). IgA-IgG disease in the intestines of rats ingesting HgCl”.. “Glomerulonephritis induced by heavy metals”. Mitt. 1984. Biological Monitoring and Surveillance. Environ Health. Apr. Arzt und Umwelt. Aug 1984. 1994. 38(2): 159-70.Gonzalez et el..J. Arch Environ Health. (266 cases) & (b) “Amalgam (271) and Allergy”. 136(9):3277-3281. “Quecksilberverkonzentration im Urin nach DMPS” in [Status Quo and Perspectives of Amalgam]. ~36-66. 14(3):539-53. Clin Immun Immunopath. Waterman SJ.1984. L. Clarkson TW. Marsh DO. Mercury Health Effects Update. & .199( 1):24-37. 173( l-2 :45-62. & (g) El-Fawai HA. 1975. “Mercury concentration in organs of contemporary Japanese”. Contact Dermatitis.44(5): 298-303. NIDRADA Workshop. GeorgThieme Verlag. March 12. Chap 4. (& (278) 38) Jenkins. 1005. EPA. Pediatriya (27% Akusherstvoi Ginekologiya. Tang C. JADA. Immunopharmacol lmmunotoxicol.2548.1982. 1992. 1986.1966. Agency for Toxic Substances and Disease Registry. & K. & (e)J Immun. 1994. &(c) F. 137(g). (266) . & (267) L. 14(3):555-77. 1986. Lakartidningen. http://www. 50:187-194. 3272-3276. “Alternative treatment of Multiple Schlerosis..Weening et al.& (f)Cossi et al. 1993. & J.M. & Cemichiari E. Univ. Brewer R. 124(3):2 1 l-24.Nebenfuhrer et al. 1998. 83(7):5 19(274) 52 1.T.Mikhailova et al.J Prosthet Dent.1 6(4):705-l 0: & M. EPA: In Risk Information System.G. 1997. VanDendergen. Friberg(ed.S. of Toxic Trace Metals. New York. J hnmun. Apr.Gesundheitswesen. Berlin M. 1984. (& 38). 1981. Castoldi AF. R.S. Toxicology.79( 17): 1866-l 868. & J of the American Medical Assoc. 1989.S.86:159-169. “The hair-organ relationship in mercury concentration in contemporary Japan”. 1(4):214-2 17.33(6):56-58.Eggleston.Friberg et al.Insug et al.Schmid et al.A.. “Hg allergy .J. EPA. B. &(b) PAndres.Numberg.Schiele et al. 1984.atsdr._NaturheiIverfahren/patinf. Arch Toxicol. (272) 1999. Bioloeical Monitorino. 4 l(1): 60-l.136(9). Neuroimmunotoxicolog: Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms. http:/ /home. De Feo A.gov/99list. Cologne. 30:488-494.W. & “Quecksilber-Mobiliztion durch DMPS bei Personen mit und ohne Amalgamfullungen”. “Studies of organ (273) mercury content related to number of amalgam fillings”. 1991. Shamy MY. (27% U. Institute for Naturopathic Medicine 1997 (40 MS cases).482(a)C. Contact Dermatitis 1999. D. 1O(2): 12 lJ.4:69-75. Toxic Appl (269) Pharmacology. 1992.1971 (276) ATSDIUEPA Priority List for 1999: Top 20 Hazardous Substances.. Effects of inorganic and organic mercury on intracellular calcium levels in rat T lymphocytes. development of mitochondrial membrane permeability. L. Neurotoxicology 1995 Winter.Matsuo et al. Vol XlV(3). Sept 1980. Brim. & R. Zentralbl Hyg Umweltmed. U. J Toxic01 Environ Health 1993.1982 & Transplantation Proceedings. “mercury induced immune complex glomerulopathy”.“. Hazardous Air Pollutant Hazard Summary Fact Sheets. or Cancer”. “Mercury in human hair. 1986 & (d)J. “Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species(ROS). Zahnarztl. (268) 1980. & Q “Conjunctivitis sicca(dry eye study)“. Ind Health.). 1989.

J Appl Toxicol. Vol95(5):2642-2647. "Deaths from 281 Selected Causes. “Lithium treatment protects neurons in CNS corn glutamate induced excitability and calcium influx”. Mar 3. Arch Int Physiol Biochem 1990. & (b) J. and brain tumors”.Arnetz et al.Perlingeiro et al. 1996. “Effect of exposure to elemental mercury on short term memory”. Neurosurgery. of Mental Health. 19 February. Washington D. and Psychiatry. 1994. Press Release. Effects of mercury compounds on the spontaneous and potassium-evoked release of (3Hldopamine fi-om mouse striatial slices. Bioprobe Newsletter. et al. & (g) Levine SP. & M. Validity of Hair Anlysis for Diagnosis of Mercury Status.Airey. Simpson et al. I994. “Chronic elemental mercury intoxication”.Hua et al. March 8. Mercury in human hair: a review” Environmental Health Perspectives.Warfiinge et al. & 0 L. Sci Total Environ 1983. Journal of Neurology. www. Jan 1988. British Medical Journal. & S.W. Sakata M. Toxicol Appl Pharmacol 1995 & Chuang D.. Queiroz et al. ~262.S. Idel H. Lewis RN.. 1994. Chetty CS. Science News.Glass.. Arch Environ Health. Cherian MG.Rajanna.1983.&Vital Statistics of the U. 1966.A.“Behavioral consequences of in utero exposure to mercury vapor in squirrel monkeys”.34( 19):3405-13 . Stockholm. & Endo T. 158:309. & McKay SJ.C. Can J Physiol Pharmacol 1986.(280) (281) (282) (283) (284) (28% (286) (287) (288) residents of Madrid. “Suicide rates of Iowa dentists”. dental nurses.27:2-3:7-14.I 5( 1):5-7. & Moore G. 1998. 0ct. Cavender GD. Biochem Pharmacol 1985 Ott 1. I6( 12): IO l l-7.Soleo et al.67: 196-208. by Age. Nov I I. Public Health Service. Moosmayer M. II. Toxicol Appl Pharmacol. 1990. 14(3):28 l-6. & M. Et al.Nonaka et al. & Hum Exp Toxic01 1995. 21:239-244. T.R.vI 07:44 I -.60(3):339-34 1. Neurobiology. Swedish Council for Planning and Coordinating Research (FRN). 52:303-3 16.S. Reynolds IN. Repeated neurobehavioral investigations in workers . -1970. “Influence of mercury on uptake of dopamine and norepinephrine”. 1983. & Anner BM. 1985. Dental Assoc. 1986. & D. Table l-26. 126( 1):6-l 5. & Wilhelm M. Mercury uptake by primary cultures of rat renal cortical epithelial cells.com. 1972. IO(5):377-84. & U. et al. halide ions.afier exposure to mercury vapor”.bioprobe. 1972. & “Prolonged behavioral effects of in utero exposure to methyl mercury or lead”. National Center for Health 15(4):243-6.Smith et al. A. Rat brain (Na+-K+)ATPase: modulation of its ouabain-sensitive K+-PNPPase activity by thimerosal. Vo1292. Int J Biochem 1983.I 34(2):32 l-325 2000. statistics from 31 states.88( l-3):221 -6. Pharmacol Toxicol. and alkali metal ions. sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors. Bethesda Md. & Ziff. Nat. National Institute of Mental Health.B.C. Experientia.24(5):65 l-9 . Shaikh ZA.1994. M. J. & Science News.C. Langolf GD.. R. “Effects of low exposure to inorganic mercury on psychological performance”.Greenwood et al.200O. Toxicol Lett 1996 Nov. Newland et al. Muller F. ~276. & (f) Gunther W. Br J Ind Med. Br J Ind Med 1983. “Suicide among Swedish Dentists”. Toxic01 Letters.Hobson & B. 12(2): 79-84. “Mercury distribution in neonatal cortical areas . Brain Inj.. Albers JW. Lai et al.64( 12): 1507. & (e)M. “Polymorphonuclear phagentosis in workers exposed to mercury vapor”. Biol. “Neurological abnormalities associated with remote occupational elemental mercury exposure”. “Sensitivity of MS detections by MRI”. 8c B. 139: 374-386.. Bowler K. 1996. 1987. “Dentists. & (d)P.. Of Amer. & K. 28:1455-1456. and Sex. Lancet Ott 7. “Mortality of New England Dentists”. “Use of hair analysis for evaluating mercury intoxication of the human body”. Race Statistics.14. Dept.39(2): 136-9. & Scheuhammer AM. 47(2): 105-9. Elemental mercury exposure: peripheral neurotoxicity.40(4):225-g. 1996. Toxicology & Applied Pharmacology. Hobson M.32(2): 157-80.S.Ann Neurol 1988. 3-14-98. 17(3-4):605-14. Racz WJ. S. Surgeon General Report.40(4):413-9. Rajanna B. death 2000 R. Effects of pH.. Clarkson et al. Of Health.S. Spain”. Ware L. 1992. Br J Ind Med 1982 May. M. ~164. 98(5):291-6. Neurotoxicology 1996. Int J Immounopharmacology”. Effects of cadmium and mercury on Na(+)K(+)ATPase and uptake of 3H-dopamine in rat brain synaptosomes. & R.J.Ahlbom et al. 1O-3 l-98.74(2):72-5.J. “Transfer of metallic mercury into the fetus”. & Science News. Dep 1985. 1998. U.Katz et al. Harris L. Effects of heavy metal cations.Albers et al. & M. Environmental Research. Neonate.W. “Transport of elemental mercury into fetal tissues”.. Stand J Sot Med. Inst. Biological monitoring of mercury vapor exposure by scalp hair analysis in comparison to blood and urine. Mercury inhibits Na-K-ATPase primarily at the cytoplasmic .L. & “Total mercury concentrations in human hair form I3 countries”.

1998. 1977. & “Anorexia Hydragyra: . “Quecksilberdepots im Organismus korrelieren mit der Anzahl der Amalgamfullungen”.Verschaeve.423( l-2):65-72. (292) M. “Comparative in vitro cytogenetic studies in mercury-exposed low level lymphocytes”. & N. 1996. 1988. & and Health. .Gradl et al.K.A.“A study of the release of mercury vapor from different types of amalgam alloys”. “Long term corrosion studies of amalgams and Casting alloys in contact”.htm (295) Cecil Textbook of Medicine. Ermittlung der Quecksilberbelastung aus Amalgamfullumgen. Klin Lab 38. 11:2.Mayer et al. 1972. in Akute und chronische Toxizitat von Snurenelemente.25( 10):800-S C. 1977.. & Comprehensive Psychiatry. Rupp et al. & L. Aug 1998.E. “Studies of mercury vapor emission from different dental amalgam alloys”.B.Mai et al.1992. “Increased blood mercury levels in patients with Alzheimer’s’s disease”. cellular distribution and DNA damage produced by mercuric chloride in a human fetal hepatic cell line.Boyer. & Editors of Alternative Medicine Digest.“Genetic damage induced by mercury exposure”.Sarkar et al. & Harrison’s Principles Of Internal Medicine. Vol. & A. 1989 Apr-Jun. Kilicarslan MA. #630. & Kedici SP. Swed Dent J. & Ultrastructural studies of the nervous system after mercury intoxication.. 1. & Environmental Illness. Source Mol Toxicol. Psychometric evidence that dental amalgam mercury may be an etiological factor (294) in manic depression. & L. Biol.Gebhardt. J. p197-. Toomvali. 1993.E.Schneider et al. Mutat Res 1999 Jan 25. McGraw-Hill. & (297) N. “Amalgamation reaction of Dispersalloy Reexamined”. 1988. (296) L.y. H.Huggins & TE Levy. Wissenschaftliche Verlagsgesellschaft nbH. J. Environ. Kinderheilkd.Chronic Fatigue Fibromvalnia U. & N. Acta Neuropathol(Berlin). pp. 1998. 3(4):295-300. “Risikobestimmung der Amalgambelastung”. & D. 1985. 105(4):213-218 & 105(5):280-283. Aksut AA. Siblerud. & Sunderman FW. Swedish Council for Planning and Coordination of Research. Robert L. Journal of Orthomolecular Medicine. Alternative Med Rev.1994. 1985. IADR Abstrats. 1995.384-386.Moberg. 1999. Thiol cells. IADR Abstracts # 356. Lichtenberg. . Envir Res. &Poisoning & Toxicoloev Compendium. Res. IADR Abstracts. Uptake. & “Amalgam: zeitbombe in mund?“. J Oral Rehabil 1998 Oct.depression. LIU-IFM-Kemi(298) EX 150. 1976. Echeverria et al. (300) 1998. Die Quintessenz 45.Mateer et al.Sarkar. 105( 1):59-68. “Mercury vapor in the oral cavity in relation to the number of amalgam fillings and C-9) chronic mercury poisoning”. & R.Mayer. Labormedizin 16. Saunders and Company. 1979. & JGD Birkmayer et al. “Neurobehavioral effects from exposure to dental amalgam: new distinctions Amalgam between recent exposure and Hg body burden” FASEB J. Ann Clin Lab Sci 1988 Mar-Apr. &V. Biological Trace Element Research. “Zur Ermittlung de Quecksilberfreisetzung aus Amalgamfullungen”. 137(S): 472. et al.Verschaeve et al. Published Dissertation.S. Stockholm. Aug 1998. et al. Exp Neurol. Bennett & Plum. & K. 1978.. First Quarter 1998. Neural Transm. 14th Ed. & L. No. Lexi-Comp. (289) (290) . Inc. 1998. IADR Abstracts # 895. J Dent Res. ~~595-598. #358.24:109-117. 391-403. in Korpermaterial von Amalgamtrager”. 1989. 3 1. ZWR. 1993.W.Dorffer.Hock et al. Journal of Orthomolecular Medicine. 8~ A.Psanas et al. (291) H. & N. Moberg.35( 1): 122-37.l990. 1S(6).“.K.l977. 157(2-3):22 l-6. Cleveland.. & R. 14(3):329-73. “Effect of selenium on mercury vapor released from dental amalgams”.. 12:306-l 0. IADR Abstracts #240. 13.Bucio et al. p 69. Stuttgart. Bayramoglu G. & Histochemical study on (301) the localization and distribution of mercury in the nervous system after mercury intoxication. “Mercury release from Dispersalloy amalgam”. 12( 11):971-980. ~297-307. C. Corrosion behavior of dental metals and alloys in different media. Zahnmedizin.Schiwara.104(3):209-214. 1982.B. ZWR.1992. 6(2):57-61. & M. 199 1. 262(5 Pt2):F84308.43:163-l 77. Acta Odontal Stand 1985.l8(2):89-101. Sarkar et al.Daunderer. “Corrosion products from dental alloys”.1976: P. Am J Physiol 1992.40 http://www. 87-94. Leikin and Palouchek.. 20th Ed. 1990. Philadelphia.20(2):122-38 and 20(4):316-34. 1996. Perils of mercury.Berglund. 117-28 & L. Neurotoxic effects of mercury. Chang LW. Gokdemir K. 1994. . (293) H.com/news/news~981116. & Snyder RD. IADR Abstracts #2 17. Muta Res.72:939-946. Future Medicine Publishing. W. Methylquecksilber.. involvement in the inhibition of DNA repair by metals in mammalian human 2:2. N.side. 18: 15-23. “Mercury vaporization from corroded dental amalgam” Dental Materials. Burton Goldberg. ~65-71..Huggins. 1143-l 152.E. 1972. H. Monatsschr.4:89-93. D. Lachmann PJ.. Quecksilber. “Cerebrospinal fluid protein changes in MS after Dental amalgam removal”.

Toxicology & Applied Pharmacology 1993.Utt. 22(5): 362-3.7:348-55. & M. (3 16) B.“Immunotoxicology of mercury and cadmium on B-lymphocytes”. Univ. 76(4):9. Clin Exp Immunol.1997. & J. .F. 17: 195-23 1. N. J.M..Stejskal et al.Joumal of Calif. Brain Research & Developmental Brain Res.“. 15(3):383-94.30(3): 21 I-214.Malt et al. Int Arch Allergy Immunol.Engin-Deniz et al.Sorenson et al. 1995. 1997. Acta (311) Neuropathol (Berl) 1972..& L. AZ. 1995. Dept. Pendergrass JC.Schneider. 13 Apr 1998. R. & K. 122 (2): 273-80.12(2):41. Psychosomatic medicine. (310) Science of the Total Envir.. “Prenatal methyl mercury exposure as a cardiovascular risk factor at 7 years of age” (308) Epidemiology. 1995. “An Ultrastructural study on the blood-brain barrier dysfunction following mercury intoxication”. Apalachee Junction) . 85:96-108. “Mercury from Maternal Silver Tooth Fillings: a source of neonatal exposure”. 89:471-179.3 l-40. Haley BE: HgEDTA complex inhibits GTP interactions with the E-site (307) of brain beta-tubulin. The Tribune.l992. Nordic J of (309) Biological Med. 1991 . 1999. The Kev to Ultimate Health. (321) R. “Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice”. (3 17) SZinecker.Daunderer(Germany) of MS patients after amalgam removal”. .Oliveira et al. & “Urinary Mercury after Administrationof DMPS”.J. & Prenatal and neonatal toxicology and pathology of heavy metals” Adv Pharmacol Chemother. (303) H. Clin Exp Pharmocol Physiol. Mesa. Vol 16( I).Goldman et al. Of Pennsylvania School of Dental Medicine. Burkholder PM. “Comparison of neurite outgrowth with neurotilament protein levels In neuroblastoma cells following mercuric oxide exposure”. Of Clinical Immunology. der Kassenarzt.“Die queckssilberkonzentration im spichel zehnjariger kinder in korrelation zur anzahl und Grobe iher amalgamfullungen”. 1998.21(3): 179-84.Marsh et al. 99(1-2): 23-35.“. Supp 4. 32(4):23. (1800 patients) (3 18) V. 1976. Zeitschrift fur Stomatologie. (3 19) H. 1998.l2:223-. “Fetal Methyl mercury Poisoning”.Daum. &“Mercury-induced autoimmunity”. Chang LW.“Chemically induced autoimmunity .Siblerud.V. Ann Neural. 15(1):87-I 12. 1984. 1980. “Mercury effects on the contractile activity of the heart muscle”. “Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes: Alterations in B-cell function and viability” Immunopharmacol Immunotoxicol. (3 14) M. Klinghardt. “Physical and mental problems attributed to dental amalgam fillings”.. FASEB J. Toxicol Appl Pharmacol. (320) U. E. (800-31 l-6265) (3 13) V. Of Pathology.M. Warfyinge et al. Richard Hanson. 114(1):9-12. 1:86-91.97( I-3): 23-38. 1995.Aposhian et al. 1995. Frankfurt.1 I. Dencker L. Ebendal T. 199Ob.V. 1990. What Your Doctor May Not Tell (312) You About Hormones.Shenker et al. Toxicol Appl (306) Pharmacol.Kubicka-Muranyi et al. A. Envir. “Hg release from amalgam fillings into oral cavity”.Siblerud. “Praxiproblem Amalgam”. “The relationship between mercury from dental amalgam and the cardiovascular system”. Dissertation. Hartmann HA. 109( 1): 1 l-20.l996. 6: 2472-2476. hnmunol Res. & Ware RA. 1992.D.Lee(MD). a>M.“Mercury Breath”. “Mercury induced autoimmunity in humans”. “Relationship between dental amalgam and health”. 1998.1994.(302) D. Abdulla et al. 59:32-4 1. Biological (304) Trace Element Research. “Mercury-specific Lymphocytes: an indication of mercury allergy in man”. 1993. Der Allgermeinarzt. Health Perspectives. M. “Mobilization of Mercury in Humans by DMPS”.. Volozhin Al. 1993.M. 132(2):299-309..L.Acta Neurolpathol(Berlin). Slevin JT. “The effect of mercury vapor on cholinergic (305) neurons in the fetal brain. 1996. & Toxicol Lett 1995.20( 1): 67-78. Bagentose et al. & (b) Motorkina. 2000. .D.M. & J. Int J Immunophannacol.. 75( I-3): 133-44. Toxic Substances Journal.O. & Toxicology. 1974. 10(4):370-4: & D. Fredriksson A. & Kyle BP. & E.R. 1992. Vol 106.Immunology Today. “Amalgam: Quecksilberdamfe bis ins Gehim”. IAOMT Conference & tape. Barer GM. DAMS. Dental Assoc. (Paul Mills. (315) B.Vimy et al.J. 1980. “large study by M. “Systemic autoimmune disease induced by mercuric chloride”. Stomatologiiia(Mosk): 1997. 1999. Duhr EF... 56: I43-52. “Untersuchungen . Aug. Chang LW.L.17( 11): I2 15-1221.. 1999. Soderstrom S.“Blood-brain barrier dysfunction in experimental mercury intoxication”..

Neurotoxicology 1996. Biometals. near (these clinics use MELISA test for diagnosis of immune reactivity) Czech border). Acta Neural Stand. Tanner et al.Nord med Ark Stockholm 1880 xii no 17 l-48 1 pl & P. J.“Abnormal Liver Enzyme Metabolism in Parkinson’s”. 1991. Director. MD. Madsen.globalpoint.“Metal-induced diseases of the nervous system”. Suppl:59-61. Parkinson’s Disease. Localization of mercury in CNS of the Rat. Neurosci Lett. EAACI. 1998. 124. 1978. Tsunetoshi Kohdera. vol 108(8). . Stockholm. Vestn. & Heavy Metal Bulletin. Horsted-Bindslev P. & (I) Pamphlett R. 1982. 216. Inorganic mercury is transported from muscular nerve terminasl to spinal and brainstem motomeurons.20. 1986. Faculty of Dentistry. 80(5): 2 18-24. 1990.Pean et al. “Beobachtungen uber die gesundheit vor und nach amalgamentfemug”.l998.ch/paul-engeI(89% significant improvement) (323) Dr. 41: 29-43. 15: 108994.or.Dallmann. Waley P. 1996. Prog Histochem Cytochem. “interaction of mercury compounds with muscarinic receptor subtypes in the rat brain”. (86 cured) (322) P. Schweiz arch Neural Neurochir Psichiatr.Neurology.Diagnose und Therapie. Le Quesne. “umweltgifie und multiple sklerose”. Ionescu.Engel. Mibu Nakagyo-ku Schimazu Clinics Kyoto 604 Japan e-mail:smc-inet@mbox. J neural Sci. Ott 1994. & E. 1995. 1998. Der Allgremeinarzt. “Dental amalgam and multiple sclerosis”. & S. Arvidson(Sweden).Separatdruckaus Schweiz.Venerol. Issue 2. 1990. “Retograde axonal transport of mercury in primary sensory neurons” 1990.Dermatol. 1991. Muscle Nerve. “Unithiol in treatment of dermatoses”.kyoto-inet. Traces of mercury in organs from primates with amalgam fillings. Neurological Sciences 135: 63-67 (1996). Muscle Nerve 1992.. Environmental Research. 1998. Vol I. 156(l): 12-7. Arvidson et al. “Motor Neuron Uptake of Low Dose Inorganic Mercury”. 15(2): 143-50 & M.. & (c) “Ultrastructural localization of mercury after exposure to mercury vapor”. Schwermetallbelastung bei atopisher dermatitis and psoriasis. APMIS 1999 Mar. 115:29-32. & P. Johansson K. & “Effects on health following removal of dental amalgams”. “Patterns of antigenic expression in human glioma cells”. “Entry of low doses of mercury vapor into the nervous system”. Osaka Univ.28:534(327) (a)G.Heafield et al. chronique simulant la sclerose en plaque”.82:324-237 & Neurosci Letters. & J. 1992. 7 (3) ~261-263 1994. & “Sur un cas de mercurialisme 98:1-19.5(2): 95106.1998. “Is multiple sclerosis a mercury allergy?“. 89-92. 1990. and Alzheimer’s’s Disease”. Amino Acids.10:425-444. owns 2 Clinics. 20:22262220. Candura et al. & “Relationship between amalgam fillings and oral cavity health” Ann Dent.M. (329) Arvidson B. 27(4):667-71.52(3):291-9. “Mercury and MS”. 19(1):39-47. Environ Res.Baasch. Mauch et al. SS Tsyganok. allergology.“kon nen durch Quecksilber entstehen? PeDa-Eigenverisg. “Oxidative damage to nucleic acids in motor neurons containing Hg”. & Castoldi AF et al. 41:29-43. 23:249-255. 41(5): Suppl 2. International J of Epidemiology.jp & G. Exp Mol Pathol 1990.de fax: 0049 9947 IO 51 11 (324) D. &(b) Danscher G. Pharmacol Toxic01 1997. “Autometallographic inorganic mercury correlates with degenerative changes in dorsal root ganglia of rats intoxicated with organic mercury”. Danscher G.T.159(2): 121-6. &(g) Schionning JD. & Arvidson B. Acta Neural Stand. Ghadirian P et al.Br J Hosp Med. 49(2): 6-10. Danscher et al. & Neukirchen (clinic)(Germany. Arvidsson J. J Neural Sci. B. (2): 65-68. “Mercury Deposits in Neurons of the Trigeminal Ganglia ARer Insertion of Dental Amalgam in Rats”. Kohdera. (330) C. (326) E.Coote P . Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motomeurons. Monatsschr Zahnm. 1 lO(l-2). 1991. & (e) Pamphlett et al.87:461-. Biol Med. “Localization of mercury in the CNS”. 1994. “Pathways of cysteine metabolism in MND/ALS”. 1996. J Orthomolecular Med. Clausen.McKeever et al. (rats & primates). &c(d) Pamphlett R. Neurotoxicology. 1998. (9): 67-69. Rungby J. Selective involvement of large motor neurons in the spinal cord of rats treated with methyl mercury. “Plasma cysteine and sulphate levels in patients with Motor neurone disease. & A. 1986. Gruia Ionescu. (325) B. International Congress of Allergology and Clinical Immunology. Email: Spezialklinik-Neukirchen@toolpool. & M. Danscher. cases paid by insurance companies in Germany. 17(3-4): 735-4 1.Watanabe et al. dermatology. (I 60 3 1 Higashitakada-cho cases cured-eczema).(75 cases amalgam removal) http://soho. & Moller. Crit Rev Neurobiology.M. 1993. J Neural Sci.107(3):303-10 (328) P. “Effects of mercuryic chloride and methyly mercury on cholinergic neuromusular transmission”. 1089-94. 15( 10). Bangsi. & M. 1966. June 1994. Su et al. 6:119-147. Aug.

Freitas et al.& 0 Karp W. The Lancet. Semczuk-Sikora A. (333) A. Cell Struct Funct 1995 Jun. 40:1095-98. Pharmacol..Bigazzi. (334) T.G. Yaqob A et al. Modifications of Ca2+ signaling by inorganic mercury in PC12 cells. 13:470. Brain 1996. 1999..20(3):233-8. Dept. Engqvist et al. 51:3. of Obstetrics & Gynecology. (344) G.. Effect of mercuric acetate on selected enzymes of maternal and fetal hamsters” Environmental Research.Gordon et al. “Lymphocytes transformation induced by inorganic and organic mercury”. Popescu M.Emory et al. Lindvall A. 3582-. 1996. European J Immunology.Tosti et al.82-83:255-61. “Autoimmunity induced by metals”. & T. Dec. 14( 1):37-44. & L. Mol Immunol. (343) P.Busselberg. 1994. U. Toxicolozv of Metals.J. Karp et al. “Factors affecting internal mercury burdens among German children”. “Calcium channels as target sites of heavy metals”. (34 1) A. Arch Environ Health.J Biol Chem. 1997.Toxicol Lett. 1998. Schulz C. Ann Rheum Dis. Rambam Medical Center. Stockholm Univ. and cadmium: A Public Health Perspective”. 1997. 164(4): 325-30. lnt Arch .7:1507-14. 116(l): 17-23.Eggleton et al. Gale TF et al. & P. 1997. “Speciation of mercury excreted in feces from individuals with amalgam fillings”. “Contact stomatitis”. Protein binding of mercury in milk and plasma from mice and man--a comparison between methyl mercury and inorganic mercury. ~835-52. lead. Hill. & Dept. Environ Res. Of Food Engineering and Biotechnology. “Drug Associated glomerulopathies” Toxic01 Pathol. 1996.1977. 1995. 1992. J Appl toxicol. Effects of SH-blocking compounds on the energy metabolism and glucose uptake in isolated rat hepatocytes.477. ATSDR. 1998. G Ital Med Lav Ergon.Soleo et al. and Hg in particular) and Mg status during pregnancy.Nakada et al. 53(3):205-13. & M. “In vitro effect of mercury on enzyme activities and its accumulation in the first-trimester human placenta”. & (b)J.3(4):379-86. et al. Proceedings: 33rd Annual Meeting of American Academy of Environmental Medicine. 1992.B. Abadin.7(2):332-340 (339) H.318-20. “The mercury concentration in breast milk resulting from amalgam fillings and dietary habits”. 1992. & P. “Breast-feeding exposure of infants to mercury.Drexler et al.. & metal concentration in W. Stand J lmmunol.. “Patch test materials for mercury allergic contact dermatitis”. p 644-47. Hypersensitivity phenomena and the kidney: role of drugs and environmental agents. 1992. 36:35 l-358. & Semczuk M. of Toxicology & Chemistry. Wichmann HE. Ersson B. & Adler SG. Zentralbl Hyg Umweltmed. & Stejskal VDM. 263:8.Urbach et al.A. 8~Neurology 1990.Yallapragoda et al. 1992. 1992. in Chang. 1993. 13(4): 495-5 17. 1985 Feb (337) H. Wjst M. 3 1:7. & (d) Boot JH. 52(2):134-g. Oskarsson A. (340) Herrman M.20(2): 7581 . Research. Lonnerdal B. & & Steventon GB. 29(3): 723-30. “Influence of amalgam fillings on urinary mercury excretion”(S. Am J Kidney Dis. Br J Rheumotol.Emory et al. Xenobiotic metabolism in motor neuron disease. Israel. 1988. (342) V. Toxicology 1999 Ott I.(331) C.Caron et al.17(3): 273-8. Environ Res.Chavez et al. & D. 137(3): 169-84. 1998.S.R. 738(2): 257-64. Szucs et al. “Mercury burden from amalgam fillings”.Monestier et al. Neuroendocrinology Letters.niwl. & Cell Mol Neurobiol 1994 Dec. “Pathophysicological roles of calreticulin in autoimmune disease”. “MELISA: A New Technology for Diagnosing and Monitoring of Metal Sensitivity”. CRC Press Inc.“lnhibition of calcium transport by Hg salts” in rat cerebellum E. Lewis Publishers. Med Sci Monit 2001 Mar. & release by Hg+2”. Danersund A. & P. “Poor sulphoxidation in patients with rheumatoid arthritis”. Lancet. Metalspecific memory lymphocytes: biomarkers of sensitivity in man.& “In vitro exposure to mercury and cadmium alters term human placental membrane fluidity”. Reprod Toxicol. & Rossi AD. & Sundberg J. Maryland.Nguyen et al. Dermatitis. Dept. FASEB J 1993. 16(4):314-9. Arch Environ Health. et al.L. Schweinsberg F. Cell Mol Neurobiol. “Correlation of human placental enzymatic activity with trace placenta”.l996. “Effect of inorganic mercury on in vitro placental nutrient transfer and oxygen consumption”.S. Environ Res. “Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in the rat brain”. et al.194(3):27 1-9 1. Pb. A. T-I lnst of Tech.Stejskal. “Mitochondrial calcium and cerebral cortex”. 1999. Israel.. 1997.se/ah/l998-02. (332) Trepka MJ. National Institute for Working Life. 36(5):237-9. 1998 (www. 20: 289-98.339:8784. 49(5): 466-73.449-51. Sept 17 1988. Hudecek R. 57( 1):96-106. 1986. & P.14(6):675-87. 77(2): 124-9. et al. 1997. (335) A.Jtaly). Krause C.25-6. Nordman V.Y.Boadi et al.6(1):69-75.html) (336) G.l998. Toxic01 Ind Health. L. “Abnormal sulphur oxidation in systemic lupus erythrmatosus(SLE)“. Haifa. New data on toxic metal intoxication (Cd.. Haifa. Semin Cutan Med Surg. (338) (a)W. Nov. Heinrich J. Baltimore.

“Risk estimation of mercury intake from different sources”. 30(2): 44-66. Die Zahn Arztwoche. 1996. Mineraloscope. Influence of DMPS on the mobilization of mercury from tissues of rats pretreated with mercuric chloride. glutamate. Akush. Eigenschaften und Einsatzgebiete des Chelatbildners:DMPS”. Intensivmed.H. “Thiol chelators and mercury effects on isolated heart muscle”. 1979. (346) Clauw DJ. DE. & “lmmunschaden durch Toxine” Argumente+Fakten der Medizin. Allgem.Umweltmedizin 1997.. (349) M.I. Mussmann GV. (347) G. Der Artikulator(30): 11-12. & W. (4): 30-34.. Zentralbl Hyg Umweltmed 1996. 1982(g): 875-9. amalgam 198(3): 275-91. Z. Gramza G. “Schwermetalle schadigen das Immunsystem”. (345) N. 134:669-72. Vrach. 1991. “Disintoxication therapy of patients with nonspecific inflammatory diseases of the female genital organs”. 1994.1996. 1972. 105(10): 586-569 & Therapie der Schwermetallbelastung.( 12):50-3.3 I (5):905. The Glostrup Allergy Study.D. & E. 37:76-87. Plzen. Ginekol 1977. and total mercury in blood and urine. Scheicher. J Toxicol Clin Toxicol. Forum Prakt. Fibromyalgia. Die Quecksilberintoxikation. alteration by mercury”. 36(4): 272-78. “Kompendium Umweltmedizin”. & “Sulfhydryl-induced restoration of myocardial contractility after 1990. British J of Dermatol. & O. Sbom. & Kozik MB. Der Allgemeinarzt. 1996.Bonnet.62(Supp).54(3):323-33 .V. “Quecksilber-Mobilisation mit dem DMPS bei arztlichem und zahnarztljchem Persona] im Vergleich”. Moyer TP. “Morpholcial changes in the skin in Scleroderma after treatment with unithiol”. 1995.“Comparative treatments of rheumatoid arthritis”. “Kopfschmerz un Migrane: Schon mal an Amalgam gegcht?“. “Quecksilbervergiftung durch Amalgam: Diagnose und Therapie” ZWR. 1970.Legrum. Z. “Konnen Amalgamplomben angebomene lnnenohrschaden verusachen?“. 1992 (360) Buchet JP. & A.I. Heavy Metal Bulletin. “Therputic efficacy of unithiol in Buschke’s Scleroderma”. (350) F.und Metalloidintoxikation-2.II. &(b) Maas C. (352) B. 05. 1996. Forum Medizin Verlagsgesellschaft.Daunderer. 1992. & (353) P. (362) G. (11):665-. 1989. Toxicol.Lechner.I I Allergy.“. 1995.ZWR.Lek. Lett. & P. 22(3): 130-9 (358) N. “OkopadiatrieVerbindung zur Naturheilkunde”. & M. Accumulation of mercury in neurosecretory neurons of mice after long-term exposure to oral mercuric chloride. 7( 11): 492-496. Dissertation.Delo.104(5):4 12-417. 1985. 1995.12( 1): 126-3 1. & “Treatment of patients with chronic circulatory insufficiency” Kardiologila. “Risikofaktor Amalgam-Ein Problemstoff’.Benga “Water exchange through erythrocyte membranes” Neurol Neurochir Pol 1997 Sep-Oct. “Wie problematisch ist der . Inorganic.Schaeffer et al. & (b)Nixon.. 44:369-78. “Jugendicher starb an Amalgam”. Pzheusskaia.Bohmer et al. & Hanson S. 63(Supp 13) 349-352. Andres A. :Toxische Untersunchungen zu Amalgam”. Toxicol.8(l): 8-14.Kostler.Schleicher.1983..H. Die Amalgamvergiftung und ihre medizinische Folgen”.Behnke.Oster et al. & W. “The relationship between &E-mediated and cell-mediated hypersensities”.Friese. Arztezeitschr Naturheikunde.Daunderer. Delo. 30(2):62-3. Histochemical changes in the neurosecretory hypothalic nuclei as a result of an intoxication with mercury compounds.. Bruck W. (1):49-52. Biol.Dubinskii et al. Diagnose und Therapie der Metall.(361) K.Arzt. Shtelmakh et al. phenylmercury acetate.Allgen. MediVerlagsgesellschaft. and mercury. Schweinsberg. (355) W. Vrach. Arzt. & Diagnostik un Monitorung vonSchwermeta1lbelastungen. 1996. Therapeutikon. &(c) Villegas J.Schrifenreihe mweltmedizin. “Beeinflubung der zellularen Immunabwehr drch Quecksilberfreisetzung”. 72: -4551.Neuburger et al. 22:367-80. “The many faces of methyl mercury poisoning”. Forum Prakt. Hamburg.Delo. Delo.Allgem. Dtsch. “The pathogenesis of chronic pain and fatigue syndromes: Fibromyalgia” Med Hypothesis. Mineraloscope. & N. 1996.Nielsen et al. (10): 112-l 14. “Quecksilberbelastung. or mercury vapor. 1995.13 (348) A Kistner. Toxicology 1989. (354) W.Elhassani.P Guida.5( 1):38. & “Amalgamvergiftungmoglicher Zusammenhang mit angeborener Schwerhorlgkeit. (356) M. Tapparo.Amold. 10(l): 17-22.& N. Forum Prakt. Arzt. 1995. & L. & J. 1999. “Treatment of patients with myocardial infarction”. “Study on the significance of mercury accumulation in the brain from dental fillings through direct mouth-nose-brain transport”. Lauwerys RR.l982. 39-4 1. Acta Histochem Suppl 1980. Denmark.Halbach et al.B. (1): 37. 1990.( 1):22-23. 1989. Crespo D. 1991. 1993. 17(l I): 1222-1223. Der Naturarzt. J Anal Toxicol. “Die Pathobiochemie. Arch. 135(g): 13-l 5. Issue 4.1978. ~596. 271: 93-96. 29(11): 294 (357) S. organic. (8): 36-38. Zahnmed. 1996. Martinez R. (351) S. (359) G. Vrasch.Klykov. Neurosci Lett 1999.A. Universitat Karlsruhe. 1992. 1977. Vrach.

51-68. Dtsch.W. Stuttgart.1990. Thomas HC. Sbom. in: Reproductive Toxicology. and Cd2+ on some neurochemicals in rats.CFS. (371) Halbach S. (368) Olin R. 27(4):441-7. Serotonin function. 991(1):85-9. 1978. Arch Gen Psychiatry 1990. Neuroendocrinology Letters 1999. 4:285-294. Contact Dermatitis. Weidenhammer W. 167-83. Sonntag-Verlag. Estimation of mercury dose by a novel quantification of elemental and inorganic species released from amalgam. 1995. New York. R. Nov 21. Are cytokines associated with neuropsychiatric syndrome in humans? lnt J Immunopharm 1995. Effects of neurotoxicants on synaptic transmission.. 1994. Daily vitamin C consumption and fatigability.298. & ‘The frequency of mercury intolerance in patients with CFS and healthy controls”. 1999 Ju1. & “Die Quecksilberbelastung von Zahnmedizinstudenten anch beruflicher Amalgaexposition. Stejskal VDM et al. and TMS. Preventive Dental Health Care Center. Neurotoxicol Teratol 1998. Eur J Oral Sci 1998. (365) C. Toxic01 Lett 1982. Hudson AR. An oral examination based study. 67(5): 295-300. Mann AH. Toxic01 Pathol 1999. Naturheilkunde. & Smith KA et al. Burnout and its causes in Finnish dentists. & Hickie I. Hg2+. Arch Gen Psychiatry.4I( 1):60-l (374) Benkelfat C et al. Arch Toxicol. 1993.). 51(9): 68797. “There are new realizations to the Amalgam problem”. & . Kremers L. Metal-specific memory lymphocytes: biomarkers of sensitivity in man.Cikrt et al.Richardson(ed. Haavio-Manila e. & Young SN et al. Psychological and somatic subjective symptoms as a result of dermatological patch testing with metallic mercury and PHA. Prochazkova J.F. “Reproductive risks of heavy metals and pesticides in women”. Biochemistry. 52(7):383-396. 1982. 10(5):3934 16. 1992. Interferons as mediators of psychiatric morbidity. Axelsson P. Lindvall A.). Geburtshilfe Frauenheikd. Stuttgart. environmental illnesses. & B. JD. “Amalgam from gynacological view”. Sweden. 1998. J Am Gerialr sot 1976. 47(5):41 l-18. Int Arch Occup Environ Health 1995. & H. 1993. VCH Weinhelm. Medford FH. 1175-78. (375) Stejskal VDM. 20: 289-298. (378) Cheraskin E. FMS. &(b) T. Mayer W. autoimmunity. Schulte-Uebbing. “Side effects: mercury contribution to body burden from dental amalgam”. (369) Sterzl I. (363) J. & Sidransky H. ZahnarztLZ 1995. 18:208-12. 87(2): 173-77. (370) Magos L. and the mechanism of antidepressant action. 115(39): 1490-1494. The effects of dose of elemental mercury and first pass circulation time on organ distribution of inorganic mercury in rats. 20:221-228. Functional changes induced by heavy metal ions. 50(7): 506-10. Danersund A. Paulander J. Neuroendocrinology Letters. 39(4): 289.Hickel et al. Ann Rev Med 1998. Adv Dent Res. 106:770-77 (6. Kandolin 1. 1995. Psychopharmacology. Karlstad. and (367)(a) Gerhard I. Biochem Biophys Acta 1989. Community Dental Oral Epidemiol 1990.eine chronische Krankheit und ihre Therapie”. Pscheidl. Schwermetalle und Mineralstoffe. Plzen Lek. & Stejskal V. & (b)“Schdstoffe und Fertillitatsstorungen”. (373) Marcusson IA. Vemey E. Chandra SV. “Umweltbedingte Frauenkranheiten”. 1999 (376) Melchart D. 349(9056):915-19. Lloyd A. Chronic fatigue syndrom: an update. Hudecek R. Univ. Med. 49: l-13. & (c) Gerhard I. 1985. ACD. “Amalgamvergiftung. Mood lowering effect of tryptophan depletion. 1992. ~1-7.744 patients in 34 clinics) (377) Murtomaa H. Wochenschr. Ringsdorf Wm. (366) (a)“Tooth amalgam and pregnancy”. & Shukla GS. A multicenter survey of amalgam fillings and subjective complaints in non-selected patients in the dental practice.36(6): 627-28. Influence of lead acetate and selected metal salts on tryptophan binding to rat hepatic nuclei. 1994. “Metal-specific lymphocytes: risk factors in CFS and other related diseases”. Effect of interaction of Mn2+withZn2+. 68(Supp) 119. Dtsch. 1996. & Delgado PL et al.Reinhardt. Zinke. Dentalwerkstoff Amalgam?“. Geburtshilfe Frauenheikd. (380) Komaroff AL. Lancet 1997. Arztezeitschr. 24:136-37. & M. Clarkson TW. 10(2-3): 163-8. Wuhr E. & Umweltmedizin in der Frauenheilkunde. 1993. Der Frauenarzt. 84(2): 113-22.Gabard. & (d)Gerhard I. Georg=Thieme-Verlag. “Mobiliztion of mercury using DMPS”. 6: 110-3. (364) W. Erfahrungsheikunde 1992. &Brouwer M et al. (379) MacDonald EM. L. Kruse-Jarres(Ed.Prevalences in a Swedish County. Mercury and nickel allergy: risk factors in fatigue and Neuroendocrinology Letters 1999. depletion of plasma tryptophan. 55(6): M63-M65. 21(20): 2529-38. (372) Atchison WD. Friberg(Ed. Bayer. Tryptophan depletion causes a rapid lowering of mood in normal males. 35(2):9-17. Toxicol Lett 1996. “Infertility with women by M.41(10): 628-633. Buchwald DS. 3(4):153-166. in Status Quo and perspectiveves of Amalgam Other Dental Materials.). Relapse of depression after depletion of tryptophan. The Lancet 1978. 1995. Of Iowa College of Dentistry.

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. & MetaMetrix Lab. Danersund A. Song KB. J Rheumatol 1997. research web pages (by condition) http://www. Bartova J. et al. J Mol Gen Genet 1996. 17-21. & Williams MV. & Hooper A. Women in dental surgeries: reproductive hazards in occupational exposure to . J Clin Endocrinol Metabol 1991. 251(3). (388) Sata K. Med Pr 1981. 7:39-45. Exposure of dentists and assistants to mercury: levels in urine and hair related to conditions of practice. Immunogentic findings in patients with altered tolerance to heavy metals. Sumner AJ. (401) Sikorski R. lmi. The fatigue syndrome in autoimmune thyroiditis with polyglandular activation of autoimmunity. Mercury levels in urine and head hair of dental personnel.doctorsdata. Markers of inflamation and immune activation in CFS. Kusada Y. Thomassen Y.com/mSDSDFU/DISPERSDFU.doctorsdata. 24~372-76. Kim YJ. Aug 1980. (393) Furuhjelm M. Comblath DR. 20:253-75. fodda sedan 1967.45(9):527-3 I (383) Saito K. Stejskal VDM. & Tumbull AV. (395) Baranski B. 46:201-6. Prochazkova J. In: Amalgam and Health: The Swedish Council for Planning and Research Coordination. van der Star M. 1: 1147-I 150. Cancoon. Koh R.com. Mori T. (396) Epidemiologisk undersokning av fosterkador hos 1.html. (384) Kuklinski B.com. Liu WK. Zhang Z. Mercury poisoning in Dentistry. 73: 1224-1234. Z Emahrungswiss 1990. study reported in Washington Star Newspaper. Community Dent Oral Epidemiol 1988. 38(4): 170-9. 6: 175. J Dent Assoc Thai 1988. Seitschrift fur Umweltmedizin 1999. Of Arkansas. http://www. . Taehan Chikkwa Uisa Hyophoe Chi 27(7): 649-59. Norgeyrkesmed. Chronic low-level mercury exposure and neuropsychological functioning. 7(I). The Lancet 1982. & (b)Ionescu G. & Szzell BP and Oler J. Wisconsin Medical J. 63: 53-69. (398) Saengsirinavin C. Toxic effect of heavy metals on cells isolated 6om the rat adrenal and testis. Juszkiewicz T. An epidemiological study of mercury sensitization. Environ Mol Mutagen 1996. Ott 1997. (399) Herber RF. J Appl toxicol 1995. 29(1):54-73. Vnitmi Lekarstvi 1998. Dale JK. (381) Demitrack MA. In Vitro Cell Dev Biol 1990 Jan. Ivaskova E. (391) Schumann K. Effect of mercury on the sexual cycle and prenatal and postnatal development of progeny. Uninary selenium excretion in workers with low exposure to mercury vapor.26( 1):24-S. 1979. XVI International Congress of Allergology and Clinical Immunology. 1999. Roeleveld N. Environmental Health Perspectives 1993. 2:65-68. Ueda K.Cd.com . Rivier C. Jonson B. 27(l): 30-3. (382) Sterzl I. (386) Great Smokies Diagnostic Lab. (400) Kim DE. 8~581-93. 32(4): 271-6. Univ. Kokubyo Gakkai Zasschi 1996. (article in German with English abstract) (392) Gebbart E. J.metametrix. Neurophysiological and neuropsychological function in mercuryexposed dentists. & & Baranski B. &(d) Biospectron Lab. Bartova J. Mexico. Biol Med 1996. & (c) A subset of patients with common variable immunodeficiency. Int Archieves of Occup and Environ Health 1987. Pringsulaka P. Allergology International 1997. Antigen-specific lymphocyte stimulation test on patients with psoriasis vulgaris. Int J of Fertility 1962. Fucikova T. vol 79. Blood 1993. lOl(supp1 2): 85-90. Avd. 16(3): 153-8. Koh N. (394) Blatter B. (397) Hudecek R. & Shapiro IM. 15(l): 33-6. Vnitr Lek 1999 Sep. & Doctors Data Lab . 59: 551-7. Jan 7. Haukelands sykehus. Wibowo AA. & Prochazkova J. & Dr. Kith P. Sedlmeier R. Rother D. (390) Ellingsen DG. J of Clin and Exper Neuropsych 1986. Wener MH.com.caulk.com. Glutathione Transferasen und Krankheit. & Sterzl I.Buchwald DS.2 milj. Chromosone Damage in Individuals exposed to heavy metals. inquiries @doctors data. www. The toxicological estimation of heavy metal content(Hg. (amalgam manufacturer). Regulation of the HPA axis by cytokines. Nordhagen HP. Cur-r Top Environ Toxicol Chem 1985. Brain Behav Immun 1995. Aftenposton 6 mpv 1997.Pb) in food for infants and small children. lshi Y. http://www. Inc. ~78-84. Analysis of a genetic factor of metal allergy-polymorphism of HLA-DR-DO gene. 44: 456-60. Heavy metal load with atopic Dermatitis and Psoriasis.analyslab@swipnet. barn. Zamrazil V.(385)(a) Kohdera T. Reactions to metals in patients with chronic fatigue and autoimmune endocrinopathy.se (387) Caulk. LMI.gsdl. Lennart Mhsson International AB. 8: 213-25. www. & Ng TB. Hrda P. 82(I): 192-20.. Mercury contents in hair of dental personnel and evaluation of various agents suppressing mercury vaporization. (389) Brunker P.K Sherman. Eur J Human Genet 1998.

Exacerbation of pustular psoriasis in mercury poisoning. Yamazaki K. Envir Health Perspect. & Alfred V.126(2):359-65.326: 1464-8:&c (c) Leigh Pn. p473-88. “Cord Serum Immunoglobulin E Related to Environmental Contamination of Human Placentas with Oganochlorine Compounds”. 107( 11):895-99. Takesada M. J. 105(4-5): 525-35. (405) Stejskal J. 160(6): 1897. Heymann E. Knight LC. 14(4): 553-63.garynull. 25(4):341-5. 1 l( 1): 64-70. Epidemiology 2000. Dugger DL. Valera V.Cancer Lett. Mar 1999. (403) Maya11 FG. & http://www. (4 16) (a) Plaitakis A. Pearson CM. 63(5):593-6. Autism: xenobiotic influences. DJ. & Edelson SB.htm (4 10) J. Burrows D. Fay A. Altem Med Rev 1998. melanoma growth by copper chelates. & Kramer U et al. New Engl J Med 1992.). Decreased glutamte transport by the brain and spinal cord in ALS. & Kar NC. Airway Responsiveness. ‘Isolation and characterization of dipeptyl peptidase IV from human Biochem 1982 Aug. Singharo S. J. http://www. Med. Haarman FY. N-acetyl-aspartate and Nacetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Dysbiosis and Amalgam. Candida. & Yonk LJ et al. Fierlbeck G. (408) Eedy DJ. (409)Autism:auniqueformofmercurypoisoning. Autism and Pervasive human muscle disease. In: Came DB(Ed. Miller SB. Cochran SR. & Romani L. J Laryngol Otol. Clin 1996. 29(Pt 1): 15-22. Hayashi T. Immunity to Candida Albicans: Thl. Constantakakis E. (4 14)Wecker L. Appl Toxicol 1992. Kehrer H. Dlifford T.html : & Yazbak FE(MD. Schweinsberg F. Elevated T cell subpopulations in dental students. & Liska. Neurodegenerative Diseases.37(2): 113-28. Strober W. Curr Opin Microbial 1999. Autism and schizophrenia%nked to malfunctioning enzyme for milk protein digestion. WB Saunder Co. 43(6):1063-g. Brain Res Bull 1993. 87(5): 3 12-6. Mentlein R. “An amalgam tattoo of the soft palate: a case report with energy dispersive X-ray analysis. Scherwitz C. 82(l): 192-20. Dipeptyl Peptidases in placenta’.com/ari/mercurylong. Eur J 1978. 221-33. Altered metabolism of excitatory amino acids.com/documents/autism 99. Immunol Lett. (415) Reichrtova E et al.FAAP) Autism 99 : A National Emergency. Martin LJ.com. Residual Oil Fly Ash Amplifies Allergic Cytokines. (411) Puschel G.1904. see #2 18 (406) Goering PI. J prosthet Dent 1990. Fundam. Mercury concentration in gray hair. web group of parents with autistic kids and autism doctors and researchers.R. CANDIDA ALBICANS THERAPY: Dental mercury removal. Adv. Nippon Eiseigaku Zasshi 1989. . Blood 1993. & Seroussi K. 106:9. 1989. 1999. Detic Res 1985. 1998. The role of metals in autoimmune diseases and the link to neuroendocrinology Neuroendocrinology Letters. 2 l(2): 18 l-9. 82(1-2): 185-92. 59(6):551-7. Hautarzt 1994 Oct. Godfrey.30(3-4):38 1-6 &(b)Rothstein JD.45( 10):708-l 0. Traffic-related air pollution is associated with atopy in children living in urban areas.. CD+4 helper T-cell depression in autism. & and amino (c)Naruse H. Hickman J. “Pharmacological perturbation of murine 2612. and Inflamation in Mice. Borjas L. & Jaffe JS. (407) Wehner-Caroli J.autism. 1997. 1985 Mar. No To Hattatsu. The detoxification enzyme systems. 1990. 1992 Sep. Int Arch Occup Environ Health 1987. Toxicol Ind Health 1998. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Hatano H. Serotonin acid content in platelets of autistic children. Autism. Arrieta A. & (b)Rolf LH. vol 9 no 2 (1996). 1999. (402) Ando T. Med. 1999. & Gavett SH et al. & Pierson HF. Trace element concentrations in hair from autistic children. http://www. 834-5. Kuncl RW. Pathologic mechanisms in ALS and other motor neuron diseases. 2(4):363-7. Rowland AS. Toxicity assessmentof mercury vapor from dental amalgams.com. 19:3 19-329. Cade et al. Is infantile autsim a hypoglutamatergic disorer? J Invest Neural Transm 1998. Am J Respir Crit Care Med. Plasma excitatory amino acids in autism. (404) M. pl74. Zamm. Stejskal V.edelsoncenter. E. Clin Chim Acta Developmental Disorders . vl#4 ~~261-5 (1986) Orthmol. Grotemeyer KH. Sneller MC. Wakisaka 1. Acta Psychiatr Stand 1993.Th2 cells and beyond.etc. Johnson WD. 3(3): 187-98. (412) (a) Moreno-Fuenmayor H. Metabolic changes in aromatic amino acids and monoamines in infantile autism and a new related treatment.mercury. Cantor DS. 20:345-358.& Carlsson ML. an effective adjunct. (4 13) Autism-Mercury@egroups.

Wong A. Tabuse M.(417) Folkers K et al. 194 1. FASEB J 1994.43(3):249-54. Contact allergy and psoriasis. (428) O’Carroll RE. Schweiz 1990. Baillod R. Chem & Engin News. Pitts K. Akama Y. Arch Int Physiol 98(5):261-7. against glutamate cytotoxicity in cultured cortical neurons. Lutz F. Arch Dermatol 1991 Sep. & (d) HultmanP. Kishimoto T.l27(9):1333-8. Appl Environ . Sands S. Hirai M. McBride V.96(3):348-57. 100( 11): 1299-303. Developing brain as a target of toxicity. Biochem Biophys Res Comm 198 1. Imfeld T.77(2): 141-8. & Yiannias JA.105(8):1023-8 (421) Yoshida M. & Felmus MT. & M. Studies on the metabolism of vitamin B6 in the small intestine. Can J Public Health 1998. & Brown IA. 1602. DC. & 1996. & Lancet 1998. & Crinnion WJ. J Neurol Neurosurg Psychiatry 9. 103(Supp 6): 73-76. Contact Dermatitis 1998 Sep. Moller G. Br J Psychiatry 1995. Winkelmann RK. The Mad Hatter’s disease revisited. Goodwin GM. 8: 1183-90. “Inorganic mercury intoxiflcation similar to ALS”.and T helper 2-type responses are involved. Abedi-Valugerdi M. Turley SJ. (430) Fukino H. Acute generalized exanthematous pustulosis. Johansson U.Barber. The effect of toxicokinetics on murine mercury-induced autoimmunity. (422) Reese Km. Lee DK. Husstedt I. Mercury Monatsschr Zahnmed emission measurements in a crematorium. Toxic01 Appl Pharmacol I984. Riederer P. & Patten BM. Summers AO.24 l(1): 1-6 . J Autoimmun I 997 Ott. Effects in vitro on rat brain Mg(++)-ATPase. Rajanna B. The dentistry aspects. 1985 ? Biochem 1990.37(6):3 18-2 1. 5( 1):52-63. Contact sensitivities in palrnar plantar pustulosis (acropustulosis). Advanced glycation end products in neurodegeneration: markers of oxidative stress? Ann Neural 1998 Sep. Abedi-Valugerdi M. Connolly SM. I 9(3): 373-377. Environ Health Perspect 2000. Gerlach M. Arh Hig Rada Toksikol 1992 Roujeau JC et al. Adverse immunological effects and autoimmunit induced by dental amalgam in mice. Schweiz Monatsschr Zahnmed 1995. Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney. 89(Suppl): S3 I-40. 4(5-6): 325-332. Issues in developmental neurotoxicology: interpretation and implications of the data. Magnesium. Jz Rice DC.7(3):15 l-6. (423) ‘T. Barone S. more than early (425) (a) Hu H. The neuropsychiatric sequelae of mercury poisoning. Yamamura Y. Master-ton G. & Matter-Grutter C. (429) Rodier P.39(3): 108-l 1 (420) Rivola 1. Indian J Biochem 1970 Sep. & (b) Hu H. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular structure ad antigenic properties. Critical Periods of Vulnerability for the Developing Nervous System: Evidence horn human and animal models. Molter G. Rice. Antecedent events in amyotrophic lateral sclerosis Neurology 1976 Feb. Arch Neurol Psychiatry 1954. Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro. (424) Munch G. Mechanism of mercury-induced autoimmunity: both T helper I. ~80-81.60:698. Casiano CA. Cremation and the environmental mercury burden. & (c) Hu H. Lutz F. &(e) Pollard KM. Yamane Y. Abedi-Valugerdi M. 158: 342 l-8. 12-7-98. Satoh H. (427) Chetty CS. Patten BM. Environ Res 1998. MC Garvey JA. Neurochemical Research 1994. Mercurialism and its control in the felt hat industry. Krejci 1. Sian J. & Akaike A et al.44(3 Suppl I):S85-8. J Immunol 1997. (426) Hultman P. 10(5):44 I-6. Radhakrishnan AN. Environmental toxins and their common health effects. & cases. 20:667-9.90(2): 198-204.Burk et al. Immunology 1999 Mar. & PUBLIC HEALTH REPORTS. Mercury emissions from crematoria. 352. 167( 1): 95-8. (418) Purification and properties of monkey intestinal pyridoxal kinase. J of Occup Med.M. immunology response in T cells from 1997 Feb. 100: 972. Srikantaiah MV. Biochemical evidence for a deficiency of vitamin B6 in subjects reacting to MSLGlutamate. & Felipo V et al. (43 1) Smith T. (419) Lipozencic I.26(2): 167-72. European J of Pharmacology 1993. Protective effects of a vitamin-B 12 analog(methylcobalamin. L-camatine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity.73(3): 395-401. Analysis of 63 Sep. Chronic mercurialism-a cause of the clinical syndrome of ALS. Moller G. Dis Nerv Syst 1976 Jun. Swanke L. Mallette LE. Environ Health Perspect 1995. Bacterial oxidation of mercury metal vapor. Amount of mercury from dental amalgam filling released into the atmosphere by cremation.4 1(7):6 18-24. Nippon Koshu Eisei Zasshi 1994 Jul. March 28. 72:674Schwarz S. Pretreaunent of lymphocytes with mercury in vitro induces a genetically determined low-responders and a shift of the interleukin profile. Motor neuron disease: retrospective study of associated abnormalities. PUBLIC HEALTH BULLETIN #263. Nielsen JB. Imfeld T. ALS after accidental injection of mercury. 1978. Altem Med Rev 2000. Pasic A. Milavec-Puretic V. Hsueh YM.108(supp 3):5 ll533.

Sakoda S. Afienposton 6 mpv 1997. (443) Troy CM. & Kasarskis EJ(MD).71(4):1043-8. et al. Ogawa Y. Inc.64(4): 132832. National Research Council. Neurosci Lett 1999. 6. root canals. 2000. H. Henshaw DR.6(1):83-86. June 22. Proc Nat Acad Sci USA. 1:28. April 2001.Dept. (Medical Laboratory) Arzte fur Laboratoriumsmedizen. DATABASE. 6 x 9. Board on Environmental Studies and Toxicology. Colo. B. 262 pages. CoQlO Use Leads To Dramatic Improvements In Patients With Muscular Disorder. Committee on Developmental Toxicology. Norge yrkesmed. between recent (435) Norwegian Board of Health. 1999. 265(3): 159-62. A potent antioxidant and stimulator of nerve growth factor. ID: FEDRJP/l999/07802766. Baik M.com & Peak Energy Performance. ALS Newsletter Vol. Neurobehavioral effects fi-om exposure to dental amalgam vapor(HgO): new distinctions exposure and Hg body burden. fodda sedan 1967. & Matthews RT.-W. Snutch TP.7(6):54858. Neuroscience 1996 Apr. Inhibition Gupta PK..no (436) Schiwara. & National Environmental Trust (NET). The Gazette. oral toxicity testing technology and tests. (437) Affinity Labeling Technology. of bovine xanthine oxidase activity by Hg2+ and other metal ions. Report 2652. Kidney ectopeptidases in mercuric chloride-induced renal failure. Metals and free radicals in neurodegeneration. P/Q-type calcium channels mediate the activity-dependent Nature 1999. National Acad Sci.91(10):4155-9. & Heavy Metal Bul. paper for Conference on Male-Mediated Developmental Toxicity. Dental Materials Reactivity Testing. Results of dental amalgam removal and mercury detoxification. Colorada Springs. http://www.peakenergy. & Sastry KV. http://www. National Research Council. Biofactors 1999. “Polluting Our Future: Chemical Pollution in the U. Coenzyme QlO administration and its potential for treatment of neurodegenerative diseases. cavitations.200l. Inc.200l. Dristol LA.org (442) Olanow CW. Swedish Council for Coordinating and Research. & ImmunoSciences Lab. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. June 1. 1980. In vitro inhibition of digestive enzymes by heavy metals 1996.immuno-sci-lab. Microbial 1998. Cut-r Opin Neurol 1994.W. June 22. Metallothionein in ALS Motor Neurons(IRB #91-22026). mercuric chloride intoxication. (434) Echeverria D et al. 62(4): 27 l-9.safekidsinfo. & Rothstein JD. and their reversal by chelating agents: (440) Kidd RF. Altem Ther Health Med 2000 Jul. 9(2-4):262-6. Montreal. http://www. see research web pages on amalgam toxicity. that Affects Child Development and Learning” Sept 2000.coml Testing. No. Committee on Toxicology. 1994. inc. Physicians for Social Responsibility and the Learning Disabilities Association of America. S(5): 278-84. “Sperm on the wane”. Proc Nat1 Acad Sci U S A 1998 Jul 21. Coenzyme QlO administration increases brain mitochondrial concentrations and exerts neuroprotective effects. D-28357 Bremen.95( 15):8892-7.ccrlab.Monograph. & Evaluating Chemical and Other Agent Exposures for Reproductive and Developmental Toxicity Subcommittee on Reproductive and Developmental Toxicity. Shelanski ML.6(4):49-55. Brown RH. 3 June 2001 (445) Clifford Consulting & Research. barn. & DiMauro S. University of Newcastle in Australia. Moses LG. McRory JE. Beal MF. Cell Physiol 1998. 91( 14):6384-7. http://ww-w. (432) Sutton KG. & John Aitken.com B iochem (438) Stefanovic V. & (c) C.helsetilsynet. 1994. Head.2 milj. 20(6): 729-35 Mondal MS. (433) Epidemiologisk undersokning av fosterkador hos 1. & ldebenone . Bull Environ Contam Toxic01 1978. 3 13 pages. Proc. Scientific Frontiers in Develonmental Toxicology and Risk Assessment. http://www. Altem Med Rev 2001 Feb. (444) (a7 Beal MF. Eleanor & Lou Gehrig MDA/ALS Center at ColumbiaPresbyterian Medical Center in New York. Arendash GW. Yanaghara T. & Schulz JB. 1999. feedback of syntaxin-l A. & (b)Nagano S. Beal MF. FEDRJP National Technical Information Service(NTIS). National Academy Press. Browne S. Skinner’s Science of Dental Materials. USA. Haukelands sykehus. J lnorg Biochem Mitra S.(Dental Lab). Neurology. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.401(6755):800-4. Gooch et al. (44 1)National Academy of Sciences. Matthews RT. Yang L. Down-regulation of copper/zinc superoxide dismustase causes apoptotic death in PC12 neuronal cells. Kunci RW.altcorp. .Phillips. Chronic inhibition of superoxide dismustase produces apoptotic death Hosier of s inal neurons. Avd.2001. (439) Part 1.com (446) P. Dental Materials Biocompatibility http://www. Of Biological Sciences. Guthrie H.S.

Metal Profiles in 25 Patients with Long-Term Illness. Muller-Spahn F. pgs. v. “Mercury toxicity and dental amalgam fillings”. Gedik Y. induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau Mercury phosphotylation in SHSYSY neuroblastoma cells. The journal Psychosomatics. 535-536. n. Sweden. July 1986. Przegl Dermatol 1980. Metal-Metabolism and Human Functioning. Optimal Center Newsletter. #2. member of Editorial board for Ganzheitliches Medicine Journal. Rosenbaum. Int J Psychiatry Med 1989. J Neurochem 2000 Jan. Iannacone EA. (464) Walsh. Orrin. Zoeller RT. 1988 (456) Panasiuk J . Med Hypotheses 2000 Sep. Mental health in the workplace in Finland. Mortensen PB. D. “Mercury vapor produced during sterilization of amalgam-contaminated instruments” The Journal of Prosthetic Dentistry.55(3):239-41. Altamura C. BRD fax: 0049 7562 550 52 (460) Edwards AE. Ott 2000. (461) Rasmussen HH. Meltzer HY. Hock C.200o. Robert.htm. (45 1) Miszta H.. vol. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.J. Journal of Neuropsychiatry. 1979. Vandoolaeghe E.3. 27. 93 Congress & Rheumatol. vitamins 82.53.39(2): 136-9 (450) Dr. Demedts P. Albers JW. (www. & (c)(Human Reproduction Jun2000.74( 1):231-6. Am J Public Health 2000.org.org/autism. Germany. Pfeiffer Treatment Center. University of Connecticut Health Center. 116( 1): 15 l-5. Depression associated with Candida albicans infections. Autism and Metal Metabolism. Wauters.67(6):823-9 [Article in Polish] .amalgam. B6. p304. Stilley JS.hriptc.melisa. S J Walsh and L M Rau. and E and essential fatty acids in multiple sclerosis. Ott 20. “Autoimmune Disease Overlooked as a Leading Cause of Death in Women. http:Nwww.org). WJ. Relationships between serum free fatty acids and zinc with ADHD. Jennifer: Bear.90:1463-1466. Langolf GD. www.neurological) (453) Blumer W. lead and iron depletion of zinc. Norman.42(5):349-358. & Devinsky. n3. A.3:105-12). p. Keman. Aslan Y. Lindh. Endocrinology 2001 Jan 1.69:97-107. (462) Olivieri G. J Child Psycho1 Psychiatry 1996.nulenglinfoengl . 189-199. http://www.ilo. Aggression in cat and human precipitated by a cholinesterase inhibitor. & Maes M. cadmium. David. Health Research Institute. (449) Schaumburg H. & Mult Scler 1997. Brockhaus M.11. Br J Ind Med 1982 May. Aug 2000. R. Brack C. http://www. Neels H. The possible role of gradual accumulation of copper. & J Steroid Biochem Mol Biol 1999. United Kingdom and United States. N.html (448) Dr. Of Dental Mercury Patients-U. (452) Uppsala Amalgam Clinic.org/pubIic/english/bureau/int7pr/2000/37. Stahehn HB. Elemental mercury exposure: peripheral neurotoxicity. Neurology 29:43 1.308 (455) Lindvall A: Lindh U. David.253(23): 3400. Dabrowski Z. & Bamett JH. 37(2):225-7. Cutis 1990 Nov. Danersund A. http://www. Spencer P: Toxic Neuropathies. 1988 & Hallgren. Desnyder R. Renard P. JAMA.mercola. Depression and Candida.25 1:22. U. Herrmann M. Biol Psychiatry 1997. Wassertomstrasse 6 . & Bear. . Jerrold.com.S. Karahan C. J. magnesium. selenium. 4. DAMS: Assoc. CFS. & Walsh WJ.219 (454) Cooley RL. 15:308. Jensen IW. #7.MCS. Presented at Eurotox Lindh. & Crook WG.htm (not used) (458) Dowling AL. 1984.tf. Aggressive Behavior Following Exposure to Cholinesterase Inhibitors. 1985. vol.46(5):430-2 (nickel & lupus) (457) International Labor Organization. Effect of mercury and combined effect of mercury on the activity of acetylcholinesterase of rat lymphocytes during in vitro incubation. Nucl lnstr and Meth B30:404. MD. Lubow RM. (over 800 patients. (463) Johnson S.19(1):57-63: &Bekaroglu M. Spring 1992. & Swedish Association of Dental Mercury Patients. Isny. JAMA. Folia Haematol Int Mag Klin Morph01 Blutforsch 1989. Depression and magnesium deficiency. March 1985.(447) Amalgam/mercury poisoned patients organizations. Peripheral blood lymphocyte transformation test in various skin diseases of allergic origin. Journal of Advancement in Medicine. pgs. Cavender GD. v. & Levine SP. Fall 1998. Feltelius. Suppl:l-13. U.142(1):390-399 (459) Isny Clinic(South Germany) Kurt Muller . Discoid lupus (nickel & lupus) erythematosus exacerbated by contact dermatitis. Maternal Hypothyroidism Selectively Affects the Expression of Neuroendocrine-Specific Protein A Messenger Ribonucleic Acid in the Proliferative Zone of the Fetal Rat Brain Cortex. Mercola.

2000,http://www.hriptc.org/mhfies.htm;
& Q HRI-Pfeiffer Center Autism Study; paper presented to Dan Conference, Jan 200 1;
(465) Walsh WJ, HeaIth Research Institute, Biochemical Treatment of Mental Illness and Behavior Disorders,
Minnesota Brain Bio Assoc, Nov 17, 1997; http://www.hriptc.org/Minnesota.htm; & William J. Walsh, Laura
B. Glab, and Mary L. Haakenson; Pfieffer Treatment Center, Biochemical Therapy and Behavior Outcomes;
2000, http://www.hriptc.org/btbres.htm
(466) Chen KM, Department of Neurology, Guam Memorial Hospital; Disappearance of ALS From Guam:
implications for exogenous causes, 2000.
(467) Interpretation of Diagnostic Tests, A Synopsis of Laboratory Medicine, Fifth Edition.
(468) Overzet K, Gensler TJ, Kim SJ, Geiger ME, van Venrooij WJ, Pollard KM, Anderson P, Utz PJ. Small
nucleolar RNP Scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors
apoptosis. Arthritis Rheum 2000 Jur1;43(6):1327-36
during
(469)BrainRecovery.com, the book, by David Perlmutter MD; Perlmutter Health Center, Naples, Florida,
http://www.perlhealth.com/about.htm; &
M.M. Van Benschoten and Associates, Reseda, Calif. Clinic; http:/?‘WWw.Illmvbs.corn
(470) Dr. Garth Nicholson, Institute for Molecular Medicine, Huntington Beach, Calif., www.immed.org
& Michael Guthrie, R.Ph. h-nmuneSupport.com 07-l 8-2001 Mycoplasmas - The Missing Link in Fatiguing
New Treatments for
Illnesses, www.immunesupport.com/library/showarticle.c6n?ID=3066; &
Chronic Infections Found in Fibromyalgia Syndrome, Chronic Fatigue Syndrome, Rheumatoid Arthritis,
and Gulf War Illnesses, http://www.immed.org/reports/autoimmune~illness/repl.html;

& Prof. Garth L.

Nicolson, Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Other Fatigue Conditions,
http://www.immed.org/ilIness/fatigue_ilIness_research.html; & Dr. G. Nicholson, Institute for Molecular
Medicine, New Treatments for Chronic Infections Found in
Fibromyalgia Syndrome, Chronic Fatigue Syndrome, Rheumatoid Arthritis, Multiple Sclerosis,
Amyotrophic Lateral Sclerosis, and Gulf War Illnesses,
http://www.immed.org/reports/autoimmune~illness/repl
.html & (b) Imrnunosciences Lab,
http://www.immuno-sci-lab.com/iidex2.html
(47 1) Schwartz RB, Garada BM, Komaroff AL, Gleit M, Holman BL. Detection of intracranial abnormalities in
patients with chronic fatigue syndrome: comparison of MRl and SPECT. Am J Roentgenol, 1994,
162(4):935-4 1; & Spect Imaging: comparison of findings in patients with CFS, AIDA dementia complex, and
major unipolar depression, Am J Roentgen01 1994, 162(4): 943-5 1; & Ichiso M, Salit IE, Abbey SE.
Assessment of regional cerebral perfusion by SPECT in CFS. Nucl Med Commun 1992; 13:767-72.
(472) Patarca-Monero R, Klimas NG, Fletcher MA. Immunotherapy of chronic fatigue syndrome. Journal of
Fatigue Syndrome. 2001,8( 1): 3-37; & DeBecker P, De Meirleir K, Joos E, Velkeniers B. DHEA
Chronic
response to 1.V. ACTH in patients with CFS. Horm Metab Res 1999,3 l(1): 18-2 1.
(473) De Meirleir K, Bisbal C, Campine I, De Becker, et al. A 37 kDa I-5A binding protein as a potential
biochemical marker for CFS. Am J Med 2000,108(2): 99-105; & Suhadolnik RJ, Peterson DL, Obrien K, et al,
Biochemical evidenc,efor a novel low molecular weight 2-SA-dependent Rnase L in CFS. J Interferon Cytokine
Res, 1997, 17(7): 377-85.
(474) Richards SCM, Bell J, Cheung, YL, Cleare A, Scott DL. Muscle metabolites detected in urine in FM and
CFS suggest ongoing muscle damage. Conference Proceedings of the British Society of Rheumatologists, April
2001, Scotland, Abstract 382; http://fi-eespace,virgin.net/david.axford/me-nb-o4.htm.
(475) Hugh Fudenberg, MD, paper: NVIC lntemational Vaccine Conference, Arlington, VA September, 1997.
(http://members.aol.com/nitrf
(476) Dr Thomas Verstraeten, US Centres for Disease Control and Prevention, Summary Results: Vaccine Safety
Datalink Project - a database of 400,000 children , May 2000.
(477) Lars Landner and Lennart Lindestrom. Swedish Environmental Research Group(MFG), Copper in societv
and the Environment, 2nd revised edition. 1999.
(478) Ganser, AL; Kirschner, DA. The interaction of mercurials with myelm: Comparison of
in vitro and in vivo effects. Neurotoxicol, 6( 1):63-77, 1985; & Windebank, AJ. Specific Inhibition of

Myelination by Lead in vitro; Comparison with Arsenic, Thallium, and Mercury. Exp Neurol,
94(1):203-l 2, 1986; & International Labor Organization (ILO). Encyclopaedia of Occupational Health and
Vol. 2. ED: Parmeggiani, L., pp. 1332-59 1983.
Safety, 3rd Ed.,
(479) Amphotericin B, HgCl2 and Peritoneal Transport in Rabbits, Zweers MM, Douma CE, van der Wardt AB,
Krediet RT, Struijk DG. Department ofNephrology, Academic Medical Center, Amsterdam, The Netherlands.
Accepted Abstracts : The 3rd European Peritoneal Dialysis Meeting - 5-7 April 1998, Edinburgh, U.K.
(480) Salzer HM, Relative hypoglycemia as a cause of neuropsychiatric illness, J National Med ASSOC,1996,
58( 1): I2- 17; & Heninger GR et al, Depressive symptoms, bolucose tolerance, and insuIin tolerance, J Nervous
and Mental Dis, 1975; 16 1(6):42 l-32; & Winokur A et al, Insulin resistance in patients with major depression,
Am J Psychiatry, 1988, 145(3): 325-30.
(48 I) Virkkunen M, Huttunen MO; Evidence for abnormal glucose tolerance among violent offenders,
Neuropsychiobilogy, 1982, 8:30-40; 8c Markku I, Virkkunen L; Aggression, suicidality, and serotonin, J
Clinical
Psy 1992,53( 10): 46-5 1;
(482) Linnoila M et al, Low serotonin metabolite differentiates impulsive horn
nonimpulsive violent
behavior, Life Sciences, 1983,33(26): 2609-2614; & Lopez-lbor JJ , Serotonin and psychiatric disorders,
lnt Clinical Psychopharm, 1992,7(2): 5-l 1.
(483) Thomas DE et al, Tryptophan and nutritional status in patients with senile dementia, Psychological Med 1986,
16:297-305; & Yaryura-Tobias JA et al, Changes in serum tryptophan and glucose in psychotics and neurotics,
Nutrition, No.4557, ~1132; Camey MWP, Brit Med J, 1967,4:5 12-5 16.
(484) Urberg M, Zemel MB; Evidence for synergism between chromium and nicotinic acid in the control of glucose
tolerance in elderly humans, Metabolism, 1987,36(g): 896-899; & J Family Practice, 1988,27(6): 603-606;
& Anderson RA et al, Effects of supplemental chromium on patients with reactive hypoglycemia, Metabolism,
1987,36(4): 351-355; & Metabolism, 1983,32(9): 894-99.
(485) Hulda Clark, The Cure for all Diseases, 2000, www.drclark.net (amalgam replacement and treatment for
parasites)(U.S. CDC confirms parasites common in those with chronic immune conditions)
(486) Hulda Clark, The Cure for All Cancers, 1998, www.drclark.net; & Gerson
Clinics, www.gerson.org.
(487) Haut MW; Morrow LA; Pool D; Callahan TS; Haut IS; Franzen MD. Neurobehavioral effects of acute
exposure to inorganic mercury vapor. Appl Neuropsychol 1999;6(4): 193-200.
(488) Huang X; Cuajungco MP et al; Cu(l1) potentiation of Alzheimer’s abeta neurotoxicity. Correlation with
cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999 Dee 24;274(52):37111-6
(489) Waggoner DJ, Barn&as TB, Githn JD. The role of copper in neurodegenerative disease. Neurobiol Dis
1999 Aug;6(4):22 l-30; & (b) Torsdottir G, Kristinsson J, Gudmundsson G, Snaedal J, Johannesson T.
Copper, ceruloplasmin and superoxide dismustase (SOD) in amyotrophic lateral sclerosis. Pharmacol oxicol
2000 Sep;S7(3): 126-30; & 0
Estevez AG,Beckman JS et al, Induction of nitric oxide-dependent
apoptosis in motor neurons by zinc-deficient superoxide dismustase. Science 1999 Dee 24;286(5449):
2498-500; & (d) Cookson MR, Shaw PJ. Oxidative stress and motor neurons disease. Brain Path01 1999
Jan;9( 1): 165-86.
(490) Rojas M, Olivet C . Occupational exposure and health effects of metallic mercury among dentists and dental
assistants: a preliminary study. Valencia, Venezuela; Acta Cient Venez 2000;5 1(1):32-S; & Nadorfy-Lopez
E, Bello B. Skeletal muscle abnormalities associated with occupational exposure to mercury vapors.
Histol Histopathol2000 Jul;l5(3):673-82.
(491) Nerudova J, Cabelkova Z, Cikrt M; Mobilization of mercury by DMPS in occupationally exposed workers.
Int J Occup Med Environ Health 2000; 13(2): 13 l-46 .
(492) Glina DM, Satut BT, Andrade EM. Occupational exposure to metallic mercury in the dentist’s ofice ofa
public primary health care clinic in the city of Sao Paulo. Cad Saude Publica 1997 Apr;13(2):257-267.
(493) Moller AT, Spangenberg JJ. Stress and coping amongst South African dentists in private practice. J Dent
Assoc S Afi 1996 Jun;S 1(6):347-57; & Stefansson CG, Wicks S, Health care occupations and suicide in
Sweden 196 l-l 985. Sot Psychiatry Psychiatr Epidemiol 199 1 Dec;26(6):259-64
(494) (a)Kobayashi MS, Han D, Packer L. Antioxidants and herbal extracts protect HT-4 neuronal cells against
glutamate-induced cytotoxicity. Free Radic Res 2000 Feb;32(2):115-24(PMID: 10653482; & Ferrante

U
U
1
U
U
1
U
U
1
U
U
U
U
U
U
u
U
u
U

efficacy
of EGb761 (Gingko
RJ, Klein
AM, Dedeoglu
A, Beal MF. Therapeutic
biloba
extract)
in a transgenic
mouse model of amyotrophic
lateral
FP, Steffen VM,
J Mol Neurosci
2001 Aug; 17 (1) : 89-96
& Bridi RCrossetti
sclerosis.
rats.
Henriques AT. The antioxidant activity of standardized extract of Ginkgo biioba (EGb 761) in
Phytother Res 2001 Aug;l5(5):449-5

1 ; & Packer

L, Tritschler HJ, Wessel K. Neuroprotection by the

metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997;22(1-2):359-78(PMID:
8958163); &
McCarty MF. Versatile cytoprotective activity of Iipoic acid may reflect its ability to activate signalling
intermediates that trigger the heat-shock and phase II responses. Med Hypotheses 2001 Sep;57(3):3 13-7 &
(b)Whiteman M, Tritschler H, Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and
alpha I-antiproteinase inactivation by oxidized and reduced Iipoic acid. FEBS Lett 1996 Jan 22;379(1):746(PMID: 8566234); & 0 “Decreased phagocytosis of myelin by macrophages with ALA. Journal of
Neuroimmunology 1998,
92:67- 75; & (d) & ZGregus et al, “Effect of lipoic acid on biliary excretion of
glutathione and metals”, Toxicol APPI Pharmacol, 1992, 114(1):88-96; & (e) Li Y, Liu L, Barger
SW, Mrak RE, Griffin
WS. Vitamin
E suppression
of microglial
activation
is
J Neurosci
Res 2001 Ott 15;66(2):163-70.
neuroprotective.
(495) Kang JH, Eum WS. Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated
Cu,Zn-superoxide dismustase mutants. Biochem Biophys Acta 2000 Dee 15;1524(2-3): 162-70; & (b) JH, Eum
WS. Enhanced oxidative damage by the familial amyotrophic lateral sclerosis- associated Cu,Zn-superoxide
dismustase mutants. Biochem Biophys Acta 2000 Dee 15; 1524(2-3): 162-70; & Q Liu H, Zhu H, Eggers
Nersissian AM, Faull KF, Goto JJ, Ai J, Sanders-Loehr J, Gralla EB, Valentine IS. Copper(2+)
DK
binding to the
surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismustase, a familial
lateral sclerosis mutant. Biochemistry 2000 Jul 18;39(28):8125-32; &c(d) Wong PC, Gitlin JD; et
amyotrophic
al, Copper
chaperone for superoxide dismustase is essential to activate mammalian Cu/Zn superoxide
dismustase. Proc Nat1
Acad Sci U S A 2000 Mar 14;97(6):2886-91; & (e)Kruman II, Pedersen WA, Springer
JE, Mattson MP.
ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to
excitotoxicity by a mechanism
involving increased oxidative stress and perturbed calcium homeostasis. Exp
Neurol 1999 Nov;l60( 1):28-39
(496) Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther
1999 Mar;8 l(3): 163-22 1; &
Urushitani M, Shimohama S. N-methyl-D-aspartate receptor-mediated
mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic
neurotoxicity after Ca(2+) influx. J Neurosci Res 2001 Mar 1;63(5):37’7-87; & Cookson MR, Shaw PJ.
Oxidative stress and motor neurons disease. Brain Path01 1999 Jan;9( I): 165-86
( 4 97 ) Torres-Aleman 1, Barrios V, Berciano J. The peripheral insulin-like growth factor system in amyotrophic
lateral sclerosis and in multiple sclerosis. Neurology 1998 Mar;50(3):772-6 ; & Dal1 R, Sonksen PH et al; The
effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis
In women and men. GH-2000 Study Group. J Clin Endocrinol Metab 2000 Nov;85( 1 I):4 193-200; & Pons S,
Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine
phosphatase calcineurin. J Biol Chem 2000 Dee 8;275(49):38620-5;
(498) Lai EC, Rudnicki SA. Effect of recombinant human insulin-like growth factor-1 on progression of ALS. A
placebo-controlled study. Neurology 1997 Dec;49(6): 162 l-30; & Yuen EC, Mobley WC. Therapeutic
applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Mol Med Today 1995
Sep; I (6):278-86; & Dore S, Kar S, Quirion R.
Rediscovering an old tiiend, IGF-I: potential use in the
treatment of neurodegenerative diseases. Trends Neurosci 1997 Aug;20(8):326-3 1; & Couratier P, Vallat JM.
Therapeutic effects of neurotrophic factors in ALS; Rev Neural (Paris). 2000 Dee; 156( 12): 1075-7. French.
(499) Van den Berghe G, Bowers C et al, Neuroendocrinology of prolonged critical illness: effects of
exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
J Clin Endocrinol Metab 1998 Feb;83(2):309-19.
(50l)AnthonyIacopino.
Conference
Paper,American
Academy of Periodontology
(AAP) at
the US National
Institutes
of Health
in Bethesda,
Maryland,
April,
2001;
&

Rosenberg IH.200l (502) Dr. www. www.. McColgan B. Meyer JS. Thyroid in Pregnancy. Thyroid antibodies and fetal loss. (506) Leistevuo J. R. paper given at American College for Advancement in Medicine. Vaccines are the largest cause of insulin-dependent diabetes in young children. Pieragostini E. Education. & Thienes.sdl. ISBN O-684-81849-3. Hypothyroidism and aging: The Rosses’ Survey. Committee on Appropriations. Mocchegiani E. & Chen M.. Smith. Bart Classen. Paffenberger. House of Representatives. & Dr.sdl.con/news/connections/vol12/conn200104 I 1.com/ (503) Rupp. (5 13) (a) Valentino M. Fifth International Conference on Mercury. & (b) Nordlind K. & Dr..esdl. (methyl mercury sniffer) RNA ribose nucleic acid purpose of RNA is to take genetic information from DNA and translate it into proteins. Medical Neurolow. wwl~. Potential Occupational Hazards: Dentistrv. Engelhardt Jl. The Colorado thyroid disease prevalence study. Haley. Haddow JE. Pyy L. Jacques PI. Clincial Toxicology of Commercial Products. Canaris GJ. which subsequently fold-up to become enzymes. 5th Ed.C.1999. CRC Press. Philadelphia. 1984. Mitchell ML. National Health and Nutrition Examination Survey. Mosier DR. Vol II1. Ridgway EC.21 o-78-00 19. N. Moe S. Artherosclerosis 2001. & Katzung. Baltimore. www. Hadian D. Clinical Toxicolo. Health and Human Services.n. Orbregon MF.F. Atkins. Soliman A.html (5 12) Zeeman Mercury Spectrometer RA-9 15 Demonstration. 3975-3987. www. subcommittee on Labor. The Vitamin and Nutrient Solution to Chronic Health Problems.coticdiabetes. 10(9):821-827. Specific inhibition of rRNA transcription and dynamic relocation of fibrillarin induced by mercury. Williams. Releation of severity of maternal hypothyroidism to cognitive development of offspring. Basic Clinical Pharmacolow. Shanoudy H.Y. Term. p 1552. Veldhuis F. Toxicity of Mercury. Thyroid 2000. Sci Total Environ 200 1 Apr 10. Smith and D. April 16. and Related Agencies. Iranmanesh A.eom (509) Klein RZ. which make all of the compounds from which we are formed. Smith DR.tzv. 14th Edition.35(3): 163-6 (507) Appel SH. 7(2):146-52. Vo137. 3rd Ed. GSDL. Hefferen. de1 Rey FE. von Mikecz A. 1997. Santarelli L. 1979. Calcium: the Darth Vader of ALS.html (5 10) Morris MS. & Brenner. Williams HSmyth PPA.909shot. Dental amalgam fillings and the amount of organic mercury in human saliva.S. Nashville. Contract No.htm.html. Darke C. Vol 182. 160(4):526-34. Boca Raton. (505) Gilroy J. & Thyroid Imbalances in Pregnancy Linked to Poor Child Neurodelopment. 2nd Ed.comlnewsicrlnfiections/vrlll IIconn20niO228. 1972. Int Arch Allergy Appl lmmunol 1983. Caries Res 200 1 May-Jun. Arch Neural. Soleo L. Significance to health of mercury used in dental practice. June 1971. Macmillian Publishing Co. 1 l(1): 57-63. May 14. MD. May 23-28.Harris Coulter. Siklos L. Syracuse Research. Childhood Vaccinations and Juvenile-Onset (Type-l) Diabetes.C. Sargent JD. & Rao.gsdI. Russell D. Bostom AG. Rona. GSDL. Hodge. Mayor G. & Thyroid Dysfunction Linded to Elevated Cardiac Risk. & Thyroid Antibodies May Spur Pregnancy Loss. Biocompatibilitv of Dental Materials. J Med Screen 2001: 8:18-20. Great Smokies Diagnostic Lab.2 Suppl l:S47-54 (508) Bonar DB. Rio de Janeiro. Return to the Joy of Health. GSDL. Exp Cell Res . Larsen PR. Brazil.. Manowitz NR. (511) Abramson J. Snyder” Late EEG Findings and Clinical Status after organic mercury poisoning. Eds. Guttridge MG. In vitro inhibition of thymulin production in mercury-exposed thymus of young mice. 1998. Thyroid 2001. (504) Gosselin. J Card Fail 2001. Fl 1982. & de Escobar DM. Arch Tntem Med 2000. Waisbren Se. Early manifestations of “sick eythyroid syndrome” in patients with compensated chronic heart failure. Beers D. Lea & Febeger. Stimulating effect of mercuric chloride and nickel sulfate on DNA synthesis of thymocytes and peripheral lymphoid cells. Williams and Wilkins Publisher. May 1980. 155:195-200. & Merck Manuel.n.srvitamins.D. Reports of Councils and Bureaus.72(2): 177-179.con~lnews:connections!vclll2~conn2001041 I. www. 1980. Testimony before the Congress of the United States.. & GS Connection 1 l(12): Prevelence of Thyroid Imbalance. Is neuropsychological development related to mertnal hypothyroidism or to maternal hypothyroxinemia? C Clin Endocrin Metab 2000. 5th Ed. Osterblad M. Stagnaro-Green A. Selhub J. & Center for Chemical Hazard Assessment. Amyotroph Lateral Scler Other Motor Neuron Disord 2001 Mar.270( l-3): 109-l 12 . Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third U. JADA.

Med Lav 1995 Nov-Dee. & (b) el-Fawal HA. Jr. Acta Neuropathol (Berl) 2001 Nov. Cox JW. Brain Res Brain Res Rev 1999. Luster MI. Exposure to methyl mercury results in serum autoantibodies to neuro typic and gliotypic proteins. William P. J Neurol Neurosurg Psychiatry 1974. and cell death in neurodegeneration. Annu Rev lmmunol 1995. Lymphocyte sensitization to basic protein of brain in multiple scherosis and other neurological diseases. Inhibition of acetylcholine synthesis and tyrosine nitration induced by peroxynitrite are differentially prevented by antioxidants. Vol. (5 17) Earl C. (5 18) Landay AL. The shocking tooth about trigeminal neuralgia. Murray C. Gaudry-Talarmain YM. Giovanneli S. Neuroendocrine-immune system interactions and autoimmunity. Heavy metals and trace elements in amyotrophic lateral sclerosis. & Sienko DG.35:75-87. Sangyo lgaku 1993. Schmidt R. & 0 Dieter MP. 34:393-5.2(2):7 l-8 1. Cognitive dysfunction in patients with amyotrophic lateral sclerosis. Ducrocq C.47(4):524-7 (525) Cheshire. & Vanacore N. 2003 . Elveback LR. Dean JH. Mitochondrial degeneration in motor neurons triggers the onset of ALS in mice expressing a mutant SODI gene.Mitochrondrial mutations and oxidative pathology. Clin Infect Dis 1994.44: i89-95. Zinc ions stabilize the association of basic protein with brain myelin membranes. Kobayashi S. 86(6):522-33. p85 l-88. Henzi H. & (c) Pamham M. (521) Guermonprez L. Gong 2. Neurodegenerative disorders: the role of peroxynitrite. Matsubara K. 18: 136-4 1. Bonifati V. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Arch Neurol 1990. Blake D. “Relationship between exposure to environmental toxins and motor neuron disease: a case report”. Antecedent events in ALS: do they influence clincal onset and prgression? Neuroepidemiology 1990. Rheumatoid arthitis. O’Brien PC. Torreilles 1. Phenotypic and functional deficiency of natural killer cells in patients with CFS. Neurochem Res 1995. 102(5):467-72 (523) CBS Television Network. Neurotoxicology 1996. & (c) Schwyzer RLJ. 18:324 I-50. 37:701-3. Bobba A. Sledge J. Fujirmura SF..60(4):838-46. 139:3306-13. Multiple sclerosis: plaques caused by 2-step demyelization? Med Hypothesis. 1983. & (b) Firestein GS. June 29. USA: WI3 Saunders Company 1997. television program narrated by Morley Safer. Corsi L. & Torreilles F. Fadem MB. Lenette ET. & (b) Wilder RL. Shimohama S.. & (b)Cassarino DS. Giovagnoli A. 9:255-62. & Caliguri M. (5 19) Kong J.” 60 Minutes”.2000. Lancet 199 I. Davis JP. Jessop C. Toxicol Appl Pharmacol 1983 Apr. Little AR. Taylor JA. J lmmunol 1987.259( 1):225-238. Amyotroph Lateral Scler Other Motor Neuron Disord 2001 Jun. (514) Kusaka Y. Chantry A. & Aoyama K. (Eds( Textbook of Rheumatology. & Barker E. Xu Z. Specificity of zinc binding to myelin basic protein. & ArmonC. 29: l-25.2000 Aug 25. Jameson CW. Arch Neural 1998: 55: 66-72. (520) Mitchell JD. 338:707-12. & Provinciali L. Immunological and biochemical responses in mice treated with mercuric chloride. 13:307-38. Ann Neural 2000 Apr. Mohammad N. & Riccio P. Immunologic abnormalities associated with CFS. chronic fatigue syndrome: clinical condition associated with immune activation. Kikuchi H. 4 1: 1077-84.30(2): 153-63. 9:255-62.is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala. Neurology 1991. 12:129-42. but not in the neostriatum. December 12. Doh-ura K. (522 ) Kawashima T. 1990 (524) Urushitani M. New England Journal of Medicine. RoelofsIverson RA. p. J Neurochem 1988. Occupational diseasescaused by exposure to sensitizing metals. The role of nitric oxide in amyotrophic lateral sclerosis. Mol Pharmacol 2001 Oct. Iwaki T.5(1):43-60. in:KelIey G. Buchwald D. Boorman GA. protective nuclear responses. 17:267-76. Mossner R. HarrisL. ALS and heavy metals. Antioxidants as antirheumatics. Agents Actions SuppI 1993. J Neurosci 1998. 342. ALS: A csse-control study following detection of a cluster in a small Wisconsin community. Fabrizio E. (5 15) Casspary EA. Guerin M. Neurology 1984. 20: 1107-13. 5 I:71 8-24.68(2):218-228. Neural Clin 1987 Feb. (5 16) Fassbender K. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in conditions such as MS: association with cerebra1 inflammation. Salman-Tabcheh S. Bennett JPJ. Meco G. Epidemiologic correlates of sporadic ALS.Brain Res Brain Res Rev 1999 Aug.

www.I (526)Ahlbom II. Illinois.l09 Suppl 6:911-933. Environ Health the Epidemiologic Literature on EMF and Health.com/Default. http://www. Linet M. Cardis E. P. Fecal Elements Test..O.oceansidemedicine. 2001 Dec.htm (528) Doctors Data Inc.com DNA or deoxyribose nucleic acid is what holds each cells genetic code or information. Savitz D.Box 111. 60186-01 I 1. Swerdlow A. Green A.doctorsdata. Vancouver Island. (527) Cline Medical Center. West Chicago. Review of Perspect .